Grow Solutions Holdings, Inc.
$2,000,000
4,000,000,000 SHARES OF COMMON STOCK
$0.0005 PER SHARE
This is the public offering of securities of Grow Solutions Holdings, Inc., a Nevada corporation. We are offering 4,000,000,000 shares of our common stock, par value $0.001 (“Common Stock”), at an offering price of $0.0005 per share (the “Offered Shares”) by the Company. This Offering will terminate on twelve months from the day the Offering is qualified, subject to extension for up to thirty (30) days as defined below or the date on which the maximum offering amount is sold (such earlier date, the “Termination Date”). The minimum purchase requirement per investor is 20,000,000 Offered Shares ($10,000); however, we can waive the minimum purchase requirement on a case-by-case basis in our sole discretion.
These securities are speculative securities. Investment in the Company’s stock involves significant risk. You should purchase these securities only if you can afford a complete loss of your investment. See the “Risk Factors“ section on page 8 of this Offering Circular.
No Escrow
The proceeds of this offering will not be placed into an escrow account. We will offer our Common Stock on a best effort’s basis. As there is no minimum offering, upon the approval of any subscription to this Offering Circular, the Company shall immediately deposit said proceeds into the bank account of the Company and may dispose of the proceeds in accordance with the Use of Proceeds.
Subscriptions are irrevocable and the purchase price is non-refundable as expressly stated in this Offering Circular. The Company, by determination of the Board of Directors, in its sole discretion, may issue the Securities under this Offering for cash, promissory notes, services, and/or other consideration without notice to subscribers. All proceeds received by the Company from subscribers for this Offering will be available for use by the Company upon acceptance of subscriptions for the Securities by the Company.
Sale of these shares will commence within two calendar days of the qualification date and it will be a continuous Offering pursuant to Rule 251(d)(3)(i)(F).
This Offering will be conducted on a “best-efforts” basis, which means our Officers will use their commercially reasonable best efforts in an attempt to offer and sell the Shares. Our Officers will not receive any commission or any other remuneration for these sales. In offering the securities on our behalf, the Officers will rely on the safe harbor from broker-dealer registration set out in Rule 3a4-1 under the Securities Exchange Act of 1934, as amended.
This Offering Circular shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the laws of any such state.
The Company is using the Offering Circular format in its disclosure in this Offering Circular.
Our Common Stock is traded in the OTCMarkets Pink Open Market under the stock symbol “GRSO.”
Investing in our Common Stock involves a high degree of risk. See “Risk Factors“ beginning on page 8 for a discussion of certain risks that you should consider in connection with an investment in our Common Stock.
| | Per Share | | Total Maximum |
Public Offering Price (1)(2) | | $ | 0.0005 | | | $ | 2,000,000.00 | |
Underwriting Discounts and Commissions (3) | | $ | 0.000 | | | $ | 0 | |
Proceeds to Company | | $ | 0.0005 | | | $ | 2,000,000.00 | |
(1) | We are offering shares on a continuous basis. See “Distribution – Continuous Offering. |
(2) | This is a “best efforts” offering. The proceeds of this offering will not be placed into an escrow account. We will offer our Common Stock on a best effort’s basis primarily through an online platform. As there is no minimum offering, upon the approval of any subscription to this Offering Circular, the Company shall immediately deposit said proceeds into the bank account of the Company and may dispose of the proceeds in accordance with the Use of Proceeds. See “How to Subscribe.” |
(3) | We are offering these securities without an underwriter. |
(4) | Excludes estimated total offering expenses, including underwriting discount and commissions, will be approximately $18,000 assuming the maximum offering amount is sold. |
Our Board of Directors used its business judgment in setting a value of $0.0005 per share to the Company as consideration for the stock to be issued under the Offering. The sales price per share bears no relationship to our book value or any other measure of our current value or worth.
THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION DOES NOT PASS UPON THE MERITS OF OR GIVE ITS APPROVAL TO ANY SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING CIRCULAR OR OTHER SOLICITATION MATERIALS. THESE SECURITIES ARE OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE COMMISSION; HOWEVER, THE COMMISSION HAS NOT MADE AN INDEPENDENT DETERMINATION THAT THE SECURITIES OFFERED ARE EXEMPT FROM REGISTRATION.
TABLE OF CONTENTS
We are offering to sell, and seeking offers to buy, our securities only in jurisdictions where such offers and sales are permitted. You should rely only on the information contained in this Offering Circular. We have not authorized anyone to provide you with any information other than the information contained in this Offering Circular. The information contained in this Offering Circular is accurate only as of its date, regardless of the time of its delivery or of any sale or delivery of our securities. Neither the delivery of this Offering Circular nor any sale or delivery of our securities shall, under any circumstances, imply that there has been no change in our affairs since the date of this Offering Circular. This Offering Circular will be updated and made available for delivery to the extent required by the federal securities laws.
In this Offering Circular, unless the context indicates otherwise, references to “Grow Solutions Holdings, Inc.”, “we”, the “Company”, “our” and “us” refer to the activities of and the assets and liabilities of the business and operations of Grow Solutions Holdings, Inc.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Some of the statements under “Summary”, “Risk Factors”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, “Our Business” and elsewhere in this Offering Circular constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “may”, “plan”, “potential”, “should”, “will” and “would” or the negatives of these terms or other comparable terminology.
You should not place undue reliance on forward looking statements. The cautionary statements set forth in this Offering Circular, including in “Risk Factors” and elsewhere, identify important factors which you should consider in evaluating our forward-looking statements. These factors include, among other things:
The speculative nature of the business;
Our reliance on suppliers and customers;
Our dependence upon external sources for the financing of our operations, particularly given that there are concerns about our ability to continue as a “going concern;”
Our ability to effectively execute our business plan;
Our ability to manage our expansion, growth and operating expenses;
Our ability to finance our businesses;
Our ability to promote our businesses;
Our ability to compete and succeed in highly competitive and evolving businesses;
Our ability to respond and adapt to changes in technology and customer behavior; and
Our ability to protect our intellectual property and to develop, maintain and enhance strong brands.
Although the forward-looking statements in this Offering Circular are based on our beliefs, assumptions and expectations, taking into account all information currently available to us, we cannot guarantee future transactions, results, performance, achievements or outcomes. No assurance can be made to any investor by anyone that the expectations reflected in our forward-looking statements will be attained, or that deviations from them will not be material and adverse. We undertake no obligation, other than as may be required by law, to re-issue this Offering Circular or otherwise make public statements updating our forward-looking statements.
SUMMARY
This summary highlights selected information contained elsewhere in this Offering Circular. This summary is not complete and does not contain all the information that you should consider before deciding whether to invest in our Common Stock. You should carefully read the entire Offering Circular, including the risks associated with an investment in the company discussed in the “Risk Factors” section of this Offering Circular, before making an investment decision. Some of the statements in this Offering Circular are forward-looking statements. See the section entitled “Cautionary Statement Regarding Forward-Looking Statements.”
Company Information
Grow Solutions Holdings Inc., a Nevada corporation, and its wholly owned subsidiaries, Pure Roots Holding, Ltd.(“Pure Roots”), a Wyoming Company, Pure Roots Holding Inc., a Saskatchewan Canada corporation, are the exclusive manufacturer of the AeroPod Grow Solution as well as designing and operating urban farms that also utilize the AeroPod grow system. The AeroPod Grow Solution has been tested since January 2017, by FarmBoys Design Corp., and has been able to yield high quality produce year-round. We plan on selling and using the Aeropods in four distinct business strategies. One, enter into lease to own agreements; and team up with purchasers of our AeroPods, they will deposit a portion of the purchase price and we will receive lease payments with the AeroPods being secured. Two, we will sell our AeroPods directly to purchasers who can finance the entire purchase, and then utilize the AeroPods to grow plants of their choice. Three, we will build our own AeroPods and grow and sell our own produce to consumers, under our Pure Roots Urban Farms brand, Four,we will have maintenance and operation agreements with our purchasers in order to assist with the entire growing process.
Our business strategy is structured into various operating divisions to attain penetration within our customer base and create opportunities and client relationships between our operating divisions. We have experienced personnel in each area of our business model in order to best facilitate the growth of our corporation., Our planned retail agricultural grow stores (“Urban Farms”) will be staffed with individuals knowledgeable in all products and growing needs.
Our AeroPods a vertical aeroponic system, licensed from FarmBoys Design Corp., mean plants are grown without soil by exposing roots to mineral nutrient solutions in a water misting that aims to reduce expenses associated with energy, water, space, and labor. Our system has been tested and testing has shown that our system can reduce water usage and produce healthy plants. Our system is fully scalable and allows potential clients to maximize their space with the ability to expand their AeroPod farms not only horizontally but vertically. We plan to sell our licensed proprietary vertical growing systems to farmers and produce growers who wish to establish higher produce sales yields. We plan to assemble all of our systems on and off site and utilize bulk sourced materials from outsourced manufacturers.
The Company plans on producing revenue from the sales of AeroPods, produce plant sales through our urban farms, design build construction management services and licensing fees. Our vertical grow columns and systems can also be adapted for a variety of other uses such as horticulture research, medicinal plant production, pharmaceutical plant production, plant cloning and hardwood propagation.
Additional revenue will come from construction of management services when consumers purchases our AeroPod system and engage our Company to coordinate design, procurement and construction work to assure that the whole project is completed and that the AeroPods operate as intended.
Future plans are to acquire or lease our own land and build our own urban farms using our AeroPod system tosell organic produce, under our brand Pure Roots Urban Farms., We plan to offer joint venture opportunities where we can establish and maintain farms in a joint venture format and provide them with profit sharing opportunities.
There is a potential for a conflict of interest between FarmBoys Design Corp., and the Company, as Mr. Chad Fischl, is the founder of FarmBoys Design Corp., and is the individual responsible for creating the AeroPod, he is also a Director of FarmBoys Design Corp. and has the ability to effect decisions over the Company’s operations through contractual arrangements. Mr. Fischl was our Chief Executive Officer and Director until his resignation on November 16, 2020 as an Officer and there remains the potential for a conflict of interest between the Company and FarmBoys Design Corp. because Mr. Fischl remains a Director. On November 16, 2020, Philip Sands was appointed to replace Mr. Fischl as the Company’s sole Officer and Mr. Sands is also a currentDirector.
Our fiscal year-end date is December 31.
Our mailing address is 230-111 Research Drive, Saskatoon SK, Canada S7N 3R2. Our telephone number is (306) 220-0484. Our websites are www.aerogrowmanufacturing.com, www.purerootsfarms.com, www.GRSOinvest.com and our email address is info@AeroGrowManufacturing.ca.
We do not incorporate the information on or accessible through our websites into this Offering Circular, and you should not consider any information on, or that can be accessed through, our websites a part of this Offering Circular.
Section 15(g) of the Securities Exchange Act of 1934
Our shares are covered by section 15(g) of the Securities Exchange Act of 1934, as amended that imposes additional sales practice requirements on broker/dealers who sell such securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouses). For transactions covered by the Rule, the broker/dealer must make a special suitability determination for the purchase and have received the purchaser’s written agreement to the transaction prior to the sale. Consequently, the Rule may affect the ability of broker/dealers to sell our securities and also may affect your ability to sell your shares in the secondary market.
Section 15(g) also imposes additional sales practice requirements on broker/dealers who sell penny securities. These rules require a one-page summary of certain essential items. The items include the risk of investing in penny stocks in both public offerings and secondary marketing; terms important to in understanding of the function of the penny stock market, such as bid and offer quotes, a dealers spread and broker/dealer compensation; the broker/dealer compensation, the broker/dealers’ duties to its customers, including the disclosures required by any other penny stock disclosure rules; the customers’ rights and remedies in cases of fraud in penny stock transactions; and, the FINRA’s toll free telephone number and the central number of the North American Securities Administrators Association, for information on the disciplinary history of broker/dealers and their associated persons.
Dividends
The Company has not declared or paid a cash dividend to stockholders since it was organized and does not intend to pay dividends in the foreseeable future. The board of directors presently intends to retain any earnings to finance our operations and does not expect to authorize cash dividends in the foreseeable future. Any payment of cash dividends in the future will depend upon the Company’s earnings, capital requirements and other factors.
Trading Market
Our Common Stock trades in the OTCMarkets Pink Open Market Sheets under the symbol “GRSO”.
THE OFFERING
______
Issuer: | | Grow Solutions Holdings, Inc. |
| | |
Securities offered: | | A maximum of 4,000,000,000 shares of our common stock, par value $0.001 (“Common Stock”) at an offering price of $0.0005 per share (the “Offered Shares”). (See “Distribution.”) |
| | |
Number of shares of Common Stock outstanding before the offering | | 2,792,045,990 shares issued and outstanding as of June 5, 2021 |
| | |
Number of shares of Common Stock to be outstanding after the offering | | 6,792,045,990 shares, if the maximum amount of Offered Shares are sold |
| | |
Price per share: | | $0.0005 |
| | |
Maximum offering amount: | | 4,000,000,000 shares at $0.0005 per share, or $2,000,000 (See “Distribution.”) |
| | |
Trading Market: | | Our Common Stock is trading on the OTC Markets Pink Open Market Sheets division under the symbol “GRSO.” |
| | |
Use of proceeds: | | If we sell all of the shares being offered, our net proceeds (after our estimated offering expenses) will be $1,982,000. We will use these net proceeds for working capital and other general corporate purposes. |
| | |
Risk factors: | | Investing in our Common Stock involves a high degree of risk, including:
Immediate and substantial dilution.
Limited market for our stock.
See “Risk Factors.“ |
RISK FACTORS
______
The following is only a brief summary of the risks involved in investing in our Company. Investment in our Securities involves risks. You should carefully consider the following risk factors in addition to other information contained in this Disclosure Document. The occurrence of any of the following risks might cause you to lose all or part of your investment. Some statements in this Document, including statements in the following risk factors, constitute “Forward-Looking Statements.”
Our business and future operations may be adversely affected by epidemics and pandemics, such as the recent COVID-19 outbreak.
We may face risks related to health epidemics and pandemics or other outbreaks of communicable diseases, which could result in a widespread health crisis that could adversely affect general commercial activity and the economies and financial markets of the country as a whole. For example, the recent outbreak of COVID-19, which began in China, has been declared by the World Health Organization to be a “pandemic,” has spread across the globe, including the United States of America. A health epidemic or pandemic or other outbreak of communicable diseases, such as the current COVID-19 pandemic, poses the risk that we, or potential business partners may be disrupted or prevented from conducting business activities for certain periods of time, the durations of which are uncertain, and may otherwise experience significant impairments of business activities, including due to, among other things, operational shutdowns or suspensions that may be requested or mandated by national or local governmental authorities or self-imposed by us, our customers or other business partners. While it is not possible at this time to estimate the impact that COVID-19 could have on our business, our customers, our potential customers, suppliers or other current or potential business partners, the continued spread of COVID-19, the measures taken by the local and federal government, actions taken to protect employees, and the impact of the pandemic on various business activities could adversely affect our results of operations and financial condition.
The price of our common stock may continue to be volatile.
The trading price of our common stock has been and is likely to remain highly volatile and could be subject to wide fluctuations in response to a range of factors, some of which are beyond our control or unrelated to our operating performance. In addition to the factors discussed in this “Risk Factors” section and elsewhere, these factors include: the operating performance of similar companies; the overall performance of the equity markets; the announcements by us or our competitors of acquisitions, business plans, or commercial relationships; threatened or actual litigation; changes in laws or regulations relating to our businesses; any major change in our board of directors or management; publication of research reports or news stories about us, our competitors, or our industry or positive or negative recommendations or withdrawal of research coverage by securities analysts; large volumes of sales of our shares of common stock by existing stockholders; and general political and economic conditions.
In addition, the stock market in general, and the market for developmental related companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies’ securities. This litigation, if instituted against us, could result in very substantial costs; divert our management’s attention and resources; and harm our business, operating results, and financial condition.
There are doubts about our ability to continue as a going concern.
The Company is an early stage enterprise and has commenced principal operations. The Company had no revenues and has incurred net losses of $1,409,753 for the year ended December 31, 2020. In addition, the Company incurred net losses of $186,179 for the three-month period ending March 31, 2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources, such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations, or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant dilutive effect on the Company’s existing stockholders.
The Company intends to overcome the circumstances that impact its ability to remain a going concern through a combination of the growth of revenues, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however, the Company may not have commitments from third parties for a sufficient amount of additional capital. The Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue its operations. The Company’s ability to obtain additional funding will determine its ability to continue as a going concern. Failure to secure additional financing in a timely manner and on favorable terms would have a material adverse effect on the Company’s financial performance, results of operations and stock price and require it to curtail or cease operations, sell off its assets, seek protection from its creditors through bankruptcy proceedings, or otherwise. Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants, and strategic relationships, if necessary, to raise additional funds, and may require that the Company relinquish valuable rights. Please see Financial Statements – Note 3. Going Concern for further information.
Risks Relating to Our Financial Condition
We have a history of losses and our future profitability is uncertain.
We have recently completed the testing phase of product development and plan to begin to sell and otherwise commercialize our AeroPod farming systems. Although we believe our product is ready for commercialization, we have only built and used one vertical farming system to date, which has been in operation since April 2017. We have incurred losses since we began our company and we will continue to have losses in the future as we incur additional expenses to execute our business plan, fuel our potential growth and conduct further research and development. We expect to make significant expenditures to commercialize our AeroPod farming system, further develop our business and make technology enhancements to our AeroPod farming system. We will have to begin to generate and sustain and increase revenues to achieve or maintain profitability. We may not generate sufficient revenues to achieve or maintain profitability in the future. We may incur significant losses in the future for a number of reasons, including those discussed in other risk factors and factors that we cannot foresee.
We will require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.
We will require additional financing in the near and long term to fully execute our business plan. Our success depends on our ability to raise such additional financing on reasonable terms and on a timely basis. Conditions in the economy and the financial markets may make it more difficult for us to obtain necessary additional capital or financing on acceptable terms, or at all. If we cannot secure sufficient additional financing, we may be forced to forego strategic opportunities or delay, scale back or eliminate further development of our goals and objectives, operations and investments or employ internal cost savings measures.
Accordingly, we will need to engage in continued equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of our common stock. Any debt financing, we secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be impaired, and our business may be harmed.
We are highly dependent on the services of our key executives, the loss of whom could materially harm our business and our strategic direction. If we lose key management or significant personnel, cannot recruit qualified employees, directors, officers, or other personnel or experience increases in our compensation costs, our business may materially suffer.
We are highly dependent on our management, specifically Philip Sands. If we lose key management or employees, our business may suffer. Furthermore, our future success will also depend in part on the continued service of our management personnel and our ability to identify, hire, and retain additional key personnel. We do not carry “key-man” life insurance on the lives of any of our executives, employees or advisors. We experience intense competition for qualified personnel and may be unable to attract and retain the personnel necessary for the development of our business. Because of this competition, our compensation costs may increase significantly.
We operate in a highly competitive environment, and if we are unable to compete with our competitors, our business, financial condition, results of operations, cash flows and prospects could be materially adversely affected.
We operate in a highly competitive environment. Our competition includes all other companies that are in the business of selling indoor growing equipment, urban farming systems and organic produce companies. A highly competitive environment could materially adversely affect our business, financial condition, results of operations, cash flows and prospects.
We may not be able to compete successfully with other established companies offering the same or comparable products and, as a result, we may not achieve our projected revenue and user targets.
If we are unable to compete successfully with other businesses in our existing markets, we may not achieve our projected revenue and/or customer targets. We compete with both start-up and established companies. Compared to our business, some of our competitors may have greater financial and other resources, have been in business longer, have greater name recognition and be better established in our markets.
Our financials are not independently audited, which could result in errors and/or omissions in our financial statements if proper standards are not applied.
Although the Company is confident with its accounting firm, we are not required to have our financials audited by a certified Public Company Accounting Oversight Board (“PCAOB”). As such, our accountants do not have a third party reviewing the accounting. Our accountants may also not be up to date with all publications and releases put out by the PCAOB regarding accounting standards and treatments. This could mean that our unaudited financials may not properly reflect up to date standards and treatments resulting misstated financials statements.
Our management has limited experience operating an OTC Markets reporting company and are subject to the risks commonly encountered by early-stage companies.
Although management of Grow Solutions Holdings, Inc. has experience in operating small companies, current management has not previously had to manage expansion while being an OTC Markets reporting company. Many investors may treat us as an early-stage company. Because we have a limited operating history, our operating prospects should be considered in light of the risks and uncertainties frequently encountered by early-stage companies in rapidly evolving markets. These risks include:
| ● | risks that we may not have sufficient capital to achieve our growth strategy; |
| | |
| ● | risks that we may not develop our products and service offerings in a manner that enables us to be profitable and meet our customers‘ requirements; |
| | |
| ● | risks that our growth strategy may not be successful; and |
| | |
| ● | risks that fluctuations in our operating results will be significant relative to our revenues. |
Our future growth will depend substantially on our ability to address these and the other risks described in this section. If we do not successfully address these risks, our business could be significantly harmed.
We have limited operational history in an emerging industry, making it difficult to accurately predict and forecast business operations.
As we have limited operations in our business and are yet to generate any revenue, it is extremely difficult to make accurate predictions and forecasts on our finances. This is compounded by the fact that we operate in the aeroponic indoor farming industry, which is rapidly transforming. There is no guarantee that our products or services will remain attractive to potential and current users as these industries undergo rapid change, or that potential customers will utilize our services.
Our lack of adequate D&O insurance may also make it difficult for us to retain and attract talented and skilled directors and officers.
In the future we may be subject to additional litigation, including potential class action and stockholder derivative actions. Risks associated with legal liability are difficult to assess and quantify, and their existence and magnitude can remain unknown for significant periods of time. To date, we have not obtained directors and officers liability (“D&O”) insurance. Without adequate D&O insurance, the amounts we would pay to indemnify our officers and directors should they be subject to legal action based on their service to the Company could have a material adverse effect on our financial condition, results of operations and liquidity. Furthermore, our lack of adequate D&O insurance may make it difficult for us to retain and attract talented and skilled directors and officers, which could adversely affect our business.
We expect to incur substantial expenses to meet our reporting obligations as an OTC Markets reporting company. In addition, failure to maintain adequate financial and management processes and controls could lead to errors in our financial reporting and could harm our ability to manage our expenses.
We estimate that it will cost approximately $60,000 annually to maintain the proper management and financial controls for our filings required as an OTC Markets reporting company. In addition, if we do not maintain adequate financial and management personnel, processes and controls, we may not be able to accurately report our financial performance on a timely basis, which could cause a decline in our stock price and adversely affect our ability to raise capital.
Risks Relating to our Common Stock and Offering
The Common Stock is thinly traded, so you may be unable to sell at or near ask prices or at all if you need to sell your shares to raise money or otherwise desire to liquidate your shares.
The Common Stock has historically been sporadically traded on the OTC Pink Sheets, meaning that the number of persons interested in purchasing our shares at, or near ask prices at any given time, may be relatively small or non-existent. This situation is attributable to a number of factors, including the fact that we are a small company which is relatively unknown to stock analysts, stock brokers, institutional investors and others in the investment community that generate or influence sales volume, and that even if we came to the attention of such persons, they tend to be risk-averse and would be reluctant to follow an unproven company such as ours or purchase or recommend the purchase of our shares until such time as we became more seasoned and viable. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer, which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot give you any assurance that a broader or more active public trading market for our common shares will develop or be sustained, or that current trading levels will be sustained.
The market price for the common stock is particularly volatile given our status as a relatively unknown company with a small and thinly traded public float, limited operating history, and relatively small revenues, which could lead to wide fluctuations in our share price. The price at which you purchase our shares may not be indicative of the price that will prevail in the trading market. You may be unable to sell your common shares at or above your purchase price, which may result in substantial losses to you.
The market for our shares of common stock is characterized by significant price volatility when compared to seasoned issuers, and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. The volatility in our share price is attributable to a number of factors. First, as noted above, our shares are sporadically traded. As a consequence of this lack of liquidity, the trading of relatively small quantities of shares may disproportionately influence the price of those shares in either direction. The price for our shares could, for example, decline precipitously in the event that a large number of our shares is sold on the market without commensurate demand, as compared to a seasoned issuer which could better absorb those sales without adverse impact on its share price. Secondly, we are a speculative investment due to, among other matters, our limited operating history and lack of revenue or lack of profit to date, and the uncertainty of future market acceptance for our potential products. As a consequence of this enhanced risk, more risk-averse investors may, under the fear of losing all or most of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than would be the case with the securities of a seasoned issuer. The following factors may add to the volatility in the price of our shares: actual or anticipated variations in our quarterly or annual operating results; acceptance of our inventory of games; government regulations, announcements of significant acquisitions, strategic partnerships or joint ventures; our capital commitments and additions or departures of our key personnel. Many of these factors are beyond our control and may decrease the market price of our shares regardless of our operating performance. We cannot make any predictions or projections as to what the prevailing market price for our shares will be at any time, including as to whether our shares will sustain their current market prices, or as to what effect the sale of shares or the availability of shares for sale at any time will have on the prevailing market price.
Shareholders should be aware that, according to SEC Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities. The possible occurrence of these patterns or practices could increase the volatility of our share price.
The market price of our common stock may be volatile and adversely affected by several factors.
The market price of our common stock could fluctuate significantly in response to a range of factors and events, including, but not limited to:
| ● | our ability to integrate operations, technology, products and services; |
| | |
| ● | our ability to execute our business plan; |
| | |
| ● | operating results below expectations; |
| | |
| ● | our issuance of additional securities, including debt or equity or a combination thereof; |
| | |
| ● | announcements of technological innovations or new products by us or our competitors; |
| | |
| ● | loss of any strategic relationship; |
| | |
| ● | industry developments, including, without limitation, changes in competition or practices; |
| | |
| ● | economic and other external factors; |
| | |
| ● | period-to-period fluctuations in our financial results; and |
| | |
| ● | whether an active trading market in our common stock develops and is maintained. |
In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of our common stock. Issuers using the Alternative Reporting standard for filing financial reports with OTC Markets are often subject to large volatility unrelated to the fundamentals of the company.
We do not expect to pay dividends in the foreseeable future; any return on investment may be limited to the value of our common stock.
We do not currently anticipate paying cash dividends in the foreseeable future. The payment of dividends on our common stock will depend on earnings, financial condition and other business and economic factors affecting it at such time as the board of directors may consider relevant. Our current intention is to apply net earnings, if any, in the foreseeable future to increasing our capital base and development and marketing efforts. There can be no assurance that the Company will ever have sufficient earnings to declare and pay dividends to the holders of our common stock, and in any event, a decision to declare and pay dividends is at the sole discretion of our board of directors. If we do not pay dividends, our common stock may be less valuable because a return on your investment will only occur if its stock price appreciates.
Our issuance of additional shares of Common Stock, or options or warrants to purchase those shares, would dilute your proportionate ownership and voting rights.
We are entitled under our articles of incorporation to issue up to 10,000,000,000 shares of common stock. We have issued and outstanding, as of June 15, 2021, 2,792,045,990 shares of common stock. In addition, we are entitled under our Articles of Incorporation to issue “blank check” preferred stock. Our board may generally issue shares of common stock, preferred stock, options, or warrants to purchase those shares, without further approval by our shareholders based upon such factors as our board of directors may deem relevant at that time. It is likely that we will be required to issue a large amount of additional securities to raise capital to further our development. It is also likely that we will issue a large amount of additional securities to directors, officers, employees and consultants as compensatory grants in connection with their services, both in the form of stand-alone grants or under our stock plans. We cannot give you any assurance that we will not issue additional shares of common stock, or options or warrants to purchase those shares, under circumstances we may deem appropriate at the time.
The elimination of monetary liability against our directors, officers and employees under our Articles of Incorporation and the existence of indemnification rights to our directors, officers and employees may result in substantial expenditures by our company and may discourage lawsuits against our directors, officers and employees.
Our Articles of Incorporation contains provisions that eliminate the liability of our directors for monetary damages to our company and shareholders. Our bylaws also require us to indemnify our officers and directors. We may also have contractual indemnification obligations under our agreements with our directors, officers and employees. The foregoing indemnification obligations could result in our company incurring substantial expenditures to cover the cost of settlement or damage awards against directors, officers and employees that we may be unable to recoup. These provisions and resulting costs may also discourage our company from bringing a lawsuit against directors, officers and employees for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation by our shareholders against our directors, officers and employees even though such actions, if successful, might otherwise benefit our company and shareholders.
We may become involved in securities class action litigation that could divert management’s attention and harm our business.
The stock market in general, and the shares of early stage companies in particular, have experienced extreme price and volume fluctuations. These fluctuations have often been unrelated or disproportionate to the operating performance of the companies involved. If these fluctuations occur in the future, the market price of our shares could fall regardless of our operating performance. In the past, following periods of volatility in the market price of a particular company’s securities, securities class action litigation has often been brought against that company. If the market price or volume of our shares suffers extreme fluctuations, then we may become involved in this type of litigation, which would be expensive and divert management’s attention and resources from managing our business.
As an OTC Markets reporting company, we may also from time to time make forward-looking statements about future operating results and provide some financial guidance to the public markets. Our management has limited experience as a management team in an OTC Markets reporting company and as a result, projections may not be made timely or set at expected performance levels and could materially affect the price of our shares. Any failure to meet published forward-looking statements that adversely affect the stock price could result in losses to investors, stockholder lawsuits or other litigation, sanctions or restrictions issued by the SEC.
Our common stock is currently deemed a “penny stock,” which makes it more difficult for our investors to sell their shares.
The SEC has adopted Rule 15g-9 which establishes the definition of a “penny stock,” for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require that a broker or dealer approve a person’s account for transactions in penny stocks, and the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.
In order to approve a person’s account for transactions in penny stocks, the broker or dealer must obtain financial information and investment experience objectives of the person and make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.
The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form sets forth the basis on which the broker or dealer made the suitability determination, and that the broker or dealer received a signed, written agreement from the investor prior to the transaction.
Generally, brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make it more difficult for investors to dispose of our common stock if and when such shares are eligible for sale and may cause a decline in the market value of its stock.
Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading, and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities, and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stock.
As an issuer of a “penny stock,” the protection provided by the federal securities laws relating to forward-looking statements does not apply to us.
Although federal securities laws provide a safe harbor for forward-looking statements made by a public company that files reports under the federal securities laws, this safe harbor is not available to issuers of penny stocks. As a result, we will not have the benefit of this safe harbor protection in the event of any legal action based upon a claim that the material provided by us contained a material misstatement of fact or was misleading in any material respect because of our failure to include any statements necessary to make the statements not misleading. Such an action could hurt our financial condition.
As an issuer not required to make reports to the Securities and Exchange Commission under Section 13 or 15(d) of the Securities Exchange Act of 1934, holders of restricted shares may not be able to sell shares into the open market as Rule 144 exemptions may not apply.
Under Rule 144 of the Securities Act of 1933, holders of restricted shares may avail themselves of certain exemptions from registration if the holder and the issuer meet certain requirements. As a company that is not required to file reports under Section 13 or 15(d) of the Securities Exchange Act, referred to as a non-reporting company, we may not, in the future, meet the requirements for an issuer under 144 that would allow a holder to qualify for Rule 144 exemptions. In such an event, holders of restricted stock would have to utilize another exemption from registration or rely on a registration statement to be filed by the Company registering the restricted stock. Although the Company currently plans to file either a form 10 or S-1 with the Commission upon the conclusion of the Regulation A offering, there can be no guarantee that the Company will be able to fulfill one of these registration statements, which could have an adverse effect on our shareholders.
While the Company does not have any current intentions to perform a reverse stock split, if a reverse stock split were to occur it may decrease the liquidity of the shares of our common stock.
If a reverse split were to occur the liquidity of the shares of our common stock may be adversely affected by that reverse stock split given the reduced number of shares that will be outstanding following that reverse stock split, especially if the market price of our common stock does not increase as a result of the reverse stock split.
The Company has no current intentions on seeking a reserve stock split of its stock; nonetheless we believe that it is a possibility that if a reverse split were to occur that the resulting market price of our common stock may not attract new investors, including institutional investors, and may not satisfy the investing requirements of those investors. Consequently, the trading liquidity of our common stock may not improve.
Although we do not have any current intentions on seeking a reverse split of our common stock, we believe that a higher market price of our common stock may help generate greater or broader investor interest, we cannot assure you that a reverse stock split, if one occurs, will result in a share price that will attract new investors.
We are classified as an “emerging growth company” as well as a “smaller reporting company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies will make our common stock less attractive to investors.
We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.
Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably opted out of the extended transition period for complying with new or revised accounting standards pursuant to Section 107(b) of the JOBS Act.
We could remain an “emerging growth company” for up to five years, or until the earliest of (i) the last day of the first fiscal year in which our annual gross revenues exceed $1 billion, (ii) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock that is held by non-affiliates exceeds $1.07 billion as of the last business day of our most recently completed second fiscal quarter, and (iii) the date on which we have issued more than $1 billion in non-convertible debt during the preceding three-year period.
Notwithstanding the above, we are also currently a “smaller reporting company.” Specifically, similar to “emerging growth companies,” “smaller reporting companies” are able to provide simplified executive compensation disclosures in their filings; are exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting firms provide an attestation report on the effectiveness of internal control over financial reporting; and have certain other decreased disclosure obligations in their SEC filings. Decreased disclosures in our SEC filings due to our status as an “emerging growth company” or “smaller reporting company” may make it harder for investors to analyze our results of operations and financial prospects.
Because directors and officers currently and for the foreseeable future will continue to control Grow Solutions Holdings, Inc., it is not likely that you will be able to elect directors or have any say in the policies of Grow Solutions Holdings, Inc.
Our shareholders are not entitled to cumulative voting rights. Consequently, the election of directors and all other matters requiring shareholder approval will be decided by majority vote. The directors, officers and affiliates of Grow Solutions Holdings, Inc., beneficially own a majority of our outstanding common stock voting rights. Due to such significant ownership position held by our insiders, new investors may not be able to affect a change in our business or management, and therefore, shareholders would have no recourse as a result of decisions made by management.
In addition, sales of significant amounts of shares held by our directors, officers or affiliates, or the prospect of these sales, could adversely affect the market price of our common stock. Management’s stock ownership may discourage a potential acquirer from making a tender offer or otherwise attempting to obtain control of us, which in turn could reduce our stock price or prevent our stockholders from realizing a premium over our stock price.
Risks Relating to Our Company and Industry
The following risks relate to our businesses and the effects upon us assuming we obtain financing in a sufficient amount.
If we are not able to sell our AeroPod farming systems to other users or acquire land to build our Pure Roots Urban Farms, then our business will not be able to grow.
We may not be able to raise sufficient capital to acquire land to build for our Pure Roots Urban Farms, develop our Pure Roots Urban Farms, expand production capacity, or market our AeroPod systems effectively. If we are not able to sell our AeroPod farming systems to other users or complete the construction of our own Pure Roots Urban Farms, we may not be able to generate sales, and as a result, we may never become profitable and our business prospects will suffer.
In order for us to compete and grow, we must attract, recruit, retain and develop the necessary personnel who have the needed experience.
Recruiting and retaining highly qualified personnel is critical to our success. These demands may require us to hire additional personnel and will require our existing management personnel to develop additional expertise. We face intense competition for personnel. The failure to attract and retain personnel or to develop such expertise could delay or halt the sales and licensing of our product. If we experience difficulties in hiring and retaining personnel in key positions, we could suffer from delays in our development, loss of customers and sales and diversion of management resources, which could adversely affect operating results. Our future consultants and advisors may be employed by third parties and may have commitments under consulting or advisory contracts with third parties that may limit their availability to us.
We may not be able to successfully compete against companies with substantially greater resources.
The industries in which we operate in general are subject to intense and increasing competition. Some of our competitors may have greater capital resources, facilities, and diversity of product lines, which may enable them to compete more effectively in this market. Our competitors may devote their resources to developing and marketing products that will directly compete with our product lines. Due to this competition, there is no assurance that we will not encounter difficulties in obtaining revenues and market share or in the positioning of our products. There are no assurances that competition in our respective industries will not lead to reduced prices for our products. If we are unable to successfully compete with existing companies and new entrants to the market this will have a negative impact on our business and financial condition.
We face significant competition for our AeroPod farming systems in the vertical farming industry.
The vertical farming industry is highly competitive, and we compete with a number of other companies that provide vertical farming systems to the vertical farming industry. Our ability to compete successfully in the case of our AeroPod farming systems and to manage our planned growth will depend primarily upon the following factors:
| ● | maintaining continuity in our management and key personnel; |
| ● | ability to react to competitive product and pricing pressures; |
| ● | the strength of our brand; |
| ● | increasing the productivity of our future sales employees; |
| ● | effectively marketing and selling our vertical farming systems; |
| ● | acquiring new customers for our vertical farming systems; |
| ● | ability to respond to service repair requests if necessary; |
| ● | developing and improving our operational, financial and management controls; |
| ● | developing and improving our information reporting systems and procedures; and |
| ● | the design and functionality of our vertical farming systems. |
Many of our competitors have greater financial, technical, product development, marketing and other resources than we do. These organizations may be better known than we are and may have more customers or users than we do. We cannot provide assurance that we will be able to compete successfully against these organizations, which may lead to lower customer satisfaction, decreased demand for our solutions, loss of market share or reduction of operating profits.
The forecasts of market growth included in this offering circular may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, we cannot assure you our business will grow at similar rates, if at all.
Growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. The forecasts contained in this offering circular may prove to be inaccurate. Even if these markets experience the forecasted growth described in this offering circular, we may not grow our business at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and uncertainties. Accordingly, the forecasts of market growth included in this offering circular should not be taken as indicative of our future growth.
The Company is Reliant On Farmboys Design Corp., as a Key Supplier and any material change to that relationship would adversely affect our operations.
The Company has entered into a Manufacturing Distribution and Marketing License and Trademark Agreement with FarmBoys Design, Corp., and will be reliant on positive and continuing relationships with such supplier. Mr. Fischl our former CEO and current Director, is also a Director of FarmBoys Design Corp., If FarmBoys Design Corp., takes steps to terminate that agreement, renegotiate the terms or otherwise limit our rights in that agreement or fails to comply with its obligations under this agreement (including if a key supplier were to become insolvent) could have a material adverse effect on the Company’s consolidated financial results and on your investment.
Unless we contract with other suppliers, our business will be entirely dependent upon the relationships with this one supplier. There can be no assurance that we will be able to sustain a relationship with our supplier or that our supplier will be able to meet our needs in a satisfactory and timely manner, or that we can obtain substitute or additional suppliers, when and if needed. Our reliance on a sole supplier involves a number of additional risks, including the absence of guaranteed capacity and reduced control over the distribution process, quality assurance, delivery schedules, production yields and costs, and early termination of, or failure to renew, contractual arrangements. A significant price increase, an interruption in supply from our supplier, or the inability to obtain additional suppliers, when and if needed, could have a material adverse effect on our business, results of operations and financial condition.
We could incur delays while we locate and engage qualified alternative suppliers, and we may be unable to engage alternative suppliers on favorable terms or at all. Any such disruption or increased expenses could harm our commercialization efforts and adversely affect our ability to generate sales.
After sales of our AeroPods begin, any reductions in future sales of our AeroPod farming systems will have an adverse effect on our profitability and ability to generate cash to fund our business plan.
The following factors, among others, could affect future market acceptance and profitability of our AeroPod farming systems:
| ● | the introduction of competitive or alternative vertical farming systems; |
| ● | changes in consumer preferences among vertical farming products; |
| ● | changes in awareness of the environmental impact of vertical farming; |
| ● | changes in consumer perception about the products of vertical farming; |
| ● | the level and effectiveness of our sales and marketing efforts; |
| ● | any unfavorable publicity regarding our vertical farming systems or similar systems; |
| ● | any unfavorable publicity regarding our brand; |
| ● | litigation or threats of litigation with respect to our vertical farming systems; |
| ● | the price of our vertical farming systems relative to other competing vertical farming systems; |
| ● | price increases resulting from rising commodity costs; |
| ● | regulatory developments affecting the manufacturing or marketing of our vertical farming systems; |
| ● | any changes in government policies and practices related to our vertical farming systems; and |
| ● | new science or research that disputes the utility of vertical farming products. |
Adverse developments with respect to the manufacturing or sale of vertical farming systems would significantly reduce our net sales and profitability and have a material adverse effect on our ability to maintain profitability and achieve our business plan.
We will rely on other companies to provide materials for our future vertical farming systems.
We will depend on suppliers and subcontractors to meet our contractual obligations to our future customers and conduct our operations. Our ability to meet our obligations to our customers may be adversely affected if suppliers or subcontractors do not provide the agreed-upon supplies or perform the agreed-upon services in compliance with customer requirements and in a timely and cost-effective manner. To build our AeroPod farming systems we will require pumps, tubing, plastic molds, electronics, wood, and other supplies. Likewise, the quality of our future AeroPod farming systems may be adversely impacted if companies from whom we acquire such items do not provide materials which meet required specifications and perform to our and our customers’ expectations. Our distributors and suppliers may be less likely than us to be able to quickly recover from natural disasters and other events beyond their control and may be subject to additional risks such as financial problems that limit their ability to conduct their operations. The risk of these adverse effects may be greater in circumstances where we may rely on only one or two distributors or suppliers for a particular material.
We plan to source certain materials from a number of third-party suppliers and, in some cases, single-source suppliers.
Although we believe that alternative suppliers will be available, the loss of any of our future material suppliers could adversely affect our results of operations and financial condition. Our inability to preserve the expected economics of these agreements could expose us to significant cost increases in future years.
We may fail to appropriately assess the suitability of our AeroPod farming system in a particular space.
We plan to build our scalable AeroPod system to fit our customer’s specifications. Although we plan to assess the particular space to ensure proper space access and load resistance, there is no guarantee that we will be able to ensure that our customer has complied with local and federal regulations, zoning laws or certification requirements necessary to build their vertical farm. Furthermore, although we plan to build our AeroPod farming system to comply with applicable local and federal regulations including but not limited to building safety, electrical safety and security guidelines, there is no guarantee that we will be able to do so. As a result, our brand image may be harmed, and our business and results of operations may suffer.
Our business is dependent upon suppliers.
We plan on entering into supply agreements with manufacturers. Nevertheless, we remain dependent upon a limited number of suppliers for our products. Although we do not anticipate difficulty in obtaining adequate inventory at competitive prices, we can offer no assurance that such difficulties will not arise. The extent to which supply disruption will affect us remains uncertain. Our inability to obtain sufficient quantities of products at competitive prices would have a material adverse effect on our business, financial condition and results of operations.
We cannot assure that we will earn a profit or that our products will be accepted by consumers.
Our business is speculative and dependent upon acceptance of our products by consumers. Our operating performance will be heavily dependent on whether or not we are able to earn a profit on the sale of our products. We cannot assure that we will be successful or earn any or enough revenue to make a profit, or that investors will not lose their entire investment.
We face an inherent risk of exposure to product liability claims in the event that the products we manufacture or sell allegedly cause personal injury.
We face an inherent risk of exposure to product liability claims in the event that the products we sell allegedly cause personal injury. Although we have not experienced any significant losses due to product liability claims, we may experience such losses in the future. While our suppliers maintain insurance against product liability claims but cannot be certain that such coverage will be adequate to cover any liabilities that we may incur, or that such insurance will continue to be available on acceptable terms. A successful claim brought against us in excess of available insurance coverage, or any claim that results in significant adverse publicity, could have a material adverse effect upon our business.
We may be unable to keep pace with changes in the aeroponic and urban farm industry that we plan to serve and advancements in technology as our business and market strategy evolves.
As changes in the aeroponic and urban farm industries we plan to serve occur or macroeconomic conditions fluctuate we may need to adjust our business strategies or find it necessary to restructure our operations or businesses, which could lead to changes in our cost structure, the need to write down the value of assets, or impact our profitability. We will also make investments in existing or new businesses, including investments in technology and expansion of our business plans. These investments may have short-term returns that are negative or less than expected and the ultimate business prospects of the business may be uncertain.
As our business and market strategy evolves, we also will need to respond to technological advances and emerging industry standards in a cost-effective and timely manner in order to remain competitive, better and more diagnostic products and web accessibility standards. The need to respond to technological changes may require us to make substantial, unanticipated expenditures. There can be no assurance that we will be able to respond successfully to technological change.
Risks Relating to the Internet
We are dependent on our telephone, Internet and management information systems for the sales, distribution and monitoring of our products.
Our success depends, in part, on our ability to provide prompt, accurate and complete service to our customers on a competitive basis and our ability to purchase and promote products, manage inventory, ship products, manage sales and marketing activities and maintain efficient operations through our telephone and management information systems. A significant disruption in our telephone, Internet or management information systems could harm our relations with our customers and the ability to manage our operations. We can offer no assurance that our back-up systems will be sufficient to prevent an interruption in our operations in the event of disruption in our management information systems, and an extended disruption in the management information systems could adversely affect our business, financial condition and results of operations.
Online security breaches could harm our business.
The secure transmission of confidential information over the Internet is essential to maintain consumer confidence in our website. Substantial or ongoing security breaches of our system or other Internet-based systems could significantly harm our business. Any penetration of our network security or other misappropriation of our users’ personal information could subject us to liability. We may be liable for claims based on unauthorized purchases with credit card information, fraud, or misuse of personal information, such as for unauthorized marketing purposes. These claims could result in litigation and financial liability. We will rely on licensed encryption and authentication technology to effect secure transmission of confidential information, including credit card numbers. It is possible that advances in computer capabilities, new discoveries or other developments could result in a compromise or breach of the technology we use to protect customer transaction data. We may incur substantial expense to protect against and remedy security breaches and their consequences. A party that is able to circumvent our security systems could steal our licensed proprietary information or cause interruptions in our operations. We cannot guarantee that our security measures will prevent security breaches. Any breach resulting in misappropriation of confidential information would have a material adverse effect on our business, financial condition and results of operations.
Government regulation and legal uncertainties relating to the Internet and online commerce could negatively impact our business operations.
Online commerce is rapidly changing, and federal and state regulation relating to the Internet and online commerce is evolving. The U.S. Congress has enacted Internet laws regarding online privacy, copyrights and taxation. Due to the increasing popularity of the Internet, it is possible that additional laws and regulations may be enacted with respect to the Internet, covering issues such as user privacy, pricing, taxation, content, copyrights, distribution, antitrust and quality of products and services. The adoption or modification of laws or regulations applicable to the Internet could harm our business operations.
Changing technology could adversely affect the operation of our website.
The Internet, online commerce, internet of things and online advertising markets are characterized by rapidly changing technologies, evolving industry standards, frequent new product and service introductions and changing customer preferences. Our future success will depend on our ability to adapt to rapidly changing technologies and address its customers’ changing preferences. However, we may experience difficulties that delay or prevent us from being able to do so.
Statements Regarding Forward-looking Statements
______
This Disclosure Statement contains various “forward-looking statements.” You can identify forward-looking statements by the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “would,” “could,” “should,” “seeks,” “approximately,” “intends,” “plans,” “projects,” “estimates” or “anticipates” or the negative of these words and phrases or similar words or phrases. You can also identify forward-looking statements by discussions of strategy, plans or intentions. These statements may be impacted by a number of risks and uncertainties.
The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance taking into account all information currently available to us. These beliefs, assumptions and expectations are subject to risks and uncertainties and can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements. You should carefully consider these risks before you make an investment decision with respect to our Securities. For a further discussion of these and other factors that could impact our future results, performance or transactions, see the section entitled “Risk Factors.”
USE OF PROCEEDS
If we sell all of the shares being offered, our net proceeds (after our estimated offering expenses of $18,000) will be $1,982,000. We expect to use these net proceeds for the following:
Shares Offered(% Sold) | | 4,000,000,000 Shares Sold (100%) | | 3,000,000,000 Shares Sold (75%) | | 2,000,000,000 Shares Sold (50%) | | 1,000,000,000 Shares Sold (25%) |
Gross Offering Proceeds | | $ | 2,000,000 | | | $ | 1,500,000 | | | $ | 1,000,000 | | | $ | 500,000 | |
Approximate Offering Expenses (1) | | | | | | | | | | | | | | | | |
Misc. Expenses | | | 3,000 | | | | 3,000 | | | | 3,000 | | | | 3,000 | |
Legal and Accounting | | | 15,000 | | | | 15,000 | | | | 15,000 | | | | 15,000 | |
Total Offering Expenses | | | 18,000 | | | | 18,000 | | | | 18,000 | | | | 18,000 | |
Total Net Offering Proceeds | | | 1,982,000 | | | | 1,482,000 | | | | 982,000 | | | | 482,000 | |
Principal Uses of Net Proceeds (2) | | | | | | | | | | | | | | | | |
Employee/Officers & Directors / Independent Contractor Compensation | | | 400,000 | | | | 300,000 | | | | 200,000 | | | | 100,000 | |
Acquisition/Investment | | | 1,000,000 | | | | 750,000 | | | | 500,000 | | | | 250,000 | |
Professional | | | 300,000 | | | | 225,000 | | | | 150,000 | | | | 75,000 | |
Other corporate | | | 282,000 | | | | 207,000 | | | | 132,000 | | | | 57,000 | |
Total Principal Uses of Net Proceeds | | | 1,982,000 | | | | 1,482,000 | | | | 982,000 | | | | 482,000 | |
Amount Unallocated | | | -0- | | | | -0- | | | | -0- | | | | -0- | |
The precise amounts that we will devote to each of the foregoing items, and the timing of expenditures, will vary depending on numerous factors.
As indicated in the table above, if we sell only 75%, or 50%, or 25% of the shares offered for sale in this offering, we would expect to use the resulting net proceeds for the same purposes as we would use the net proceeds from a sale of 100% of the shares, and in approximately the same proportions, until such time as such use of proceeds would leave us without working capital reserve. At that point we would expect to modify our use of proceeds by limiting our expansion.
The expected use of net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve and change. The amounts and timing of our actual expenditures, specifically with respect to working capital, may vary significantly depending on numerous factors. The precise amounts that we will devote to each of the foregoing items, and the timing of expenditures, will vary depending on numerous factors. As a result, our management will retain broad discretion over the allocation of the net proceeds from this offering.
In the event we do not sell all of the shares being offered, we may seek additional financing from other sources in order to support the intended use of proceeds indicated above. If we secure additional equity funding, investors in this offering would be diluted. In all events, there can be no assurance that additional financing would be available to us when wanted or needed and, if available, on terms acceptable to us.
DILUTION
______
If you purchase shares in this offering, your ownership interest in our Common Stock will be diluted immediately, to the extent of the difference between the price to the public charged for each share in this offering and the net tangible book value per share of our Common Stock after this offering.
Our historical net tangible book value as of March 31, 2021 was $(8,609,079) or $(0.0037) per then-outstanding share of our Common Stock. Historical net tangible book value per share equals the amount of our total tangible assets less total liabilities, divided by the total number of shares of our Common Stock outstanding, all as of the date specified.
The following table illustrates the per share dilution to new investors discussed above, assuming the sale of, respectively, 100%, 75%, 50% and 25% of the shares offered for sale in this offering (after deducting estimated offering expenses of $18,000):
Percentage of shares offered that are so | | | 100% | | | | 75% | | | | 50% | | | | 25% | |
Price to the public charged for each share in this offering | | $ | 0.0005 | | | $ | 0.0005 | | | $ | 0.0005 | | | $ | 0.0005 | |
Historical net tangible book value per share as of March 31, 2021 (1) | | | (0.0031 | ) | | | (0.0031 | ) | | | (0.0031 | ) | | | (0.0031 | ) |
Increase in net tangible book value per share attributable to new investors in this offering (2) | | | 0.0021 | | | | 0.0019 | | | | 0.0015 | | | | 0.0009 | |
Net tangible book value per share, after this offering | | | (0.001 | ) | | | (0.0012 | ) | | | (0.0016 | ) | | | (0.0021 | ) |
Dilution per share to new investors | | $ | (0.0015 | ) | | $ | (0.0017 | ) | | $ | (0.0021 | ) | | $ | (0.0026 | ) |
(1) | Based on net tangible book value as of March 31, 2021 of $(8,609,079) and 2,792,045,990 outstanding shares of Common stock as of June 15, 2021. |
(2) | After deducting estimated offering expenses of $18,000. |
DISTRIBUTION
This Offering Circular is part of an Offering Statement that we filed with the SEC, using a continuous offering process. Periodically, as we have material developments, we will provide an Offering Circular supplement that may add, update or change information contained in this Offering Circular. Any statement that we make in this Offering Circular will be modified or superseded by any inconsistent statement made by us in a subsequent Offering Circular supplement. The Offering Statement we filed with the SEC includes exhibits that provide more detailed descriptions of the matters discussed in this Offering Circular. You should read this Offering Circular and the related exhibits filed with the SEC and any Offering Circular supplement, together with additional information contained in our annual reports, semi-annual reports and other reports and information statements that we will file periodically with the SEC. See the section entitled “Additional Information” below for more details.
Pricing of the Offering
Prior to the Offering, there has been a limited public market for the Offered Shares. The public offering price was determined by the Company. The principal factors considered in determining the public offering price include:
| ● | the information set forth in this Offering Circular and otherwise available; |
| ● | our history and prospects and the history of and prospects for the industry in which we compete; |
| ● | our past and present financial performance; |
| ● | our prospects for future earnings and the present state of our development; |
| ● | the general condition of the securities markets at the time of this Offering; |
| ● | the recent market prices of, and demand for, publicly traded common stock of generally comparable companies; and |
| ● | other factors deemed relevant by us. |
Offering Period and Expiration Date
This Offering will start on or after the Qualification Date and will terminate at the Company’s discretion or, on the Termination Date.
Procedures for Subscribing
When you decide to subscribe for Offered Shares in this Offering, you should:
Contact us via phone or email.
| 1. | Electronically receive, review, execute and deliver to us a subscription agreement; and |
| 2. | Deliver funds directly by check wire or electronic funds transfer via ACH to the specified account maintained by us. |
Any potential investor will have ample time to review the subscription agreement, along with their counsel, prior to making any final investment decision. We shall only deliver such subscription agreement upon request after a potential investor has had ample opportunity to review this Offering Circular.
Right to Reject Subscriptions. After we receive your complete, executed subscription agreement and the funds required under the subscription agreement have been transferred to the escrow account, we have the right to review and accept or reject your subscription in whole or in part, for any reason or for no reason. We will return all monies from rejected subscriptions immediately to you, without interest or deduction.
Acceptance of Subscriptions. Upon our acceptance of a subscription agreement, we will countersign the subscription agreement and issue the shares subscribed at closing. Once you submit the subscription agreement and it is accepted, you may not revoke or change your subscription or request your subscription funds. All accepted subscription agreements are irrevocable.
No Escrow
The proceeds of this offering will not be placed into an escrow account. We will offer our Common Stock on a best effort’s basis primarily through an online platform. As there is no minimum offering, upon the approval of any subscription to this Offering Circular, the Company shall immediately deposit said proceeds into the bank account of the Company and may dispose of the proceeds in accordance with the Use of Proceeds at Management’s discretion.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion and analysis of our financial condition and results of our operations together with our consolidated financial statements and the notes thereto appearing elsewhere in this Offering Circular. This discussion contains forward-looking statements reflecting our current expectations, whose actual outcomes involve risks and uncertainties. Actual results and the timing of events may differ materially from those stated in or implied by these forward-looking statements due to a number of factors, including those discussed in the sections entitled “Risk Factors”, “Cautionary Statement regarding Forward-Looking Statements” and elsewhere in this Offering Circular. Please see the notes to our Financial Statements for information about our Critical Accounting Policies and Recently Issued Accounting Pronouncements.
Management’s Discussion and Analysis
The Company has had limited revenues from operations in each of the last two fiscal years, and in the current fiscal year.
Plan of Operation for the Next Twelve Months
The Company believes that the proceeds of this Offering will satisfy its cash requirements for the next twelve months. To complete the Company’s entire deployment of its business plan, it may have to raise additional funds in the next twelve months. Contemporaneously we will work to recruit experts in the field as well as seek partners and joint ventures to develop new products.
The Company expects to increase the number of employees at the corporate level.
RESULTS OF OPERATIONS
Working Capital | | March 31, 2021 $ | | December 31, 2020 $ |
Cash | | | 26,901 | | | | 32 | |
Current Assets | | | 26,901 | | | | 32 | |
Current Liabilities | | | (8,635,980 | ) | | | (8,712,589 | ) |
Working Capital (Deficit) | | | (8,609,079 | ) | | | (8,712,557 | ) |
Cash Flows for the Six Months Ended: | | March 31, 2021 $ |
Cash Flows provided by (used in) Operating Activities | | | (187,195 | ) |
Cash Flows provided by Financing Activities | | | 214,064 | |
Cash Flows used in Investing Activities | | | - | |
Net Increase (decrease) in Cash During Period | | | 26,869 | |
Results for the Three Months Ended March 31, 2021
Operating Revenues
The Company’s revenues were $nil for the three months ended March 31, 2021.
Cost of Revenues
The Company’s cost of revenues was $nil for the three months ended March 31, 2021.
Gross Profit
For the three months ended March 31, 2021, the Company’s gross profit was $nil.
General and Administrative Expenses
General and administrative expenses consisted primarily of consulting fees, professional fees, purchasing of office supplies, marketing and legal and accounting expenses. For the three months ended March 31, 2021, general and administrative expenses were $35,491.
Other Income (Expense)
Other income (expense) consisted of interest and financing costs of $(150,688). For the three months ended March 31, 2021, there was a loss of $(150,688) on total other expenses.
Net Income (loss)
Our net loss for the three months ended March 31, 2021, was $186,179. The loss for the three months ended March 31, 2021 was mainly composed of factors described above.
Liquidity and Capital Resources
The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. Since its inception, the Company has been funded by related parties and third parties, through capital investment and borrowing of funds.
At March 31, 2021, the Company had total current assets of $26,901 compared to $32 at December 31, 2020. Current assets consisted of cash. The increase in current assets $26,869 was primarily cash received for sales of common stock.
At March 31, 2021, the Company had total current liabilities of $8,835,980 compared to $8,712,589 at December 31, 2020. Current liabilities consisted primarily of the accounts payable and accrued expenses, settlement reserves, convertible notes and derivative liabilities. The decrease in our current liabilities was attributed to the decrease in the amounts accounts payable and accrued expenses of $396,926, partially offset by increases in settlements and convertible notes in amounts of $151,820 and $188,497, respectively.
We had negative working capital of $8,609,079 as of March 31, 2021 compared to $8,712,557 as of December 31, 2020.
Cashflow from Operating Activities
During the three months ended March 31, 2021, cash used in operating activities was $187,195. The cash used for operating activities was due to general and administrative expenses and payments for accounts payable and accrued expenses.
Results for the Year Ended December 31, 2020
Operating Revenues
The Company’s revenues were $nil for the year ended December 31, 2020.
Cost of Revenues
The Company’s cost of revenues was $nil for the year ended December 31, 2020.
Gross Profit
For the year ended December 31, 2020, the Company’s gross profit was $nil.
General and Administrative Expenses
General and administrative expenses consisted primarily of development costs. For the year ended December 31, 2020, general and administrative expenses were $783,839.
Other Income (Expense)
For the year ended December 31, 2020 there was $(625,914) in other income (expense) recorded by the Company.
Net Loss
Our net loss for the year ended December 31, 2020 was $(1,409,753). The net loss is influenced by the matters discussed in the other sections of the MD&A.
We have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive business activities. For these reasons, we have stated in our financial statements that there is substantial doubt that we will be able to continue as a going concern without further financing.
Future Financings.
We will continue to rely on equity sales of the Company’s common shares in order to continue to fund business operations. Issuances of additional shares will result in dilution to existing shareholders. There is no assurance that the Company will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our business plan.
Since inception, we have financed our cash flow requirements through issuance of common stock and loans from third parties. As we expand our activities, we may, and most likely will, continue to experience net negative cash flows from operations, pending receipt of revenues. Additionally, we anticipate obtaining additional financing to fund operations through common stock offerings, to the extent available, or to obtain additional debt to the extent necessary to augment our working capital. In the future we will need to generate sufficient revenues from sales in order to eliminate or reduce the need to sell additional stock or obtain additional loans. There can be no assurance we will be successful in raising the necessary funds to execute our business plan.
We anticipate that we will incur operating losses in the next twelve months. Our lack of operating history makes predictions of future operating results difficult to ascertain. Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development, particularly companies in new and rapidly evolving markets. Such risks for us include, but are not limited to, an evolving and unpredictable business model and the management of growth.
To address these risks, we must, among other things, obtain a customer base, implement and successfully execute our business and marketing strategy, continually develop and upgrade our business model and website, respond to competitive developments, and attract, retain and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial condition and results of operations.
Critical Accounting Policies and Use of Estimates
Use of Estimates
The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about collection of accounts and notes receivable, the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets.
Critical Accounting Policies
Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.
Management regularly evaluates the accounting policies and estimates that are used to prepare the financial statements. A complete summary of these policies is included in Note 1 and Note 2 of the Company’s unaudited financial statements. In general, management’s estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.
Recently Issued Accounting Pronouncements
The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
Off-Balance Sheet Arrangements
We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.
Quantitative and Qualitative Disclosures about Market Risk
In the ordinary course of our business, we are not exposed to market risk of the sort that may arise from changes in interest rates or foreign currency exchange rates, or that may otherwise arise from transactions in derivatives.
Contingencies
Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company, in consultation with legal counsel, evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates a potentially material loss contingency is not probable, but is reasonably possible, or is probable, but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
Relaxed Ongoing Reporting Requirements
Upon the completion of this Offering, we expect to elect to become a public reporting company under the Exchange Act. If we elect to do so, we will be required to publicly report on an ongoing basis as an “emerging growth company” (as defined in the Jumpstart Our Business Startups Act of 2012, which we refer to as the JOBS Act) under the reporting rules set forth under the Exchange Act. For so long as we remain an “emerging growth company”, we may take advantage of certain exemptions from various reporting requirements that are applicable to other Exchange Act reporting companies that are not “emerging growth companies”, including but not limited to:
| ● | not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act; |
| | |
| ● | taking advantage of extensions of time to comply with certain new or revised financial accounting standards; |
| | |
| ● | being permitted to comply with reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and |
| | |
| ● | being exempt from the requirement to hold a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. |
We expect to take advantage of these reporting exemptions until we are no longer an emerging growth company. We would remain an “emerging growth company” for up to five years, although if the market value of our Common Stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, we would cease to be an “emerging growth company” as of the following June 30.
If we elect not to become a public reporting company under the Exchange Act, we will be required to publicly report under the reporting rules set forth in Regulation A for Tier 1 issuers. The ongoing reporting requirements under Regulation A are more relaxed than for “emerging growth companies” under the Exchange Act. The differences include, but are not limited to, for Tier 1 issuers, being required to file only an exit report that details the termination or completion of the offering. The Company is not registering any shares under the Exchange Act and will not be required to file anything with the SEC after the termination of this Offering.
In either case, we will be subject to ongoing public reporting requirements that are less rigorous than Exchange Act rules for companies that are not “emerging growth companies”, and our stockholders could receive less information than they might expect to receive from more mature public companies.
Grow Solutions Holdings, Inc.
Summary
Grow Solutions Holdings Inc., a Nevada corporation, and its wholly owned subsidiaries, Pure Roots Holding, Ltd.(“Pure Roots”), a Wyoming Company and Pure Roots Holding Ltd., a Saskatchewan Canada corporation, are the exclusive manufacturer of the AeroPod Grow Solution as well as designing and operating urban farms that also utilize the AeroPod grow system. The AeroPod Grow Solution has been tested since 2017 in the cold semi-arid climate of Saskatoon, Canada and has been able to yield high quality produce year-round. We plan on selling and using the Aeropods in four distinct business strategies., We will enter into lease to agreements; team up with purchasers of our AeroPods, who will deposit a portion of the purchase price and then we will receive lease payments with the AeroPods being secured. We will sell our AeroPods directly to purchasers who can finance the entire purchase, who will then utilize the AeroPods to grow plants of their choice. We will build our own AeroPods and grow and sell our own produce to consumers, and lastly, we will utilize maintenance and operation agreements with our purchasers in order to assist with the entire growing process and maintenance of the AeroPods .
Our business strategy is structured into various operating divisions to attain penetration within our customer base and create opportunities and customer relationships between our operating divisions. We have experienced personnel in each area of our business model in order to best facilitate the growth of our corporation. Further, our planned retail agricultural grow stores will be staffed with individuals knowledgeable in all products and growing needs.
Corporate History
Grow Solutions Holdings, Inc. (formerly LightTouch Vein & Laser, Inc.) is a corporation incorporated under the laws of the State of Nevada on May 1, 1981 (the “Company”). The current focus of our Company is our AeroPod grow systems, which are a vertical aeroponic farming technology with what we believe to be an exceptional vertical farming system that uses technology to allow farmers to grow plants in a far higher density, using less water, energy and nutrients than classical farming or hydroponic systems based on our past results.
Commencing in 1999 the Company acquired two subsidiary corporations having the name of LightTouch Vein & Laser, Inc. that were incorporated under the laws of the states of Ohio and South Carolina, respectively.
During 2000 the Company or its aforementioned subsidiaries acquired The Charleston Dermatology and Cosmetic Surgery Center (“Charleston Dermatology”); Bluegrass Dermatology and Skin Surgery Center, P.S.C.; Center for Weight Control, P.S.C.; and Vanishing Point, Inc. (“Vanishing Point”); all of which became subsidiaries of the Company.
During 1999 and 2000, the Company conducted its business operations primarily through its subsidiaries and reported the results of its operations and its financial condition on a consolidated basis. Subsequent to the closing of the Vanishing Point acquisition in August 2000, financial difficulties arose which prevented the subsidiary corporations from operating profitably. Consequently, each of the Company’s subsidiaries ceased operations and, in most cases, filed for bankruptcy in the applicable federal court, the proceedings of which lasted in some cases through 2005.
In 2006, Ed Bailey was appointed as our Sole Officer and Director.
Acquisition of Grow Solutions, Inc.
On April 28, 2015, LightTouch Vein & Laser, Inc. (“LightTouch”) entered into an Acquisition Agreement and Plan of Merger (the “Grow Solutions Acquisition Agreement”) with Grow Solutions, Inc., a Delaware corporation (“Grow Solutions”) and LightTouch Vein & Laser Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of the Company (“LightTouch Acquisition”). Under the terms of the Grow Solutions Acquisitions Agreement, Grow Solutions merged with LightTouch Acquisition and became a wholly owned subsidiary of LightTouch. The Grow Solutions’ shareholders and certain creditors of LightTouch received 44,005,000 shares of the Company’s common stock in exchange for all of the issued and outstanding shares of Grow Solutions. Following the closing of the Grow Solutions Acquisition Agreement, Grow Solutions’ business became the primary focus of LightTouch, and Grow Solutions management assumed control of the management of LightTouch with the former director of LightTouch resigning upon closing of the Agreement.
Effective April 28, 2015, Ed Bailey resigned from his positions as the Sole Officer and director of the Company. There were no disagreements between Mr. Bailey and the Company or any officer or director of the Company.
Effective April 28, 2015, Jeffrey Beverly was appointed as a member of the Board of Directors:
Acquisition of One Love Garden Supply LLC
Effective May 13, 2015 (the “Closing Date”), LightTouch entered into an Acquisition Agreement and Plan of Merger (the “OneLove Acquisition Agreement’) with Grow Solutions Acquisition LLC, a Colorado limited liability company and a wholly owned subsidiary of LightTouch (“Grow Solutions Acquisition”), One Love Garden Supply LLC, a Colorado limited liability company (“OneLove”), and all of the members of OneLove (the “Members”). On the Closing Date, OneLove merged with Grow Solutions Acquisition and became a wholly owned subsidiary of LightTouch. Under the terms of the OneLove Acquisition Agreement, the Members received (i) 1,450,000 shares of LightTouch common stock (the “Equity”), (ii) Two Hundred Thousand Dollars (US $200,000) (the “Cash”), and (iii) a cash flow promissory note in the aggregate principal amount of $50,000 issued by OneLove in favor of the Members (the “Cash Flow Note”), whereby each fiscal quarter, upon LightTouch recording on its financial statements $40,000 in US GAAP Net Income (“Net Income”) from sales of LightTouch products (the “Net Income Threshold”), LightTouch shall pay to the Members 33% of LightTouch Net Income generated above the Net Income Threshold. The aforementioned obligations owed under the Cash Flow Note shall extinguish upon the earlier of (i) payment(s) by LightTouch in an amount equal to $50,000 in the aggregate or (ii) May 5, 2016 (collectively, the Cash Flow Note, the Equity, and the Cash, the “Consideration”). The Consideration provided to the Members was in exchange for all of the issued and outstanding membership interests of OneLove. Following the Closing Date, OneLove’s indoor and outdoor gardening supply business was acquired by LightTouch and LightTouch management assumed control of the management of OneLove with the former managing members of OneLove resigning from OneLove upon closing of the OneLove Acquisition Agreement.
On June 24, 2015, LightTouch filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to change its corporate name from LightTouch Vein & Laser, Inc. to Grow Solutions Holdings, Inc.
On August 3, 2015, the board of directors of Grow Solutions Holdings, Inc. (the “Company”), appointed Hon. Randy Avon, Leslie Bocskor, Howard Karasik, and William Hayde as members of the Company’s board of directors.
On September 1, 2015, Grow Solutions Holdings, Inc. (the “Company”) was informed that Hon. Randy Avon resigned from his position as a member of the board of directors of the Company, and all other positions to which he may have been assigned, regardless of whether he served in such capacity. The resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On June 7, 2017, the Company filed an amendment to its Articles of Incorporation (the “Amendment”) with the Secretary of State of the State of Nevada, which, among other things, established the designation, powers, rights, privileges, preferences and restrictions of the Series A Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”).
Among other provisions, each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) – (0.019607 x 5,000,000) = 102,036).
Fifty-one (51) shares of Series A Preferred Stock were authorized and fifty-one (51) shares of Series A Preferred Stock were issued to Grow Solutions Holdings, LLC, a Colorado limited liability company (the “LLC”) controlled equally by each member of the Board of Directors of the Company (the “Board”).
The Series A Preferred Stock has no dividend rights, no liquidation rights and no redemption rights, and was created primarily to be able to obtain a quorum and conduct business at shareholder meetings. All shares of the Series A Preferred Stock shall rank (i) senior to the Company’s common stock and any other class or series of capital stock of the Company hereafter created, (ii) pari passu with any class or series of capital stock of the Company hereafter created and specifically ranking, by its terms, on par with the Series A Preferred Stock and (iii) junior to any class or series of capital stock of the Company hereafter created specifically ranking, by its terms, senior to the Series A Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary.
Additionally, all of the issued and outstanding shares of Series A Preferred Stock will be forfeited and canceled by the LLC upon the earlier of (i) the Company closing a financing transaction whereby it receives an investment in an amount equal to at least $3,000,000, or (ii) twenty four (24) months from the filing date of the Amendment in the State of Nevada (the “Holding Period”), unless such Holding Period is extended by a majority vote of the Board. On May 25, 2019, by a unanimous vote of Directors of the Company the Series A Preferred Stock was extended for three years.
On October 26, 2017, the Board of Directors (the “Board”) of Grow Solutions Holdings, Inc., a Nevada corporation (the “Company”), appointed Mr. Gerard Danos as interim President of the Company and Ms. Jacquelyn Gogin and Ms. Alyce Schreiber as members of the Board, effective immediately upon the resignations.
On October 26, 2017, the Company was informed that Mr. Jeffrey Beverly voluntarily resigned as President of the Company, a member of the Board, and all other positions with the Company and the Subsidiaries to which he has been assigned regardless of whether he served in such capacity, effective immediately.
On October 26, 2017, Mr. Peter Lau, Mr. Leslie Bocskor, and Mr. Howard Karasik (the “Directors”) voluntarily resigned as members of the Board and all other positions with the Company and the Subsidiaries to which the Directors have been assigned, regardless of whether the Directors served in such capacity, effective immediately.
On November 20, 2017, the members of the Board of Directors (the “Board”) of Grow Solutions Holdings, Inc., a Nevada corporation (the “Company”), appointed Ms. Alyce Schreiber as Interim President, effective immediately upon the removal of Gerard Danos by the Board.
On March 5, 2019, Grow Solutions Holdings, Inc. (the “Company”) entered into a securities exchange agreement (the “Securities Exchange Agreement”) with the shareholders of Pure Roots Holding, Ltd., representing 100% of the outstanding shares thereof (collectively the “Seller”), and Pure Roots Holding, Ltd., a Wyoming corporation (“PRH”), whereby the Company purchased from the Seller 100% of the issued and outstanding restricted common stock of PRH in exchange for 85,000 shares of the Company’s newly created Series B Preferred Stock (the “Series B Preferred Stock”).
In connection with the Securities Exchange Agreement, Mr. William Hayde submitted his resignation from his positions as Executive Director and member of the Company’s Board of Directors (the “Board”), effective March 5, 2019. Mr. Hayde did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On March 5, 2019, in connection with the CEO Resignation, the Board appointed Mr. Chad Fischl as Chief Executive Officer, effective March 5, 2019.
On March 5, 2019, in connection with the CFO Resignation, the Board appointed Mr. Wayne Hansen as Chief Financial Officer, effective March 5,2019.
On March 5, 2019, the Secretary of State of the State of Nevada delivered confirmation of the effective filing of the Company’s Certificate of Amendment to its Certificate of Incorporation, which established 100,000 shares of the Company’s Series B Preferred Stock, having such designations, rights and preferences as set forth therein, as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Certificate of Incorporation and bylaws.
The holders of Series B Preferred Stock rank senior to the Company’s Common Stock and Series A Preferred Stock and will vote together with the holders of the Company’s Common Stock on an as-converted basis on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). In any such vote, the number of votes that may be cast by a holder shall be equal to one (1) vote for each share of Common Stock into which such holder’s outstanding shares of Series B Preferred Stock may be converted. Each holder shall be entitled to notice of all shareholder meetings (or requests for written consent) in accordance with the Company’s bylaws.
On March 19, 2019 the Company increased the number of authorized shares of stock from 100,000,000 to 2,000,000,000. The Nevada Secretary of State approved the increase.
On November 15, 2019, Mr. Hansen resigned as an Officer and Director of the Company. Mr. Hansen, did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On November 15, 2019, in connection with the CFO Resignation, the Board appointed Mr. Chad Fischl as Chief Financial Officer, effective November 15, 2019.
On January 9, 2020 the Company increased the number of authorized shares of stock from 2,000,000,000 to 4,000,000,000. The Nevada Secretary of State approved the increase.
On July 15, 2020 the Company increased the number of authorized shares of stock from 4,000,000,000 to 10,000,000,000. The Nevada Secretary of State approved the increase.
On November 16, 2020, the Company’s Board appointed Philip Sands as the Company’s Sole Officer and as a Director, and Mr. Chad Fischl resigned from hisOfficer position while remaining a Director with the Company.
Corporate Structure
The Company through it wholly owned subsidiary, Pure Roots Holding, Ltd. (a Wyoming company) owns Pure Roots Holding Canada Inc. (a Saskatchewan, Canada corporation) and operates through its brands AeroGrow and Pure Roots Urban Farms.
BUSINESS
_________
The following description of our business contains forward-looking statements relating to future events or our future financial or operating performance that involve risks and uncertainties, as set forth above under “Special Note Regarding Forward-Looking Statements.” Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors described in this Offering Circular, including those set forth above in the Special Cautionary Note Regarding Forward-Looking Statements or under the heading “Risk Factors” or elsewhere in this Offering Circular.
Our Business Overview
We are a vertical aeroponic farming technology company with an exceptional vertical farming system that uses technology to allow farmers to grow plants in higher density, using less water, energy and nutrients than classical farming or hydroponic systems based on past results.
Aeroponics is the process of growing plants in an air or mist environment without the use of soil or an aggregate medium (known as geoponics). Aeroponic culture differs from both conventional hydroponics and in-vitro (plant tissue culture) growing. Unlike hydroponics, which uses water as a growing medium and essential minerals to sustain plant growth, aeroponics is conducted without a growing medium.
Our system is fully scalable and allows our potential clients to maximize their space with the ability to expand their AeroPod farms not only horizontally but vertically. We plan to sell our licensed proprietary vertical growing systems to farmers and produce growers who wish to establish higher produce and sales yields. We plan to assemble all of our systems off site and utilize bulk sourced materials from outsourced manufacturers.
Potential Site Configurations (AeroGrow Cannabis Facility (left), Pure Roots Urban Farm (Right)
We plan to sell, license or build our own urban farms using our AeroPods systems for our future customers. We will offer support for purchasers of our systems. We will employ contractors and experienced construction workers to insure our AeroPod system is constructed to our high standards. Once the AeroPod system is constructed, we will perform a final test on the system to make sure everything is in working order, and that the customer is satisfied with the system.
The Company plans on producing additional streams of revenue from the sales of AeroPods, produce plant sales through our urban farms design management services and licensing fees. Our AeroPods are designed for the production of healthy aeroponic edible flowers and herbs. Our vertical grow columns and systems can also be adapted for a variety of other uses such as horticulture research, medicinal plant production, pharmaceutical plant production, plant cloning and hardwood propagation.
The Company will generate additional revenue from construction management services.
We are also planning to provide our Urban farmers services to help our AeroPod Farms, identify local restaurants, wholesale distribution, and even floral shops to distribute their produce.
Manufacturing Distribution and Marketing License and Trademark Agreement
In February 2019, the Company entered into a Manufacturing Distribution and Marketing License and Trademark Agreement (Distribution Agreement) with FarmBoys Design Corp. (“FarmBoys”), wherein the Company agreed to obtain the exclusive rights to manufacture, distribute, license and use all of the trademarks and licensed proprietary AeroPod technology from FarmBoys, for an initial period of five (5) years with an automatic renewal for another five (5) year period. In consideration of the rights granted by the Licensor, the Licensee shall pay to the Licensor a royalty equal to an amount of:
| (a) | 10% of the Net Purchase Price of any and all Aeropod Units and / or Nutrients manufactured using the Licensors designs and formulas and sold by Licensee; and |
| (b) | 10% of the Net Sales Price of any and all Urban Farms Produce vegetables and fruit that are grown using the Licensors designs and formulas and sold by Licensee; and |
| (c) | In respect of all Services sold by the Licensee that Licensor is contracted to perform, Licensor shall receive its cost plus an additional 15%; and |
| (d) | Additionally, $10,000 license fee is paid out per Aeropod vertical grow container sold within the Aeropod Unit upon receiving first down payment on Purchase Order from customer to the Licensee. |
The licensed products from FarmBoys, mean the designs created and prepared by the Licensor from which the Licensee shall manufacture the Aeropod Units, and alike and at the time of manufacture shall include any modifications, improvements, or amendments to the Designs devised or developed by the Licensor either before or during the term of this Agreement and notified to the Licensee. The FarmBoys Grow Package also includes the growing specifications and techniques created and prepared by the Licensor from which the Licensee shall use in order to grow the produce under the label of Urban Farms Produce, and alike and at the time of production shall include any modifications, improvements, or amendments to the Designs in regards to the growing of the produce in the Aeropod Units devised or developed by the Licensor either before or during the term of this Agreement and notified to the Licensee.
The following are some of the important termination clauses in the distribution agreement. Licensor shall have the right to immediately terminate this agreement by giving written notice to licensee in the event that licensee does any of the following:
| ● | After having commenced sale of the Licensed Products, fails to continuously sell Licensed Products for three (3) consecutive Royalty Periods; or |
| ● | Fails to obtain or maintain product liability insurance in the amount and of the type provided for herein; or |
| ● | Files a petition in bankruptcy or is adjudicated bankrupt or insolvent, or makes an assignment for the benefit of creditors, or an arrangement pursuant to any bankruptcy law, or if the licensee discontinues its business or a receiver is appointed for the licensee or for licensee’s business and such receiver is not discharged within thirty (30) days; or |
| ● | Breaches any of the provisions of this Agreement relating to the unauthorized assertion of rights in the Trademarks; or |
| ● | Fails, after receipt of written notice from licensor, to immediately discontinue the distribution or sale of the licensed products or the use of any packaging or promotional material which does not contain the requisite legal legends; or |
| ● | Fails to make timely payment of royalties when due two or more times during any twelve-month period. |
The Distribution Agreement is only assignable upon the agreement of all Parties involved. There is a potential for a conflict of interest between FarmBoys Design Corp., and the Company, as Mr. Chad Fischl, is the founder of FarmBoys Design Corp., and is the individual responsible for creating the AeroPod, he is also a Director of FarmBoys Design Corp. and has the ability to effect decisions over the Company’s operations through contractual arrangements. Mr. Fischl was our Chief Executive Officer and Director until his resignation on November 16, 2020 as an Officer and there remains the potential for a conflict of interest between the Company and FarmBoys Design Corp. because Mr. Fischl remains a Director. On November 16, 2020, Philip Sands was appointed to replace Mr. Fischl as the Company’s sole Officer.
The foregoing summary description of the terms of the Distribution Agreement may not contain all information that is of interest to the reader. The summary description of the Distribution Agreement also contains customary events of termination and cancellation. For further information regarding the terms and conditions of the Agreement, this reference is made to such agreement, which are filed as Exhibit 6.8 hereto and is incorporated herein by this reference.
Vertical Farming Industry
According to Global Market Insights, Inc., the global vertical farming market is expected to grow at a compound annual growth rate of 27%, from $2 billion in 2017 to over $13 billion by 2024. Growth in vertical farming is being driven by low labor costs, the proximity of vertical farms to consumer bases, accessibility to fresh produce, and the lack of pesticide usage.
Source: Global Market Insights, Inc.
The three main segments of vertical farming are hydroponics (the process of growing plants in sand, gravel, or liquid, with added nutrients but without soil), aeroponics (the process of growing plants in an air or mist environment without the use of soil), and aquaponics (waste produced by farmed fish or other aquatic animals supplies nutrients for plants grown hydroponically, which in turn purifies the water). While hydroponics technology is expected to continue to dominate the market over the next few years, aeroponics and aquaponics are expected to show rapid growth due to the lower water usage of the former and the rising adoption of the latter by small-scale systems due to cost benefits.
Vertical farming has grown at a rapid pace in the Asia-Pacific region due to declining food self-sufficiency and arable lands in the Asia-Pacific region. Much of this growth is projected to be due to Asian governments’ support of indoor agriculture ranging from national policy initiatives to subsidies.
Aeroponic / Hydroponic Industry - Background
Aeroponic technology is derived from hydroponics and occurs when plant roots are suspended in an air chamber and bathed with a water and a nutrient solution. We believe that the aeroponic technology used in our indoor agriculture AeroPod products is a technological advancement over all other hydroponic and aeroponic growing systems because plant roots are partially suspended in air and allowed direct access to oxygen, while being suffused in a highly oxygenated, nutrient rich solution. Based on published research, we believe the use of a well-designed and maintained aeroponic system can increase plant growth and yield when compared to other hydroponic or soil-based systems.
Until the development of the AeroPod products, several barriers prevented aeroponic technology from being incorporated into mainstream. Growing in a controlled, indoor environment is complex, requiring knowledge of plant growth responses to variables such as lighting, irrigation, temperature, humidity, CO2, and air pressure. Soil-less production increases the complexity of the system, requiring additional management of either the hydroponic or aeroponic nutrient solutions. Water is less tolerant than soil and the nutrient content, pH, and aeration of the solution must be monitored and maintained in a tight range to grow any crop successfully. This small margin of error often resulted in growers discarding used nutrient solution rather than recirculating it.
Traditional indoor grow facilities are typically housed in large warehouses, requiring high upfront costs, and tying the grower to a building of a set size. The high energy demands of heating and cooling a large structure and operating indoor lighting lower the efficiency and increase the costs of operating traditional hydroponic facilities. Furthermore, in these large open warehouses a single growing environment is used for multiple crops at different growth stages and can’t be targeted to individual crop needs.
Existing solutions to traditional soil-less growing systems have their own limitations. In other modular systems one-size-fits-all lighting, plant canopy overlap, and root space restrictions limit the selection of crops that can be grown. Growing plants on flat surfaces, either horizontal or vertical, restricts light access. As plants grow, they overlap each other and shade their neighbours, resulting in yield loss and uneven growth. In channel type systems shallow channel depth and presence of wicking materials further limits plant growth by restricting root space.
Although aeroponic technology was developed in the 1930’s, world-wide more and more large-scale urban crop production are now being cultivated through this technology. As the aeroponics provides a controlled environment which encompass the following:
● | | a consistent crop; |
● | | intelligent growth lights and natural light; |
● | | air filtration and circulation systems for controlling heat buildup (from the lights) and eliminate exhaust odors |
● | | aeroponics designed to ensure both water, oxygen, and nutrient management systems; and a computer control system to which provide ideal levels of nutrients, lights, air circulation, oxygen, and moisture requirements at all times. |
Advantages of the aeroponics systems are:• Faster growth • Higher yields • Better quality. • Reduced labour cost
● | | Reduced risk of disease and pests |
● | | Reduced nutrient costs |
● | | Reduced water requirements. |
● | | Scalable application |
● | | Less space and easier mobility of crops |
● | | Crops easier to harvest. |
Our AeroPods
Our AeroPods bring the aeroponic technology to the mainstream by offering a highly automated indoor environment that senses and adjusts growing conditions to meet plant demands. Our differentiated AeroPod products allow a wide range of crops to be grown while tailoring the canopy space, root space, and energy demand to the crop’s needs. The F1, C1, and N1 Series AeroPods come with pre-set lighting, irrigation, temperature, humidity, CO2, air pressure, nutrient dosing, and pH optimized for produce (F1), cannabis (C1), and nursery crops (N1).
Our plant monitoring and diagnostic tools that are in development will allow monitoring and response to plant stresses before visible symptoms are present. Our licensed proprietary grow products will take the guesswork out of soil-less production, allowing both experienced and inexperienced growers to consistently harvest a high-quality and high yielding crop.
The modular design of the AeroPod allows facilities to be constructed of many, individually controlled grow rooms. This feature allows multiple crops in different growth stages to be kept in their optimal growing conditions, while allowing facility size to be readily modified. The system features high efficiency LEDs, air re-balancing and recirculation, dehumidification, insulation, conditional outside air exchange, and off the grid capabilities. Automated nutrient solution balancing allows all unused water to be collected, re-balanced, and recirculated.
Unlike many other indoor growing systems, aeroponics provides a completely controlled environment. Our licensed proprietary growing system provides direct feed to the aeroponics based root system, and the AeroPod provides an enclosed air system for the entire facility. A centralized monitoring system ensures optimal temperature and ideal nutrients are delivered continually and consistently to the plants. This results in optimal growing conditions, superior quality, and superior yields. Our management system is designed to train employees to monitor the system as well as giving us the ability to monitor all of our client’s systems (if requested) to ensure continued optimality.
AeroPod Products
We currently offer three different indoor agriculture models with list prices ranging from approximately $200,000 – $260,000 (Canadian Funds) and differentiated based on the type of produce grown within: food, cannabis or nursery plants. The AeroPod product line has been a working development for over 2 years (Jan 2017) with the current R&D unit located at the University of Saskatchewan that has remained operational since being built.
Our AeroPod product line is divided into Series of AeroPods:
| ● | F1 Series AeroPod – Food Production |
| ● | C1 Series AeroPod – Cannabis Cultivation |
| ● | N1 Series AeroPod – Nursey for Establishing Plants (Applicable to both Food and Cannabis Production) |
| ● | E1 Series AeroPod – Modular Cannabinoid Extraction Facility – In Development |
Pure Roots Urban Farms, Ltd.
Overview
Pure Roots Urban Farms, plans to engage in aeroponic urban farming, employing the use of our AeroPods and related technology for organic farming that is based on sustainable agriculture with non-genetically modified organisms, as well as providing locally sourced fresh produce as our core priority.
Urban agriculture can be defined as growing fruits, herbs, and vegetables in cities, a process that is accompanied by many other complementary activities such as processing and distributing food, collecting and reusing food waste, water, and educating, organizing, and employing local residents. Urban agriculture, a new and emerging industry, is integrated in individual urban communities and neighborhoods by making use of underutilized indoor and outdoor space.
Through the use of our AeroPods systems we will create a local sustainable agriculture that will produce food, or other plant products using farming techniques that protect the environment, public health, and our communities.
Our Strategy
Pure Roots Urban Farms will bring urban farming to any city in the world and uses our AeroPods to grow fresh, healthy foods for consumers to purchase every day. This retail concept offers multiple ways for consumers to access fresh and healthy microgreens: live greens that are still growing in compostable trays, featuring harvested-to-order microgreens, freshly cut salads that are also harvested- to-order, and juices made with Aeropod grown greens.
The primary target market for the Pure Roots Urban Farms are the cities where fresh produce cannot be grown easily or at all due to the weather conditions (to dry, hot or cold) as well as whole food and grocery stores, markets, and suppliers to restaurants. Growing fresh and nutritious leafy greens despite all weather constrictions, the Pure Roots Urban Farms will be one of the most irreplaceable stores in the area.
Pure Roots Urban Farms – Beyond Organic / Hyper Local – Advantages
The Company is also developing the aerogrowmanufacturing.com and purerootsfarms.com websites to process orders for this international network of growers and to promote the Pure Roots brand, consisting of a diversified range of fruits, herbs, microgreens, and vegetables. Social media assets, the website, and print-on-demand recipes will be used to promote our crops, chefs, and restaurants that use Pure Roots Urban Farms produce. Revenues will be generated from the sale of Pure Roots Urban Farms – branded material as well as distribution and processing fees. Below are some more advantages to our Pure Roots Urban Farms:
Supply Local Markets
With transportation and food distribution costs expected to rise in the foreseeable future and with consumers increasingly interested in buying locally, there is an opportunity to supply growing environments such as the AeroPod to commercial growers within or close to urban markets. As costs associated to food distribution increase over time, more consumers will become interested in supporting local growers.
Smaller Footprint
With increasing populations and migration to urban areas, land costs in and around urban areas are expected to continue to rise over the coming decades. Because energy and food costs and demand are expected to rise in the foreseeable future, there is an opportunity to supply commercially viable growing environments that occupy a smaller footprint that is located in or around urban areas.
More Productive Year-Round
With climate change the increased risk of droughts, floods, cold and hot temperatures will continue to impact the availability of food year-round. As a result, there is a significant opportunity to supply a growing system such as the AeroPods that can grow produce year-round, provide more crops per year, and enjoy the profits associated with out-of-season production. In addition, there is an opportunity to supply AeroPods to areas not traditionally used to grow fresh produce because of inhospitable climate.
Healthier
With climate change and the consequential adverse weather conditions expected to compromise food security, there is an opportunity to supply AeroPods that can be controlled to provide a healthier growing environment that limits exposure to pathogens, root rot, humidity, fungi, algae, and excessive cold or heat.
Improved Growing System
With the increased cost of land and need to generate profits, there is an opportunity to supply growing systems to commercial farmers that will achieve higher plant densities than currently available, allow the development of healthier roots, and that use less water and nutrient solution.
Lower Cost Branding Solution for Local Suppliers
Smaller commercial growers cannot afford to brand their produce in the same way as larger commercial growers that have sophisticated websites that incorporate social media, professional packaging designs, and access to shelf space in supermarkets. As a result, there is an opportunity to allow smaller commercial growers to market their produce under a shared brand.
Growing Systems
Most traditional greenhouse operations grow plants on horizontal surfaces; train plants to grow upwards and may suspend or stack plants in racks to form multiple layers. Because artificial lighting solutions are so costly, lights are placed high above the plants to maximize coverage. We believe that growing horizontally is not an efficient use of space.
Licensed Proprietary Aeroponic Tower Design
Our aeroponics solution that we have licensed from FarmBoys Design Corp., was originally derived from over the counter aeroponics towers.
Our chosen Aeroponic Growing System allows plants to grow on multiple layers, positions lights closer to the plants, creates an ideal micro-climate for plants, and delivers light directly to leaves. In addition, the aeroponic nutrient delivery system oxygenates plant roots, delivers optimum droplet size for nutrient uptake, and only uses 20% of water and nutrients used by hydroponic systems.
Our Competition
The vertical farming industry is estimated to reach $3.88 Billion by 2020, at a CAGR of 30.7% between 2015 and 2020 based on a report by MarketsandMarkets, the world’s No. 2 firm in terms of annually published premium market research reports. There are several Companies operating vertical farms that are offering licensing and franchises based on proprietary systems and production methods. Our primary competitors are AeroFarms, Freight Farms, Growcer, CropBox, BrightFarms, and Edenworks. The following is a description of each competitor.
AeroFarms®: Founded in 2004, AeroFarms is an indoor agriculture group that uses aeroponics, LED lights, and growth algorithms. Its patented aeroponics growing system is a closed-loop system that does not use natural light or soil. The company claims the system uses 95% less water than field farming and 40% less than hydroponics.
Freight Farms: Launched in 2010, Freight Farms provides physical and digital solutions for creating local produce ecosystems. The company’s flagship product, The Leafy Green Machine™, is a complete hydroponic growing system capable of producing a variety of lettuces, herbs, and hearty greens. Assembled inside an upcycled shipping container, the prebuilt system includes all necessary components for commercial food production and enables anyone to grow fresh produce year-round. Leafy Green Machines can be monitored in real time from any location, and users can purchase supplies directly from their mobile devices.
Growcer is a Canadian organization that has developed a horizontal stacked hydroponics system to produce their crops. This is a widely used hydroponics method simply put into a shipping container. The horizontal grow shelves are stacked on top of one another making it a task to service and harvest higher levels of growth.
Crop Box is very similar to the Growcer system utilizing a stacked horizontal grow method. This method limits the variety of produce that can be grown. Crop Box markets their product as a “farm inside of a shipping container.”
BrightFarms: BrightFarms designs, finances, builds, and operates hydroponic greenhouses at, or near, grocery retailers — cutting time, distance, and cost from the produce supply chain. Founded in 2011, the company claims its system uses 80% less water, 90% less land, and 95% less shipping fuel than long-distance field-grown produce. The company currently has three farms located in Illinois, Virginia, and Pennsylvania and is in the process of opening a new location in Ohio.
Edenworks: Founded in 2013, Edenworks is creating a scalable local food supply. It operates aquaponic ecosystems that it claims use 95% less water than conventional farms, no pesticides, and no genetically modified organisms. The Brooklyn-based company services the local Whole Foods with two varietals of microgreens.
We will be a small competitor in the industry. Many of our competitors have substantially greater financial, marketing, personnel and other resources than we do.
Marketing
We will hire sales representatives who we train to sell our AeroPod farming systems. We will also market our products through our website and social media sites. Another marketing initiative for our products will be to advertise in farming and food related print and digital magazines. As we gain experience through these different marketing initiatives, we will make adjustments to spend more on those that we believe are most effective. Once we have demonstrated viable marketing options, we will seek to expand our business both nationally and internationally.
We market our products to customers desiring to grow all varieties of agricultural products. We do not intend to exclude the growers of any agricultural products, including cannabis, from our marketing efforts. As of the date of this report, we are developing and offering AeroPods (C1) specifically for cannabis. All our current AeroPods can be adapted for use by cannabis growers. Marketing our products in the U.S. in state and local jurisdictions where marijuana is legal is still uncertain due to the uncertain legal status of the growth, sale and use of cannabis due to conflicting laws under which what is illegal federally is to varying extents legal under certain state laws to the contrary [and even greater uncertainty as to what would constitute ancillary illegal activities such as aiding or abetting if any such direct actions are deemed illegal; and even if direct illegality laws were enforced, whether any ancillary related laws such as aiding and abetting would, if ever, be enforced]. We believe that if the cannabis industry were to become fully legal under both U.S. federal and state law, then this industry may well be where the most advances in technology related to our products could come from.
Target Markets
Today, an increasing number of food consumers want to know where and how their food is produced and are thus concerned about aspects such as the environmental impacts of food production, carbon footprints, and sustainability.
Governmental Regulation and Certification
We are not aware of any governmental regulations or approvals for any of our products or services.
As the possession and use of cannabis is illegal under the Federal Controlled Substances Act, we could be deemed to be aiding and abetting illegal activities through the equipment we intend to sell in the U.S. if such equipment is used by customers who intend to purchase and use our aeroponic and vertical farm framing systems to grow cannabis. Under Federal law, and more specifically the Federal Controlled Substances Act, the possession, use, cultivation, and transfer of cannabis is illegal. Our equipment could be used by persons or entities engaged in the business of possession, use, cultivation, and/or transfer of cannabis. As a result, law enforcement authorities, in their attempt to regulate the illegal use of cannabis, could seek to bring an action or actions against us, including, but not limited, to a claim of aiding and abetting another’s criminal activities. The Federal aiding and abetting statute provide that anyone who “commits an offense against the United States or aids, abets, counsels, commands, induces or procures its commission, is punishable as a principal.” 18 U.S.C. §2(a). However, we do not believe that the Company’s current and intended business as described in this Offering Circular violates federal law and believe we would prevail if any such action were brought against us.
Environmental Laws and Regulations
Our operations and properties are subject to laws and regulations relating to environmental protection, including those governing air emissions, water discharges and waste management, and workplace health and safety. In addition, certain of our products are regulated by the U.S. Environmental Protection Agency and comparable state regulatory agencies. For a discussion of risks related to compliance with environmental and health and safety laws and risks related to past or future releases of, or exposures to, hazardous substances, please refer to the section entitled “Risk Factors—Risks Related to Our Businesses.”
Seasonality
We do not expect any seasonality in our business.
Property
Our mailing address is 230-111 Research Drive, Saskatoon SK, Canada S7N 3R2. Our telephone number is (888) 352-0826.
Employees
Other than our Officers and Directors we have three full-time employees of our business or operations who are employed at will by Grow Solutions Holdings, Inc. We anticipate adding additional employees in the next 12 months, as needed. We do not feel that we would have any unmanageable difficulty in locating needed staff.
Intellectual Property
We may rely on a combination of patent, trademark, copyright, and trade secret laws in the United States as well as confidentiality procedures and contractual provisions to protect our licensed proprietary technology, databases, and our brand.
We have a policy of requiring key employees and consultants to execute confidentiality agreements upon the commencement of an employment or consulting relationship with us. Our employee agreements also require relevant employees to assign to us all rights to any inventions made or conceived during their employment with us. In addition, we have a policy of requiring individuals and entities with which we discuss potential business relationships to sign non-disclosure agreements. Our agreements with clients include confidentiality and non-disclosure provisions.
Legal Proceedings
We may from time to time be involved in various claims and legal proceedings of a nature we believe are normal and incidental to our business. These matters may include product liability, intellectual property, employment, personal injury cause by our employees, and other general claims. We are not presently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
MANAGEMENT
______
The following table sets forth information regarding our executive officers, directors and significant employees, including their ages as of June 15, 2021:
As of June 15, 2021, the Grow Solutions Holdings, Inc. had three full-time employees, and no part-time employees.
The directors and executive officers of the Company as of June 15, 2021 are as follows:
Name | | Position | | Age | | Date of Appointment | | Approx. Hours Per Week |
Chad Fischl | | Former President, CEO, CFO, Treasurer, Secretary and current Director | | 36 | | Resigned as an Officer on November 16, 2020 | | varies |
| | | | | | | | |
Wayne Hansen | | Former Treasurer, CFO, Director | | 72 | | Resigned November 15, 2019 | | |
| | | | | | | | |
Philip Sands | | Current President, CEO, CFO, Treasurer, Secretary and Director | | 60 | | November 16, 2020 | | |
On November 16, 2020, Mr. Chad Fischl resigned from his position as the Company’s sole officer but remains a director. On that date, the Board appointed Mr. Philip Sands as the Company’s sole officer and also as a director. Mr. Sands biography is as follows:
Philip A. Sands, Age 60, Chief Executive Officer, Chief Financial Officer, and Current Director. Mr. Philip Sands brings over 20 plus years of corporate business experience, business development, project management, investment consultation, and B2B sales experience within Small Business and Corporate America. Since January 2011, he has served in diverse companies with positions of Investment Consultant, Business Development Manager, Director of Investor Relations and Principle of small business. Within his consulting firm, Cold River Capital, Inc., he has helped his clients seek private capital through private equity and institutional investors. His work with small business owners and Small-Cap companies has helped to raise capital through debt & equity structured funding, acquisition and growth capital. With Mr. Sands, vast experience in management, technology and growing small companies, we are extremely excited to have him taking over our indoor vertical farming solutions.
Chad Fischl, Age 36, Former – Former Chief Executive Officer and CurrentDirector. During his last year of University, in 2007, Chad started his first company, Shutout Solutions Inc., now called YXE Labs. YXE Labs was originally in the business of importing from South Korea, with exclusivity in North America, Nano Silver products used in the application of deodorizing sports gear. Mr. Fischl was the Co-CEO of YXE Labs and was an integral part of the growth of the business with retailers and professional sports teams across North America, earning endorsements from many of those teams. Mr. Fischl helped grow YXE Labs from having three products in 2007 through to, in 2017, having over 25 various products in four different markets and with internal intellectual property surrounding many of these products. In 2017, Chad resigned from his position with YXE Labs in order to pursue his new ventures through FarmBoys Design Corps. (“FarmBoys”) and, in 2017, Chad started a new venture with a group of partners from various backgrounds in engineering, oil & gas, biology and sales and marketing to form FarmBoys. As the CEO and President of FarmBoys Chad has worked tirelessly with his diverse team to design the world’s most productive modular aeroponic farming units that come fully equipped with proprietary monitoring and automation to make growing aeroponically simple and predictable with very little human intervention.
Wayne Hansen, Age 72, Former Chief Financial Officer, Former Director: Mr. Hansen has an extensive history of corporate fiscal management, currently serving as the President of Caulfield Capital Management Inc., a position he has held since 2004. Before working with Caufield Capital Management, Inc., Mr. Hansen was a managing partner of Asia Liaison and a practice partner of BDO Dunwoody. While Wayne was a managing partner at Asia Liaison he was involved in the development of both short- and long-term strategic planning for the clients and company, he also was in charge of client development and retention. Mr. Hansen also has extensive experience in mergers and acquisitions and has been an officer and director of several publicly traded companies and is currently the CFO for Four Twenty Property Management, Inc., a publicly traded company currently quoted on the OTC Markets. Due to Mr. Hansen’s experience in financial oversight, public companies, mergers and acquisitions as well as his ability to manage both large and small projects, we believe that Mr. Hansen will be a valuable addition to our Company.
None of our officers or directors in the last five years has been the subject of any conviction in a criminal proceeding or named as a defendant in a pending criminal proceeding (excluding traffic violations and other minor offenses), the entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited such person’s involvement in any type of business, securities, commodities, or banking activities; a finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of federal or state securities or commodities law, which finding or judgment has not been reversed, suspended, or vacated; or the entry of an order by a self-regulatory organization that permanently or temporarily barred, suspended or otherwise limited such person’s involvement in any type of business or securities activities.
EXECUTIVE COMPENSATION
______
The following summary compensation table sets forth all compensation awarded to, earned by, or paid to our named executive Officer paid by us during the years ended December 31, 2019, and December 31, 2020, in all capacities for the accounts of our executives, including the Chief Executive Officer (CEO) and Chief Financial Officer (CFO):
SUMMARY COMPENSATION TABLE
Name and Principal Position | | Year | | Salary ($) | | Bonus ($) | | Stock Awards ($) | | Option Awards ($) | | Non-Equity Incentive Plan Compensation ($) | | Non-Qualified Deferred Compensation Earnings ($) | | All Other Compensation ($) | | Totals ($) |
| | | | | | | | | | | | | | | | |
Philip Sands Current President, Chief Executive Officer, Treasurer, and Director Chad Fischl, Former President, Chief Executive Officer, Treasurer, and Current Director | | | 2020 | | | | | | | $ | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | $ | 0 |
| | | 2019 | | | | | | | $ | 176,000 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | $ | 176,000 |
| | | 2020 | | | | | | | $ | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Wayne Hansen, Former Chief Financial Officer, Treasurer, Secretary and Director | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 2019 | | | | | | | $ | 16,000 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | $ | 16,000 |
Narrative Disclosure to Summary Compensation Table
There are no compensatory plans or arrangements, including payments to be received from the Company with respect to any executive Officer, that would result in payments to such person because of his or her resignation, retirement or other termination of employment with the Company, or its subsidiaries, any change in control, or a change in the person’s responsibilities following a change in control of the Company.
Outstanding Equity Awards at Fiscal Year-End
No executive Officer received any equity awards, or holds exercisable or unexercisable options, as of the year ended December 31, 2019.
OPTION AWARDS | | STOCK AWARDS |
Name | | Number of Securities Underlying Unexercised Options (#) Exercisable | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) | | Option Exercise Price ($) | | Option Expiration Date | | Number of Shares or Units of Stock that have not Vested (#) | | Market Value of Shares or Units of Stock that have not Vested ($) | | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that have not Vested ($) | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that have not Vested ($) |
(a) | | (b) | | (c) | | (d) | | (e) | | (f) | | (g) | | (h) | | (i) | | (j) |
None | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | 0 | | | 0 | | | | 0 | | | | 0 | | | | 0 | |
Long-Term Incentive Plans
There are no arrangements or plans in which the Company would provide pension, retirement or similar benefits for our Director or executive Officer.
Compensation Committee
The Company currently does not have a compensation committee of the Board of Directors. The Board of Directors as a whole determines executive compensation.
Compensation of Directors
Directors are permitted to receive fixed fees and other compensation for their services as Directors. The Board of Directors has the authority to fix the compensation of Directors. No amounts have been paid to, or accrued to, Directors in such capacity.
Director Independence
Our Board of Directors is currently composed of two members, Philip Sands and Chad Fischl. Neither Mr. Fischl nor Mr. Sands qualifies as an independent Director in accordance with the published listing requirements of the NASDAQ Global Market. The NASDAQ independence definition includes a series of objective tests, such as that the Director is not, and has not been for at least three years, one of the Company’s employees and that neither the Director, nor any of his family members has engaged in various types of business dealings with us. In addition, the Board of Directors has not made a subjective determination as to each Director that no relationships exist which, in the opinion of the Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a Director, though such subjective determination is required by the NASDAQ rules. Had the Board of Directors made these determinations, the Board of Directors would have reviewed and discussed information provided by the Directors and the Company with regard to each Director’s business and personal activities and relationships as they may relate to the Company and its management.
Security Holders Recommendations to Board of Directors
The Company welcomes comments and questions from the shareholders. Shareholders can direct communications to the Chief Executive Officer, Philip Sands, at our executive offices. However, while the Company appreciates all comments from shareholders, it may not be able to individually respond to all communications. Management attempts to address shareholder questions and concerns in press releases and documents filed with the SEC so that all shareholders have access to information about the Company at the same time. Philip Sands collects and evaluates all shareholder communications. All communications addressed to the Director and executive Officer will be reviewed by Philip Sands, unless the communication is clearly frivolous.
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
___________
During the last two full fiscal years and the current fiscal year or any currently proposed transaction, there is no transaction involving the Company, in which the amount involved exceeds the lesser of $120,000 or one percent of the average of the Company’s total assets at year-end for its last three fiscal years.
The Company subleases office and development facilities at cost one of its subsidiaries. The terms are month to month until the Company fully occupies the planned space. The currently monthly payments are $2,700.
The Company has a shared service agreement in place, whereby the CEO and executive officers of the Company and two related party companies are paid through Pure Roots Holding, Corp. a wholly-owned subsidiary of the Company.
During the year ended the Company entered into employment contracts with the CEO and the President of one of the operating divisions. The CEO owns 100% of the outstanding Preferred Series A shares and 9.4% of the Preferred Series B shares and the President of the operating division owns 4.7% of the outstanding Preferred Series B shares.
By virtue of the employment contracts each of the officers is entitled to an annual salary, cash bonus, and a number of common shares determined by a fixed monthly dollar value of shares set by the average of monthly trading prices of the stock.
Specifically, the officers are entitled to:
CEO – will receive a bonus of $90,000, monthly cash salary of $22,000 and $15,000 in common stock; and
The President of the operating divisions – will receive a bonus of $90,000, monthly salary of CDN 14,000 and $4,000 in common stock.
For the year ended the total stock compensation for the officers amounted to approximately $322,000. Unpaid salary has been fully accrued as of December 31, 2019. The bonuses (total of $180,000) and stock compensation (total of $187,000) portions of the agreements were amended to be contingent on achievement of specific sales goals in 2020.
Disclosure of Conflicts of Interest
There are no conflicts of interest between the Company and any of its officers or directors
Stock Options
We have not issued and do not have outstanding any options to purchase shares of our Common Stock. We do not have any stock option plans.
Share Purchase Warrants
None.
Indemnification of Directors and Officers
Our articles of incorporation provide that no Director or Officer shall be personally liable for damages for breach of fiduciary duty for any act or omission unless such acts or omissions involve intentional misconduct, fraud, knowing violation of law, or payment of dividends in violation of Section 78.300 of the Nevada Revised Statutes.
Our bylaws provide that we shall indemnify any and all of our present or former Directors and Officers, or any person who may have served at our request as Director or Officer of another corporation in which we own stock or of which we are a creditor, for expenses actually and necessarily incurred in connection with the defense of any action, except where such Officer or Director is adjudged to be liable for negligence or misconduct in performance of duty. To the extent that a Director has been successful in defense of any proceeding, the Nevada Revised Statutes provide that he shall be indemnified against reasonable expenses incurred in connection therewith.
We do not currently maintain standard policies of insurance under which coverage is provided (a) to our Directors, Officers, employees and other agents against loss arising from claims made by reason of breach of duty or other wrongful act, and (b) to us with respect to payments which may be made by us to such Officers and Directors pursuant to the above indemnification provision or otherwise as a matter of law, although we may do so in the future.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to Directors, Officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy and is, therefore, unenforceable.
Review, Approval or Ratification of Transactions with Related Parties
We have planned to adopt a related-party transactions policy under which our executive officers, directors, nominees for election as a director, beneficial owners of more than 5% of any class of our Common Stock, and any members of the immediate family of any of the foregoing persons are not permitted to enter into a related-party transaction with us without the consent of our audit committee. If the related party is, or is associated with, a member of our audit committee, the transaction must be reviewed and approved by another independent body of our Board of Directors, such as our governance committee. Any request for us to enter into a transaction with a related party in which the amount involved exceeds $120,000 and such party would have a direct or indirect interest must first be presented to our audit committee for review, consideration and approval. If advance approval of a related-party transaction was not feasible or was not obtained, the related-party transaction must be submitted to the audit committee as soon as reasonably practicable, at which time the audit committee shall consider whether to ratify and continue, amend and ratify, or terminate or rescind such related-party transaction. All of the transactions described above were reviewed and considered by, and were entered into with the approval of, or ratification by, our Board of Directors.
During the last two full fiscal years and the current fiscal year or any currently proposed transaction, there are transactions involving the issuer, in which the amount involved exceeds the lesser of $120,000 or one percent of the average of the issuer’s total assets at year-end for its last three fiscal years, except compensation awarded to executives.
Disclosure of Conflicts of Interest
There is a potential for a conflict of interest between FarmBoys Design Corp., and the Company, as Mr. Fischl, is the founder of FarmBoys Design Corp., and is the individual responsible for creating the AeroPod, he is also a Director of FarmBoys Design Corp. and he also has the ability to effect decisions over the Company’s operations through contractual arrangements. As Mr. Fischl was also our Chief Executive Officer and remains a current Director there is still the potential for a conflict of interest between the Company, Mr. Fischland FarmBoys Design Corp.
Except as described above, there are no conflicts of interest between the Company and any of its officers or directors.
Legal/Disciplinary History
None of Grow Solutions Holdings, Inc.’s Officers or Directors have been the subject of any criminal proceeding or named as a defendant in a pending criminal proceeding (excluding traffic violations and other minor offenses);
None of Grow Solutions Holdings, Inc.’s Officers or Directors have been the subject of any entry of an order, judgment, or decree, not subsequently reversed, suspended or vacated, by a court of competent jurisdiction that permanently or temporarily enjoined, barred, suspended or otherwise limited such person’s involvement in any type of business, securities, commodities, or banking activities;
None of Grow Solutions Holdings, Inc.’s Officers or Directors have been the subject of any finding or judgment by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission, the Commodity Futures Trading Commission, or a state securities regulator of a violation of federal or state securities or commodities law, which finding or judgment has not been reversed, suspended, or vacated; or
None of Grow Solutions Holdings, Inc.’s Officers or Directors has been the subject of any entry of an order by a self-regulatory organization that permanently or temporarily barred, suspended or otherwise limited such person’s involvement in any type of business or securities activities.
Board Composition
Our board of directors currently consists of two members. Each director of the Company serves until the next annual meeting of stockholders and until his successor is elected and duly qualified, or until his earlier death, resignation or removal. Our board is authorized to appoint persons to the offices of Chairman of the Board of Directors, President, Chief Executive Officer, one or more vice presidents, a Treasurer or Chief Financial Officer and a Secretary and such other offices as may be determined by the board.
We have no formal policy regarding board diversity. In selecting board candidates, we seek individuals who will further the interests of our stockholders through an established record of professional accomplishment, the ability to contribute positively to our collaborative culture, knowledge of our business and understanding of our prospective markets.
Board Leadership Structure and Risk Oversight
The board of directors oversees our business and considers the risks associated with our business strategy and decisions. The board currently implements its risk oversight function as a whole. Each of the board committees when established will also provide risk oversight in respect of its areas of concentration and reports material risks to the board for further consideration.
Code of Business Conduct and Ethics
Prior to one year from the date of this Offering’s qualification, we plan on adopting a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions. We will post on our website a current copy of the code and all disclosures that are required by law or market rules in regard to any amendments to, or waivers from, any provision of the code.
PRINCIPAL STOCKHOLDERS
______
The following table sets forth certain information known to us regarding beneficial ownership of our capital stock as of June 15, 2021 for (i) all executive officers and directors as a group and (ii) each person, or group of affiliated persons, known by us to be the beneficial owner of more than ten percent (10%) of our capital stock. The percentage of beneficial ownership in the table below is based on 2,792,045,990 shares of common stock deemed to be outstanding as of June 15, 2021.
Name of Officer/Director and Control Person | | Affiliation with Company | | Number of shares owned(1) | | Share type/class | | Ownership Percentage of Class Outstanding |
| | | | | | | | |
Philip Sands | | Current Officer / Director | | | — | | | N/A | | | 0 | % |
Chad Fischl | | Former Officer / Current Director | | | 51 | (2) | | Series A Preferred | | | 100 | % |
| | | | | | | | | | | | |
| | | | | 4,745 | (3) | | Series B Preferred | | | 4.7 | % |
Wayne Hansen | | Former Officer / Former Director | | | 0 | | | N/A | | | 0 | % |
Officers / Directors as a | | | | | 51 | (2) | | Series A Preferred | | | 100 | % |
Group | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | 4,745 | (3) | | Series B Preferred | | | 4.7 | % |
| (1 ) | For each shareholder, the calculation of percentage of beneficial ownership is based upon the aggregate voting power outstanding as of June 15, 2021, and shares of capital stock subject to options, warrants and/or conversion rights held by the shareholder that are currently exercisable or exercisable within 60 days, which are deemed to be outstanding and to be beneficially owned by the shareholder holding such options, warrants, or conversion rights. The total aggregate number of votes is approximately 2,792,045,990. The percentage ownership of any shareholder is determined by assuming that the shareholder has exercised all options, warrants and conversion rights to obtain additional securities and that no other shareholder has exercised such rights. |
| | | | | | |
| (2) | Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) – (0.019607 x 5,000,000) = 102,036). |
| | |
| | The Series A Preferred Stock has no dividend rights, no liquidation rights and no redemption rights, and was created primarily to be able to obtain a quorum and conduct business at shareholder meetings. All shares of the Series A Preferred Stock shall rank (i) senior to the Company’s common stock and any other class or series of capital stock of the Company hereafter created, (ii) pari passu with any class or series of capital stock of the Company hereafter created and specifically ranking, by its terms, on par with the Series A Preferred Stock and (iii) junior to any class or series of capital stock of the Company hereafter created specifically ranking, by its terms, senior to the Series A Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary. |
| (3) | The Company has Designated 100,000 shares as Series B Preferred Shares. The shares of Series B Preferred Stock have a par value of $0.001 and a liquidation value of $1,000 per share (the “Series B Liquidation Value”) and are convertible into 2,833 shares of Common Stock (the “Conversion Ratio”). The holders of shares of the Series B Preferred Stock shall be entitled to receive dividends out of any assets legally available, to the extent permitted by Nevada law, at an annual rate equal to 8% of the Series B Liquidation Value of such shares of Series B Preferred Stock, and shall accrue from the date of issuance of such shares of Series B Preferred Stock, payable quarterly in Common Stock valued at the closing trade price per share on the last trading day of the calendar quarter. |
INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS
Other than as reported herein, during the last two full fiscal years and the current fiscal year or any currently proposed transaction, there is no transaction involving the Company, in which the amount involved exceeds the lesser of $120,000 or one percent of the average of the Company’s total assets at year-end for its last three fiscal years.
DESCRIPTION OF SECURITIES
______
The Company’s Authorized Stock
We are authorized to issue Ten Billion (10,000,000,000) shares of common stock with a par value of $0.001 per share (the “Common Stock”) and twenty-five million (25,000,000) shares of preferred stock with a par value of $0.001 per share (the “Preferred Stock”), of which fifty-one (51) such shares have been designated as Series A Preferred Stock and one hundred thousand (100,000) shares have been designated as Series B preferred Stock.
Common Stock
No shareholders of the Corporation holding Common Stock have any preemptive or other right to subscribe for any additional unissued or treasury shares of stock or for other securities of any class.
Subject to the rights of holders of Preferred Stock, holders of Common Stock shall be entitled to receive such cash dividends as may be declared thereon by the Board from time to time out of assets of funds of the Corporation legally available, therefore.
Cumulative Voting. Except as otherwise required by applicable law, there shall be no cumulative voting on any matter brought to a vote of stockholders of the Corporation.
Except as otherwise required by Nevada corporation law, the Articles of Incorporation, or any designation for a class of Preferred Stock (which may provide that an alternate vote is required), (i) all shares of capital stock of the Corporation shall vote together as one class on all matters submitted to a vote of the shareholders of the Corporation; and (ii) the affirmative vote of a majority of the voting power of all outstanding shares of voting stock entitled to vote in connection with the applicable matter shall be required for approval of such matter.
Adoption of Bylaws. In the furtherance and not in limitation of the powers conferred by statute and the Articles of Incorporation, the Board is expressly authorized to adopt, repeal, rescind. alter or amend in any respect the bylaws of the Corporation.
Shareholder Amendment of Bylaws. The Bylaws may also be adopted, repealed, rescinded, altered or amended in any respect by the stockholders of the Corporation, but only by the affirmative vote of the holders of not less than a majority of the voting power of all outstanding shares of voting stock, regardless of class and voting together as a single voting class.
Removal of Directors. Except as may otherwise be provided in connection with rights to elect additional directors under specified circumstances, which may be granted to the holders of any class or series of Preferred Stock, any director may be removed from office only by the affirmative vote of the holders of not less than a majority of the voting power of the issued and outstanding stock entitled to vote. Failure of an incumbent director to be nominated to serve an additional term of office shall not be deemed a removal from office requiring any stockholder vote.
Preferred Stock
The powers, preferences, rights, qualifications, limitations and restrictions pertaining to the Preferred Stock, or any series thereof, shall be such as may be fixed, from time to time, by the Board in its sole discretion. Authority to do so being hereby expressly vested in the Board. The authority of the Board with respect to each such series of Preferred Stock will include, without limiting the generality of the foregoing, the determination of any or all of the following:
The number of shares of any series and the designation to distinguish the shares of such series from the shares of all other series: (1) the voting powers, if any, of the shares of such series and whether such voting powers are full or limited: (2) the redemption provisions, if any, applicable to such series, including the redemption price or prices to be paid; (3) whether dividends, if any, will be cumulative or noncumulative, the dividend rate or rates of such series and the dates and preferences of dividends on such series: (4) the rights of such series upon the voluntary or involuntary dissolution of, or upon any distribution of the assets of. the Corporation: (5) the provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable for, shares of any other class or classes of any other series of the same other any other class or classes of stock or any other security, of the Corporation or any other corporation or entity, and the rates or other determinants of conversion or exchange applicable thereto; (6) the right, if any, to subscribe for or to purchase any securities of the Corporation or any other corporation or other entity; (7) the provisions, if any. of a sinking fund applicable to such series: and (8) any other relative, participating, optional or other powers, preferences or rights, and any qualifications, limitations or restrictions thereof. of such series.
Series A Preferred Stock.
Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) – (0.019607 x 5,000,000) = 102,036).
The Series A Preferred Stock has no dividend rights, no liquidation rights and no redemption rights, and was created primarily to be able to obtain a quorum and conduct business at shareholder meetings. All shares of the Series A Preferred Stock shall rank (i) senior to the Company’s common stock and any other class or series of capital stock of the Company hereafter created, (ii) pari passu with any class or series of capital stock of the Company hereafter created and specifically ranking, by its terms, on par with the Series A Preferred Stock and (iii) junior to any class or series of capital stock of the Company hereafter created specifically ranking, by its terms, senior to the Series A Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary.
Series B Preferred Stock
The Company has Designated 100,000 shares as Series B Preferred Shares. The shares of Series B Preferred Stock have a par value of $0.001 and a liquidation value of $1,000 per share (the “Series B Liquidation Value”) and are convertible into 2,833 shares of Common Stock (the “Conversion Ratio”). The holders of shares of the Series B Preferred Stock shall be entitled to receive dividends out of any assets legally available, to the extent permitted by Nevada law, at an annual rate equal to 8% of the Series B Liquidation Value of such shares of Series B Preferred Stock, and shall accrue from the date of issuance of such shares of Series B Preferred Stock, payable quarterly in Common Stock valued at the closing trade price per share on the last trading day of the calendar quarter.
DIVIDEND POLICY
______
We have never declared or paid cash dividends on our capital stock. We currently intend to retain any future earnings for use in the operation of our business and do not intend to declare or pay any cash dividends in the foreseeable future. Any further determination to pay dividends on our capital stock will be at the discretion of our Board of Directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements, general business conditions, and other factors that our Board of Directors considers relevant.
SECURITIES OFFERED
______
Current Offering
Grow Solutions Holdings, Inc. (“Grow Solutions Holdings, Inc.,” “We,” or the “Company”) is offering up to $2,000,000 total of Securities, consisting of Common Stock, $0.001 par value (the “Common Stock” or collectively the “Securities”).
Transfer Agent
Our transfer agent is Transfer Online, whose address is 512 SE Salmon Street Second Floor, Portland Oregon 97214, telephone number (503) 227-2950, and email info@transferonline.com.
The transfer agent is registered under the Exchange Act and operates under the regulatory authority of the SEC and FINRA.
SHARES ELIGIBLE FOR FUTURE SALE
_____
Prior to this Offering, there has been a limited market for our Common Stock. Future sales of substantial amounts of our Common Stock, or securities or instruments convertible into our Common Stock, in the public market, or the perception that such sales may occur, could adversely affect the market price of our Common Stock prevailing from time to time. Furthermore, because there will be limits on the number of shares available for resale shortly after this Offering due to contractual and legal restrictions described below, there may be resales of substantial amounts of our Common Stock in the public market after those restrictions lapse. This could adversely affect the market price of our Common Stock prevailing at that time.
Rule 144
In general, a person who has beneficially owned restricted shares of our Common Stock for at least twelve months, in the event we are a reporting company under Regulation A, or at least six months, in the event we have been a reporting company under the Exchange Act for at least 90 days before the sale, would be entitled to sell such securities, provided that such person is not deemed to be an affiliate of ours at the time of sale or to have been an affiliate of ours at any time during the 90 days preceding the sale. A person who is an affiliate of ours at such time would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of shares that does not exceed the greater of the following:
| - | 1% of the number of shares of our Common Stock then outstanding; or the average weekly trading volume of our Common Stock during the four calendar weeks preceding the filing by such person of a notice on Form 144 with respect to the sale; |
provided that, in each case, we are subject to the periodic reporting requirements of the Exchange Act for at least 90 days before the sale. Rule 144 trades must also comply with the manner of sale, notice and other provisions of Rule 144, to the extent applicable.
LEGAL MATTERS
_____
Certain legal matters with respect to the shares of common stock offered hereby will be passed upon by Matheau J. W. Stout, Esq. of Hunt Valley, MD.
EXPERTS
______
The consolidated financial statements of the Company appearing elsewhere in this Offering Circular have been prepared by management and have not been reviewed by an independent accountant.
WHERE YOU CAN FIND MORE INFORMATION
______
We have filed with the SEC a Regulation A Offering Statement on Form 1-A under the Securities Act with respect to the shares of common stock offered hereby. This Offering Circular, which constitutes a part of the Offering Statement, does not contain all of the information set forth in the Offering Statement or the exhibits and schedules filed therewith. For further information about us and the common stock offered hereby, we refer you to the Offering Statement and the exhibits and schedules filed therewith. Statements contained in this Offering Circular regarding the contents of any contract or other document that is filed as an exhibit to the Offering Statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the Offering Statement. Upon the completion of this Offering, we will be required to file periodic reports, proxy statements, and other information with the SEC pursuant to the Securities Exchange Act of 1934. You may read and copy this information at the SEC’s Public Reference Room, 100 F Street, N.E., Room 1580, Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, including us, that file electronically with the SEC. The address of this site is www.sec.gov.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2021
INDEX TO THE CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (Unaudited)
GROW SOLUTIONS HOLDINGS, INC. AND SUBSIDARIES
CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited)
| | March 31, 2021 | | December 31, 2020 |
| | | | |
ASSETS | | | | |
Current Assets | | | | | | | | |
Cash | | $ | 26,901 | | | $ | 32 | |
| | | | | | | | |
Total Current Assets | | | 26,901 | | | | 32 | |
| | | | | | | | |
Total Assets | | $ | 26,901 | | | $ | 32 | |
| | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | | | | | | | | |
Current Liabilities: | | | | | | | | |
Accounts payable and accrued expenses | | $ | 1,297,190 | | | $ | 1,694,116 | |
Settlement reserves | | | 1,110,065 | | | | 958,245 | |
Convertible notes payable - net of discounts and premiums | | | 5,867,817 | | | | 5,679,320 | |
Derivative liabilities | | | 324,143 | | | | 324,143 | |
Unearned revenue | | | 36,765 | | | | 56,765 | |
| | | | | | | | |
Total Current Liabilities | | | 8,635,980 | | | | 8,712,589 | |
| | | | | | | | |
Total Liabilities | | | 8,635,980 | | | | 8,712,589 | |
| | | | | | | | |
Commitments and Contingencies (Note 10) | | | | | | | | |
| | | | | | | | |
Stockholders’ Deficit: | | | | | | | | |
Preferred stock - $0.001 par value: 51 shares authorized; 51 Series A preferred shares issued and outstanding, | | | 1 | | | | 1 | |
Preferred stock - par value $0.001: 100,000 shares authorized; 100,000 and 100,000 Series B Preferred shares, issued and outstanding, | | | 100 | | | | 100 | |
Common stock - $0.001 par value, 10,000,000,000 shares authorized, 2,349,678,523 and 1,875,799,430 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively | | | 2,349,676 | | | | 1,875,797 | |
Additional paid-in capital | | | 5,330,429 | | | | 5,514,651 | |
Accumulated deficit | | | (16,298,089 | ) | | | (16,111,910 | ) |
Accumulated other comprehensive income | | | 8,804 | | | | 8,804 | |
| | | | | | | | |
Total Stockholders’ Deficit | | | (8,609,079 | ) | | | (8,712,557 | ) |
| | | | | | | | |
Total Liabilities and Stockholders’ Deficit | | $ | 26,901 | | | $ | 32 | |
See accompanying notes to the condensed consolidated financial statements
GROW SOLUTIONS HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2021 AND 2020
(Unaudited)
| | For the Three Months Ended |
| | March 31, |
| | 2021 | | 2020 |
Operating Expenses: | | | | | | | | |
Selling, general, and administrative expenses | | $ | 35,491 | | | $ | 233,306 | |
Depreciation and amortization | | | — | | | | 3,336 | |
| | | | | | | | |
Total Operating Expenses | | | 35,491 | | | | 236,642 | |
| | | | | | | | |
Loss from Operations | | | (35,491 | ) | | | (236,642 | ) |
| | | | | | | | |
Other Income (Expenses): | | | | | | | | |
Gain on debt extinguishment | | | — | | | | 86,598 | |
Derivative liability income (expense) | | | — | | | | (47,249 | ) |
Change in fair market value of derivative liability | | | — | | | | 80,780 | |
Interest and financing costs | | | (150,698 | ) | | | (170,713 | ) |
| | | | | | | | |
Total Other Expenses | | | (150,698 | ) | | | (50,584 | ) |
| | | | | | | | |
Net Loss before Provision for Income Tax | | | (186,179 | ) | | | (287,226 | ) |
| | | | | | | | |
Provision for Income Tax | | | — | | | | — | |
| | | | | | | | |
Net Loss | | $ | (186,179 | ) | | $ | (287,226 | ) |
| | | | | | | | |
Basic and Diluted Loss Per Share | | $ | (0.0001 | ) | | $ | (0.0007 | ) |
| | | | | | | | |
Weighted Average Number of Common Shares Outstanding: | | | 2,130,351,829 | | | | 420,065,372 | |
| | | | | | | | |
Net Loss | | $ | (186,179 | ) | | $ | (287,226 | ) |
Foreign Currency Translation | | | — | | | | 707 | |
Total Comprehensive Income (Loss) | | $ | (186,179 | ) | | $ | (286,519 | ) |
See accompanying notes to the Condensed Consolidated financial statements
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN
STOCKHOLDERS’ DEFICIT FOR THE THREE MONTHS ENDED
MARCH 31, 2021 AND 2020
(Unaudited)
Three months ended March 31, 2021 and 2020
| | Preferred Stock Series A | | Preferred Stock Series B | | Common Stock | | Additional Paid In | | Accumulated | | Accumulated Other | | Stockholders’ (Deficit) |
| | Shares | | Amount | | Shares | | Amount | | Shares | | Amount | | Capital | | Deficit | | Comprehensive Income | | Equity |
Balance, December 31, 2020 | | | 51 | | | $ | 1 | | | | 100,000 | | | $ | 100 | | | | 1,875,799,430 | | | $ | 1,875,797 | | | $ | 5,514,651 | | | $ | (16,111,910 | ) | | | 8,804 | | | $ | (8,712,557 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash | | | — | | | | — | | | | — | | | | — | | | | 228,124,884 | | | | 228,125 | | | | (114,062 | ) | | | — | | | | — | | | | 114,063 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for debt settlement | | | — | | | | — | | | | — | | | | — | | | | 245,754,209 | | | | 245,754 | | | | (70,161 | ) | | | — | | | | — | | | | 175,593 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss for the three months ended March 31, 2020 | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | (186,179 | ) | | | — | | | | (186,179 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Other comprehensive income – foreign currency items | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance, March 31, 2021 | | | 51 | | | $ | 1 | | | | 100,000 | | | $ | 100 | | | | 2,349,678523 | | | $ | 2,349,676 | | | $ | 5,330,429 | | | $ | (16,298,089 | ) | | | 8,804 | | | $ | (8,609,079 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance December 31, 2019 | | | 51 | | | $ | 1 | | | | 100,000 | | | $ | 100 | | | | 333,666,887 | | | $ | 330,666 | | | $ | 6,284,074 | | | $ | (14,702,157 | ) | | $ | (6,222 | ) | | $ | (8,093,538 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for conversions of notes payable | | | — | | | | — | | | | — | | | | — | | | | 214,102,636 | | | | 214,102 | | | | (85,385 | ) | | | — | | | | — | | | | 128,717 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance for 3(a)(10) settlement | | | — | | �� | | — | | | | — | | | | — | | | | 64,641,000 | | | | 64,641 | | | | (64,641 | ) | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Settlements under 3(a)(10) | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 98,523 | | | | — | | | | — | | | | 98,523 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares issued - subscription | | | | | | | — | | | | — | | | | — | | | | 39,999,999 | | | | 40,000 | | | | 20,000 | | | | — | | | | — | | | | 60,000 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Put premiums reclassified in APIC at note conversions | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 25,572 | | | | — | | | | — | | | | 25,572 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss for the three months ended March 31, 2020 | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | (287,226 | ) | | | — | | | | (287,226 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Other comprehensive income – foreign currency items | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 707 | | | | 707 | |
Balance, March 31, 2020 | | | 51 | | | $ | 1 | | | | 100,000 | | | $ | 100 | | | | 649,410,522 | | | $ | 649,409 | | | $ | 6,278,143 | | | $ | (14,989,383 | ) | | $ | (5,515 | ) | | $ | (8,067,245 | ) |
See accompanying notes to the condensed consolidated financial statements
GROW SOLUTIONS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENT of CASH FLOWS
(Unaudited)
| | For the Three Months Ended |
| | March 31, |
| | 2021 | | 2020 |
Cash Flows from Operating Activities: | | | | | | | | |
Net loss | | $ | (186,179 | ) | | $ | (287,226 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | |
Depreciation | | | — | | | | 3,336 | |
Amortization of debt discounts | | | 1,769 | | | | 106,741 | |
Accretion of premium on convertible note | | | 86,728 | | | | — | |
Convertible notes issued for expenses | | | — | | | | 6,364 | |
Derivative expense | | | — | | | | 47,249 | |
Changes in fair market value of derivative liabilities | | | — | | | | (80,780 | ) |
Gain on debt extinguishment | | | — | | | | (86,598 | ) |
Common stock issued for expenses | | | — | | | | 4,100 | |
Changes in operating assets and liabilities: | | | | | | | | |
Unearned revenue | | | (20,000 | ) | | | — | |
Accounts payable and accrued expenses | | | 3,667 | | | | 216,662 | |
Settlement reserves | | | (73,180 | ) | | | — | |
Derivative liability | | | — | | | | 24,453 | |
| | | | | | | | |
Cash Used in Operating Activities | | | (187,195 | ) | | | (45,699 | ) |
| | | | | | | | |
Cash Flows from Investing Activities: | | | | | | | | |
Purchase of furniture, computers and equipment | | | — | | | | (22,438 | ) |
| | | | | | | | |
Cash Used in Investing Activities | | | — | | | | (22,438 | ) |
| | | | | | | | |
Cash Flows from Financing Activities: | | | | | | | | |
Proceeds from common stock issued from subscriptions | | | 114,067 | | | | 60,000 | |
Repayments of convertible notes | | | — | | | | (25,000 | ) |
Net proceeds from convertible notes issued | | | 100,000 | | | | 25,000 | |
| | | | | | | | |
Cash Provided by Financing Activities | | | 214,064 | | | | 60,000 | |
| | | | | | | | |
Net Increase (Decrease) in Cash | | | 26,869 | | | | (8,137 | ) |
| | | | | | | | |
Cash - beginning of year | | | 32 | | | | 8,153 | |
| | | | | | | | |
Cash - end of year | | $ | 26,901 | | | $ | 16 | |
| | | | | | | | |
Supplemental Disclosures of Cash Flow Information: | | | | | | | | |
Cash paid for: | | | | | | | | |
Interest and Taxes | | $ | — | | | $ | — | |
| | | | | | | | |
Noncash financing and investing activities: | | | | | | | | |
Accounts payable reclassified to settlement reserves | | $ | 225,000 | | | $ | — | |
Common stock issued for debt settlement | | $ | 175,593 | | | $ | — | |
Debt discounts | | $ | — | | | $ | 35,136 | |
Initial derivative liabilities | | $ | — | | | $ | 78,749 | |
Issuance of common stock for note conversions | | $ | — | | | $ | 128,717 | |
Reclassification of debt premium upon conversion | | $ | — | | | $ | 74,833 | |
See accompanying notes to the condensed consolidated financial statements
GROW SOLUTIONS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE
THREE MONTHS ENDED
MARCH 31, 2021 and 2020
(UNAUDITED)
Note 1 — Organization and Operations
Grow Solutions Holdings, Inc. (formerly known as LightTouch Vein & Laser, Inc. and Strachan, Inc.) (the “Company” or “GRSO”) was organized under the laws of the State of Nevada on May 1, 1981. The Company provided indoor and outdoor gardening supplies to the rapidly growing garden industry.
The Merger
Effective April 28, 2015, the Company entered into an Acquisition Agreement and Plan of Merger (the “the Merger”) with Grow Solutions, Inc., a Delaware corporation (“Grow Solutions”) and LightTouch Vein & Laser Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of the Company (“LightTouch Acquisition”). Under the terms of the Merger, Grow Solutions merged with LightTouch Acquisition and became a wholly owned subsidiary of the Company. The Grow Solutions’ shareholders and certain creditors of the Company received 44,005,000 shares of the Company’s common stock in exchange for all of the issued and outstanding shares of Grow Solutions. Following the closing of the Grow Solutions Agreement, Grow Solutions’ business became the primary focus of the Company and Grow Solutions management assumed control of the management of the Company with the former director of the Company resigning upon closing of the Agreement. Shareholders maintained 1,886,612 shares as part of the recapitalization.
As a result of the Merger, the Company discontinued its pre-Merger business. The Merger was accounted for as a “reverse merger,” and Grow Solutions, was deemed to be the accounting acquirer in the reverse merger. Consequently, the assets and liabilities and the historical operations that are reflected in the financial statements prior to the Merger are those of Grow Solutions and recorded at the historical cost basis and the consolidated financial statements after completion of the Merger include the assets and liabilities of Grow Solutions, historical operations of the Company, and operations of the Company and its subsidiaries from the closing date of the Merger. As a result of the issuance of the shares of the Company’s Common Stock pursuant to the Merger, a change in control of the Company occurred as of the date of consummation of the Merger. The Merger is intended to be treated as a tax-free exchange under Section 368(a) of the Internal Revenue Code of 1986, as amended. All historical share amounts of the accounting acquirer were retrospectively recast to reflect the share exchange.
Reverse Merger and Recapitalization
On March 5, 2019, the Company entered into a securities exchange agreement with the shareholders of Pure Roots Holding, Ltd., representing 100% of the outstanding shares thereof (collectively the “Seller “), and Pure Roots Holding, Ltd., a Wyoming corporation (“ PRH “), whereby the Company purchased from the Seller, 100% of the issued and outstanding restricted common stock of PRH in exchange for 85,000 restricted shares of the Company’s newly created Series B Preferred Stock (the “ Series B Preferred Stock “). The Seller subsequently distributed the Series B Preferred Stock of the Company to the shareholders of PRH.
The shares of Series B Preferred Stock have a par value of $0.001 and a liquidation value of $1,000 per share (the “Series B Liquidation Value”) and each share is convertible into 2,833 shares of common stock (the “Conversion Ratio”). The holders of shares of the Series B Preferred Stock shall be entitled to receive dividends out of any assets legally available, to the extent permitted by Nevada law, at an annual rate equal to 8% of the Series B Liquidation Value of such shares of Series B Preferred Stock, and shall accrue from the date of issuance of such shares of Series B Preferred Stock, payable quarterly in common stock valued at the closing trade price per share on the last trading day of the calendar quarter. The Series B shareholders have agreed to defer dividend rights until the Company earns sufficient revenues.
The holders of Series B Preferred Stock rank senior to the Company’s common stock and Series A preferred Stock and will vote together with the holders of the Company’s common stock on an as-converted basis on each matter submitted to a vote of holders of common stock (whether at a meeting of shareholders or by written consent). In any such vote, the number of votes that may be cast by a holder shall be equal to one (1) vote for each share of common stock into which such holder’s outstanding shares of Series B Preferred Stock may be converted. Each holder shall be entitled to notice of all shareholder meetings (or requests for written consent) in accordance with the Company’s bylaws. As a result of the issuance of the Series B Preferred Stock, there was a change in control of the Company as of the date of consummation of the Merger
On March 5, 2019, Chad Fischl, acquired control of 51 shares of the Series A Preferred Stock of the Company, representing 100% of the Company’s total issued and outstanding Series A Preferred Stock, from TCA Share Holdings, LLC a Limited Liability Company, in exchange for agreeing to become the President, Chief Executive Officer (CEO) and a Director.
The common stockholders of GRSO before the Merger (“Predecessor”) retained 92,497,617 shares of common stock, par value $0.001 per share. Upon the effectiveness of the Merger, the holders of the Predecessor’s Series A Preferred Stock tendered all 51 shares of the issued and outstanding Series A Preferred Stock to Chad Fischl. The Series A Preferred Stock has voting rights such that the 51 shares equated to 96,268,926 voting shares which represented 51% of the common voting rights, therefore the tender of the Series A Preferred Stock pursuant to the Merger, coupled with the issuance of the Series B Preferred Stock provides for the CEO to have had majority control over the Company as of the date of consummation of the Merger.
On March 5, 2019, in connection with the Chief Financial Officer Resignation, the Board appointed Mr. Wayne Hansen as Chief Financial Officer, effective March 5, 2019, and as a Director of the Company. Mr. Hansen resigned from both roles on November 15, 2019.
The Merger is being accounted for as a “Reverse Business Combination,” and PRH is deemed to be the accounting acquirer in the merger. Consequently, the assets and liabilities and the historical operations that will be reflected in the financial statements prior to the Merger will be those of PRH, and the consolidated financial statements after completion of the Merger will include the assets and liabilities of GRSO, historical operations of PRH and combined operations of PRH and GRSO from the Closing Date of the Merger.
The Merger will be treated as a recapitalization of the Company for financial accounting purposes. The historical financial statements of GRSO before the Merger will be replaced with the historical financial statements of PRH before the Merger in all future filings.
The financial condition and operating results of the combined entities since March 5, 2019, are included in the condensed consolidated financial statements.
The Company’s new businesses are based on design, development, manufacture, sales and distribution of licensed technologically advanced systems for organic and other agricultural products farming “AeroPods”. The AeroPod offers a high efficiency grow solution having scalable, secure and low carbon footprint characteristics. The new business commenced operations during the year ended December 31, 2019.
Note 2 — Going Concern and Management’s Plan
The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. For the three months ended March 31, 2021, the Company has incurred a net loss of $186,179. The working capital deficit, stockholders’ deficit and accumulated deficit was $8,609,079, $8,609,079, and $16,298,089, respectively, at March 31, 2021. The Company has received a default notice on its payment obligations under the senior secured credit facility agreement (see Note 4), defaulted on its other pre-merger debt and has received demands for payment of past due amounts from creditors, consultants and service providers. It is management’s opinion that these matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. The ability of the Company to continue as a going concern is dependent upon management’s ability to implement a new business plan, raise additional capital as needed from the sales of stock or debt or find a partner to merge with. The Company has been implementing cost containment measures and restructuring or setting up payment plans with vendors and is working to restructure its secured obligations. The accompanying consolidated financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.
Note 3 — Summary of Significant Accounting Policies Basis of presentation
The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Pure Roots Holding Corp. All significant intercompany accounts and transactions have been eliminated in consolidation.
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Use of estimates and assumptions
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the allowance for bad debt on accounts receivable, reserves on inventory, valuation of goodwill and intangible assets for impairment analysis, valuation of the legal settlement reserve, valuation of stock-based compensation, the valuation of derivative liabilities and the valuation allowance on deferred tax assets.
Concentration of credit risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal and/or Canadian depository insurance coverage of $250,000 and CDN$100,000, respectively. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2021, the Company had cash of $26,901. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash deposits. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”) and/or Canadian Depository Insurance Corporation (“CDIC”).
Debt Discount and Debt Issuance Costs
Debt discounts and debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense based on the related debt agreements using the straight-line method. Unamortized discounts are netted against the related debt instruments.
Convertible Notes with Fixed Rate Conversion Options
The Company may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the note date with a charge to interest expense in accordance with ASC 480 - “Distinguishing Liabilities from Equity”.
Derivative Liabilities
The Company has certain financial instruments that are derivatives or contain embedded derivatives. The Company evaluates all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 810-10-05-4 and 815-40. This accounting treatment requires that the carrying amount of any derivatives be recorded at fair value at issuance and marked-to-market at each balance sheet date. In the event that the fair value is recorded as a liability, as is the case with the Company, the change in the fair value during the period is recorded as either other income or expense. Upon conversion, exercise or repayment, the respective derivative liability is marked to fair value at the conversion, repayment or exercise date and then the related fair value amount is reclassified to other income or expense as part of gain or loss on extinguishment.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.
The Company adopted Section 815-40-15 of the FASB ASC (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions.
The Company utilizes a binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The Company records the change in the fair value of the derivative as other income or expense in the consolidated statements of operations.
Revenue Recognition
Effective October 1, 2018, the predecessor company adopted Accounting Standards Codification (“ASC”) 606, Revenue From Contracts With Customers, which is effective for public business entities with annual reporting periods beginning after December 15, 2017. This new revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied. The Company’s initial application of ASC 606 did not have a material impact on its financial statements and disclosures and there was no cumulative effect of the adoption of ASC 606.
The Company sells consumer products through distributors to retail establishments. The purchase orders received specifies each item sold, the Company only needs to fulfill the performance obligation by shipment of specified items. Allowances for returns and discounts are recognized periodically. No other performance obligations exist under the terms of the contracts. The Company recognizes revenue for the agreed upon sales price when the products are shipped to the customer, which satisfies the performance obligation.
The Company sells aerogrow pods, and related products manufactured by contracted third parties to various parties. The Company also offers technical services related to use of the aerogrow pods. Contract sales of aerogrow pods, related products and services will be evaluated using the five-step process outline above. There have been no sales of aerogrow pods, related products and services during the three months ended March 31, 2021. Upon significant sales for such products and services, the Company will disaggregate sales by the lines of business to the extent that the product or service has different revenue recognition characteristics.
Stock-based compensation
Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation “, which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. The Company utilizes the Black-Sholes option pricing model and uses the simplified method to determine expected term because of lack of sufficient exercise history. Additionally, effective October 1, 2016, the Company adopted the Accounting Standards Update No. 2016-09 (“ASU 2016-09”), Improvements to Employee Share-Based Payment Accounting. Among other changes, ASU 2016-09 permits the election of an accounting policy for forfeitures of share-based payment awards, either to recognize forfeitures as they occur or estimate forfeitures over the vesting period of the award. The Company has elected to recognize forfeitures as they occur, and the cumulative impact of this change did not have any effect on the Company’s consolidated financial statements and related disclosures.
Loss Per Share
Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, which is the case for the three months ended March 31, 2021 and 2020 presented in these consolidated financial statements, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. Excluding the principal amount of $1,737,233 from the 3(a)(10) settlement, convertible note principal and accrued interest outstanding at March 31, 2021, totaled $2,679,987. Based on the conversion terms of the aforementioned notes, the Company had 2,319,182,887, potentially dilutive shares as of March 31, 2021. Under the settlement obligation there are 2,152,791,250 shares issuable to Livingston Asset Management under the 3(a)(10) settlement which will be further reduced following receipt of creditor payment information as shares already held by Livingston or sold and awaiting funds disposition at brokers.
The Company had the following common stock equivalents at March 31, 2021 and December 31, 2020:
| | March 31, 2021 | | December 31, 2020 |
Convertible notes payable | | | 2,319,182,887 | | | | 2,370,001,445 | |
Settlement obligation under 3(a)(10) | | | 2,152,791,250 | | | | 2,241,590,968 | |
Totals | | | 4,471,974,137 | | | | 4,611,592,412 | |
Income Taxes
The Company accounts for income taxes under ASC Topic 740 “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements.
The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.
Foreign Currency Translation
The Company follows Section 830-10-45 of the FASB Accounting Standards Codification (“Section 830-10-45”) for foreign currency translation to translate the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity’s functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash.
The functional currency of each foreign subsidiary is determined based on management’s judgment and involves consideration of all relevant economic facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions, including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency upon the parent and the nature of the subsidiary’s operations must also be considered. If a subsidiary’s functional currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary’s financial statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S. Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional currency would be included in the condensed consolidated statements of income and comprehensive income (loss). If the Company disposes of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the condensed consolidated statements of income and comprehensive income (loss). If the Company determines that there has been a change in the functional currency of a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the statement of income and comprehensive income (loss).
Based on an assessment of the factors discussed above, the management of the Company determined its subsidiary’s local currency (i.e. the Canadian dollar) to be the functional currency for its foreign subsidiary.
Subsequent events
The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company has evaluated events that occurred subsequent to March 31, 2021 and through the date the financial statements were issued.
Recent Accounting Pronouncements
There are no recently issued accounting pronouncements the Company has not yet adopted that will materially impact the Company’s consolidated financial statements.
Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements.
Note 4 – Settlement Reserves
The settlement reserve balance of $1,110,065, as of March 31, 2021, includes an estimate for default penalties under the terms of convertible notes payable issued by the predecessor company prior to December 31, 2018. Also included are other accrued expenses and the principal amount of $98,835, recorded by the predecessor company for the balance of amortizing notes. On June 2, 2020, $154,515 was reclassified to 3(a)(10) settlement as discussed in footnote 5 below. Additionally, $225,000 was reclassified from accrued compensation to the settlement reserve during the three months ended March 31, 2021.
Note 5 — Convertible notes
Since February 2019, the Company has been working with advisors and creditors to restructure outstanding debt issued prior to December 31, 2018, including amounts outstanding with L2 (all L2 liabilities have been assigned to Oasis Capital – “Oasis”) among other creditors. Management believes that amounts recorded as debt and settlement reserves related to notes are adequate to cover the expected settlements.
All convertible notes issued before March 2019, were reevaluated in light of ASC 480, which allows for treating certain convertible notes as stock settled debt. This treatment does not require the bifurcation of the embedded derivative, nor does it require a periodic revaluation of the fair market values. So long as the discount to the share price used for conversion remains constant a premium is calculated and charged to interest expense at the issuance date of the note and recognized as a liability which is added to note face amount net of any original issue discounts (OID). The derivative liability for each qualifying note was reclassified as put premium and allocated to each note based on the note conversion stock price discount.
Refer to the table at the end of the section of this note covering notes issued prior to December 2018 for current balance of principal, accrued interest and put premiums.
Senior Debt – TCA and Oasis
Effective December 7, 2015, the Company closed a Credit Agreement (the “Credit Agreement”) by and among the Company, as borrower, Grow Solutions, Inc. and One Love Garden Supply LLC as joint and several guarantors (such guarantors, collectively, the “Subsidiaries” and together with the Company, the “Borrowers”) and TCA Global Credit Master Fund, LP, a Cayman Islands limited partnership, as lender (“TCA”). Pursuant to the Credit Agreement, TCA agreed to loan the Company up to a maximum of $3,000,000 for the Company’s product division, construction and renovation of two stores, and inventory. An initial amount of $950,000 was funded by TCA at the closing of the Credit Agreement. Any increase in the amount extended to the Borrowers shall be at the discretion of TCA.
The amounts borrowed pursuant to the Credit Agreement are evidenced by a Revolving Note (the “Revolving Note”) and the repayment of the Revolving Note is secured by a first position security interest in substantially all of the Company’s assets in favor of TCA, as evidenced by a Security Agreement by and between the Company and TCA (the “Company Security Agreement”) and a first position security interest in substantially all of the Subsidiaries’ assets in favor of TCA, as evidenced by a Security Agreement by and among the Subsidiaries and TCA (the “Subsidiaries Security Agreement” and, together with the Company Security Agreement, the “Security Agreements”). The Revolving Note, in the original principal amount of $950,000, was due and payable, along with interest thereon, on June 7, 2017 (the “Maturity Date”), and bears interest at the rate of 18% per annum. Upon the occurrence of an Event of Default (as defined in the Credit Agreement) the interest rate shall increase to the Default Rate (as defined in the Credit Agreement).
Upon the occurrence of an Event of Default or mutual agreement between TCA and the Company, at the sole option of TCA, TCA may convert all or any portion of the outstanding principal, accrued and unpaid interest, and any other sums due and payable under the Revolving Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest daily volume weighted average price of the Company’s common stock during the five trading days immediately prior to such applicable conversion date, in each case subject to TCA not being able to beneficially own more than 4.99% of the Company’s outstanding common stock upon any conversion.
Amendment of TCA Credit Agreement
On February 14, 2017, the Company entered into a First Amendment to Credit Agreement (the “Amended Agreement”) by and between the Company and TCA. Pursuant to the Amended Agreement, the Original Note was severed, split, divided and apportioned into two separate and distinct replacement notes consisting of (i) First Replacement Note A, evidencing principal indebtedness of $325,000, and (ii) First Replacement Note B evidencing the reduced outstanding balance of principal indebtedness of $876,441.25 (collectively, First Replacement Note A and First Replacement Note B, the “Replacement Notes”). The Replacement Notes replaced and superseded the Original Note in its entirety by substituting one evidence of debt for another without extinguishing the indebtedness and obligations evidenced under the Original Note.
On March 23, 2017, a second note for $300,000 was assigned by TCA to Oasis. Leaving a principal balance due to TCA note of $576,441. TCA capitalized the interest and penalties leaving a new principal balance of $729,874.
On October 13, 2017, TCA notified the Company that there was a continuing and uncured default for non-payment.
On February 21, 2018, final results of an auction for the Company’s inventory and other assets were reported to the beneficial owner of those assets. The auctioned assets were pledged to TCA under various loan documents dated December 7, 2015. The proceeds of $141,364 less expenses were remitted to the State of Colorado for sales tax due ($100,734) and to TCA ($17,824).
On September 13, 2019, TCA entered into a settlement agreement and stipulation, whereby TCA executed a Claims Purchase Agreement with Livingston Asset Management LLC granting Livingston the right to settle the liability for $729,874, in payments following the court’s approval of the 3(a)(10) settlement contemplated.
Debt Purchase Agreement
On February 15, 2017 (the “Effective Date”), the Company entered into a Debt Purchase Agreement (the “Debt Purchase Agreement”) by and among the Company, TCA, and L2 Capital, LLC, a Kansas limited liability company (the “Assignee”). Pursuant to the Debt Purchase Agreement, on the Effective Date, TCA sold and assigned to Assignee, TCA’s right, title and interest in and to the monetary obligations evidenced under Replacement Note A thereby reducing the TCA outstanding principal indebtedness. Assignee shall subsequently purchase from TCA the remaining debt evidenced by First Replacement Note B in purchase tranches. The indebtedness underlying the Replacement Notes are evidenced by a newly issued 10% Senior Replacement Convertible Promissory Note.
Total assignments to Oasis were $600,000 before the arrangement was terminated.
Issuance of 10% Senior Replacement Convertible Promissory Note
On February 15, 2017, the Company issued a 10% Senior Replacement Convertible Promissory Note (the “Oasis Note”) to the Assignee in the principal amount of $1,201,441.25. The initial principal amount under the Oasis Note is $325,000, representing the first tranche purchased by Assignee under First Replacement Note A and such amounts shall increase in tranches upon the purchase of such tranches by the Assignee from TCA pursuant to the Debt Purchase Agreement. The maturity date for each tranche shall be Nine months from that date of the purchase of that tranche and the Company shall pay interest to the Assignee on the aggregate unconverted and then outstanding principal amount of the Oasis Note at the rate of 10% per annum.
The Oasis Note is convertible at any time, in whole or in part, at the option of the holder into shares of common stock of the Company at a conversion price equal to 62.5% of the lowest closing bid price of the common stock in the prior twenty (20) trading days, which is subject to adjustment for stock dividends, stock splits, combinations or similar events.
Additionally, the terms under the Oasis Note include make-whole rights whereby upon liquidation by the Assignee of the shares converted under the Oasis Note, provided that the Assignee realizes a net amount from such liquidation equal to less than the conversion amount specified in the relevant conversion notice (such net realized amount, the “Realized Amount”), the Company shall issue to the Assignee additional shares, as defined.
The first tranche of $325,000 was fully converted in prior periods.
On March 23, 2017, the Company issued a second tranche note to Oasis (Oasis-2) for $300,000.
Private Placement - Debt Offering 2016
During the year ended December 31, 2016, the Company entered into an agreement for the issuance of convertible notes to third party lenders for aggregate proceeds of $1,117,000. The notes accrue interest at 12% per annum maturing two years from issuance. The notes are convertible into shares of common stock at a conversion price of $0.80. These notes were analyzed, and no derivative liability has been recognized due to the fixed conversion price. One investor has assigned $277,788, of their note to third parties and the assigned notes were restated as described below under note changes. The total balance under the 2016 Debt Offering was $854,212, at March 31, 2021and December 31, 2020, respectively.
Debt Issued During the Year Ended December 31, 2016
On December 15, 2016, the Company entered into an agreement for the issuance of a convertible note to a third-party lender for $285,775 with an original issue discount of $37,275. The note accrues interest at 8% per annum and matured on December 15, 2017. The notes are convertible into shares of common stock at a conversion price equal to approximately 58% of the average of the lowest 3 trading prices for the common stock during the 20-day trading period ending on the latest and complete trading day prior to the conversion. Notwithstanding the foregoing, the minimum conversion price under the Note is $0.20 (the “Floor Price”), provided that, at any time following 180 days from the Issuance Date, if the closing price of the common stock of the Company is equal to or less than the Floor Price for two consecutive trading days, the Floor Price will extinguish and be of no further force or effect. In connection with the issuance of this Note, the Company determined that the terms of the Note contain a conversion formula that caused variations in the conversion price resulting in the treatment of the conversion option as a bifurcated derivative to be accounted for at fair value. The initial derivative liability was determined to be $286,583, since the issuance of the note periodic changes in fair market value resulted in a derivative liability balance of $222,411, which was reclassified to put premium in conjunction with the note restructuring on July 14, 2017. Debt discounts of $202,783 were fully recognized as interest expense upon note restructure.
Carebourn Capital Debt Refinancing
On July 14, 2017 (the “Effective Date”), the Company and the Purchaser Agreed to cancel the Purchase Agreement, the Note and the related transaction documents and refinanced the original loan by the Company’s issuance of a Convertible Promissory Note dated the Effective Date (the “Note”). The principal amount of the Note is $262,877.42, the Purchase Price is $228,589.06, and the Company received $50,000 in proceeds from the Purchaser. The Maturity Date of the Note was July 14, 2018. The balance of the December 15, 2016 note was rolled into the new note for a total note payable balance of $262,877 and original debt discount of $34,288 was recorded and was fully recognized as interest expense as during prior periods due to the termination of former operations.
The Note terms remain the same as the original note above. The note conversion terms satisfy the conditions for treatment as stock settled debt in accordance with ASC 480, as such a put premium of $190,360 has been recorded and is included in convertible notes payable with a reclassification adjustment to derivative liabilities. The note balance at March 31, 2021 and December 31, 2020, was $262,877.
The JSJ Investments Inc. Debt Financing
On January 30, 2017 (the “Issuance Date”), the Company issued a 10% Convertible Promissory Note (the “JSJ Note”) in the principal amount of $100,000 in favor of JSJ Investments Inc. (“JSJ”). On or about January 30, 2017, the Company received $98,000 in net proceeds after deducting fees and expenses.
The JSJ Note bears interest at a rate of 10% per annum on the aggregate unconverted outstanding principal, subject to increase according to the terms and conditions of the JSJ Note. The JSJ Note is convertible in whole or in part, at the option of JSJ into shares of common stock of the Company at a conversion price equal to 60% of the lowest closing bid price of the common stock in the prior ten (10) trading days, which is subject to adjustment for stock dividends, stock splits, combinations or similar events.
Under the terms and conditions of the JSJ Note, the Company and JSJ agreed to enter into a mutually agreed upon Leak-Out Agreement whereby JSJ shall not sell more than the greater of (i) 20% of the trading volume per week or (ii) $20,000 in shares of common stock per week. The note was partially converted during the years ended December 31, 2020 and the balance at March 31, 2021 and December 31, 2020, was $79,000 and $79,000, respectively.
The Cicero Consulting Group, Inc. Debt Financing
On February 8, 2017 (the “Issuance Date”), the Company, entered into a Securities Purchase Agreement with Cicero Consulting Group, LLC (“Cicero”) pursuant to which the Company sold $50,000 in principal amount of a Convertible Promissory Note (the “Cicero Note”), of which the Company received.
The Cicero Note bears interest at a rate of 12% per annum on the outstanding principal, subject to increase according to the terms and conditions of the Cicero Note. The Cicero Note is convertible at any time from the Issuance Date, in whole or in part, at the option of Cicero into shares of common stock of the Company at a conversion price equal to 70% of the lowest closing bid price of the common stock in the prior five (5) trading days, which is subject to adjustment for stock dividends, stock splits, combinations or similar events. The note was partially converted during the years ended December 31, 2020 and the balance at March 31, 2021and December 31, 2020, was $23,000 and $23,000, respectively.
Note issued for past due legal fees
On October 26, 2017, the Company issued a convertible note payable to Lucosky Brookman LLP for $378,461. The note was issued for unpaid legal services. The note has 8% annual interest and matured on October 26, 2018. The note has a default interest rate of 18%. The note and accrued interest can be converted into common stock at 60% of the average lowest 3 trading prices in the 10 trading days prior to conversion. In accordance with ASC 480, the Company is treating the note conversion feature as stock settled debt and a put premium of $252,307, has been recorded. The note principal was charged to accounts payable and settlement reserve. On September 13, 2019, the note holder executed a Claim Purchase Agreement for the amounts owed ($426,694) to Livingston Asset Management LLC which was approved for inclusion in the 3(a)(10) settlement approved by the court (as discussed below).
Promissory Note
On May 25, 2017 (the (“Issuance Date”), the Company, issued a Promissory Note to Brandi Blank (an individual investor) in the principal amount of $100,000 (the “note”). The Company received $100,000 in net proceeds from the sale of the note. The note is due on demand 180 days from the Issuance Date (the “Maturity Date”). Payment by the Company to Lender under the terms of the note may be made in either cash or common stock of the Company, at the option of the Lender. In the event the Company repays the note in common stock, such common stock will be issued at a price equal to the closing price of the Company’s common stock on the Maturity Date (the “Conversion Price”). The note bears interest at a rate of fifteen percent (15%) per annum, to be accrued through the Maturity Date. Interest may be paid in cash or common stock of the Company at the option of the Lender on the Maturity Date at the Conversion Price. Additionally, the Company will issue the Lender shares of common stock in an amount equal to thirty three percent (33%) of the outstanding balance of principal and interest under the note within 10 days of the issuance date. The obligation to issue stock was treated as a warrant for 494,012 shares of stock with an exercise price of $.0668, having a fair market value of $19,530 which was credited to additional paid in capital with a corresponding charge to debt discount and subsequently charged to interest expense due to the termination of operations during the year ended December 31, 2017. Subsequent changes to fair market value will be recognized on each reporting date. The value of the warrant was remeasured on December 31, 2020 and was not material for adjustment.
Below is summary of notes with conversion features issued prior to December 31, 2018, and are currently in default:
Name of Note holder | | Original Note Amount | | Principal | | Put Premium | | Accrued Interest |
| | | | March 31, 2021 | | March 31, 2021 | | March 31, 2021 |
Oasis | | $ | 625,000 | | | | 170,670 | | | | 120,755 | | | | 26,122 | |
Carebourn | | $ | 262,877 | | | | 262,877 | | | | 190,360 | | | | 53,277 | |
JSJ | | $ | 100,000 | | | | 79,000 | | | | 52,667 | | | | 68,098 | |
Cicero | | $ | 50,000 | | | | 23,000 | | | | 9,857 | | | | 39,535 | |
Blank | | $ | 100,000 | | | | 100,000 | | | | — | | | | 57,783 | |
2016 Debt Offering | | $ | 1,117,000 | | | | 839,212 | | | | — | | | | 470,059 | |
Total Principal and Premium | | | | | | | | | | $ | 1,848,398 | | | | | |
Total Interest Accrued | | | | | | | | | | | | | | $ | 714,874 | |
The notes listed above have current principal following conversions and restructuring that totals $1,474,759, and related put premiums (as calculated by the Company) of $373,639. The Company believes that claims for default penalties may arise in future periods and has taken those contingent liabilities into consideration in establishing settlement reserves as discussed at Note 4.
Pre-merger notes (see table above): | | March 31, 2021 | | December 31, 2020 |
Principal | | $ | 1,474,759 | | | $ | 1,474,759 | |
Put premiums on stock settled debt | | | 373,639 | | | | 373,639 | |
Total pre-merger notes, net | | | 1,848,398 | | | | 1,848,398 | |
Post-merger (see descriptions below): | | | | | | | | |
Principal new issues | | | 437,645 | | | | 331,644 | |
Put premiums on stock settled debt | | | 142,100 | | | | 55,372 | |
Debt discount (OID and derivative liabilities) | | | (4,792 | ) | | | (560 | ) |
Assigned and restated notes | | | — | | | | — | |
Debt under 3(a)(10) settlement | | | 1,722,233 | | | | 1,722,233 | |
Put premium for 3(a)(10) liability | | | 1,722,233 | | | | 1,722,233 | |
Total post-merger notes, net | | | 4,019,419 | | | | 3,830,921 | |
Total convertible notes, net | | $ | 5,867,817 | | | $ | 5,679,320 | |
Issuance of New Convertible Notes
On March 7, 2019, the Company issued a convertible note payable to Trillium Partners LP for $55,000. The note has $5,000 original issue discount (OID), 10% annual interest and matured on March 31, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated at issuance to be $155,868, of which $105,868 was charged to derivative expense and $50,000 to debt discount. Debt discount along with OID is amortized to interest expense over the term of the note and was fully amortized during the years ended December 31, 2020. On June 2, 2020 the principal balance of $55,000, accrued interest of $8,634 and the related derivative liability of $67,019, were reclassified as 3(a)(10) settled liabilities as discussed below.
On March 12, 2019, the Company issued a convertible note payable to Ralph Aiello for $55,000. The note has $5,000 original issue discount (OID), 10% annual interest and matured on March 31, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated at issuance to be $175,012, of which $125,012 was charged to derivative expense and $50,000 to debt discount. Debt discount along with OID is amortized to interest expense over the term of the note. At December 31, 2020, the derivative liability decreased to $69,557. OID and debt discount were fully amortized and the principal balance was $55,000.
On March 29, 2019, the Company issued a convertible note payable to Oscaleta Partners LLC for $12,500. The note has $2,117 original issue discount (OID), 12% annual interest and matured on March 31, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated at issuance to be $49,903, of which $39,520 was charged to derivative expense and $10,383 to debt discount. Debt discount along with OID is amortized to interest expense over the term of the note. OID and debt discount were fully amortized at December 31, 2020. The principal balance was $12,500, accrued interest of $2,334 along with the related derivative liability of $15,808, were reclassified as 3(a)(10) settled liabilities as discussed below.
On June 6, 2019, the Company issued a convertible note payable to Ralph Aiello for $35,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on June 5, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $63,182, with $33,182 charged to derivative expense and $30,000 charged to debt discount. The fair market value decreased to $47,014 as of December 31, 2020. The principal balance was $35,000 at March 31, 2021.
On June 21, 2019, the Company issued a convertible note payable to Ralph Aiello for $35,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on June 5, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $62,648, with $32,648 charged to derivative expense and $30,000 charged to debt discount. The fair market value decreased to $49,193 at December 31, 2020 and the principal balance was $35,000 at March 31, 2021.
On July 15, 2019, the Company issued a convertible note payable to Ralph Aiello for $35,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on July 14, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $98,917 with $68,917 charged to derivative expense and $30,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $35,024 as of at December 31, 2020 and the principal balance was $35,000 at March 31, 2021.
On August 27, 2019, the Company issued a convertible note payable to Ralph Aiello for $30,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on August 26, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $59,834 with $34,834 charged to derivative expense and $25,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $41,018 as of at December 31, 2020 and the principal balance was $30,000 at March 31, 2021.
On October 9, 2019, the Company issued a convertible note payable to Ralph Aiello for $27,500. The note has: $2,500 original issue discount (OID, 10% annual interest and matured on October 8, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $63,795 with $38,795, charged to derivative expense and $25,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $30,034 as of at December 31, 2020 and the principal balance was $27,500 at March 31, 2021.
On November 27, 2019, the Company issued a convertible note payable to Ralph Aiello for $33,000. The note has: $3,000 original issue discount (OID, 10% annual interest and matures on November 30, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $65,792 with $35,792, charged to derivative expense and $30,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $30,035 as of at December 31, 2020 and the principal balance was $33,000 at March 31, 2021.
On November 13, 2019, the Company issued a convertible note payable to Livingston Asset Management LLC (LAM) for $5,000. The LAM paid expenses of $4,864 for the Company and an additional $136 was charged as OID. The note bears interest at 12%, and matured on May 12, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50%, of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $7,239, with $5,000 charged to debt discount to be amortized over the life of the note and $2,239 was charged to derivative expense. The derivative liability will be revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The derivative liability balance decreased to $6,335 and the principal was unconverted at March 31, 2021.
On January 30, 2020, the Company issued a convertible note payable to Trillium LP for $30,000. The Company received $25,000, in cash and an additional $1,500 was paid by Trillium directly to a third party on behalf of the Company. The note has $3,500, original issue discount (OID, 12% annual interest and matured on July 31, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50%, of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value of $71,510, with $26,500 charged to debt discount to be amortized over the life of the note and $41,010 was charged to derivative expense. The derivative liability will be revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The Company repaid $25,000 during the years ended December 31, 2020. As a result of the repayment the Company recognized a gain on debt extinguishment of $56,810. The fair market value decreased to $7,342 during the year ended December 31, 2020.
On June 4, 2020, the Company issued a convertible note payable to Carebourn Capital in exchange for $40,000 in cash. The note has 8% interest and matures on June 1, 2021. The note can be converted into the Company’s common stock at a discount equal to 55% of the average of the three lowest trading prices during the twenty days prior to the conversion. Due to the fixed percentage discount the conversion feature is treated as stock settled debt under ASC 480. Accordingly, a put premium was calculated to be $32.727 and was charged to interest expense on the date the note was effective.
On August 4, 2020, the Company issued a convertible note payable to Trillium LP for $8,500. Trillium paid expenses of $8,032 for the Company and an additional $468 was charged as OID. The note bears interest at 12%, and matures on May 12, 2021. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50%, of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $911, which was charged to debt discount to be amortized over the life of the note. The derivative liability will be revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The derivative liability balance decreased by an immaterial amount and remains at $911 and the principal was unconverted at March 31, 2021.
On January 19, 2021, the Company issued a 0% interest rate convertible promissory note in the principal amount of $53,000 in favor of Carebourn Capital, L.P. The note matures on January 19, 2022 and is convertible into shares of common stock of the Company at a conversion price equal to 55% of the lowest closing bid price in the prior twenty-five (25) trading days, the note will be treated as stock settled debt in accordance with ASC 480. Accordingly, a put premium was calculated to be $43,364 and was charged to interest expense on the date the note was effective.
On March 17, 2021, the Company issued a 0% interest rate convertible promissory note in the principal amount of $53,000 in favor of Carebourn Capital, L.P. The note matures on March 17, 2022 and is convertible into shares of common stock of the Company at a conversion price equal to 55% of the lowest closing bid price in the prior twenty-five (25) trading days, the note will be treated as stock settled debt in accordance with ASC 480. Accordingly, a put premium was calculated to be $43,364 and was charged to interest expense on the date the note was effective.
Note Assignments
On October 7, 2019, Ralph Aiello, sold and assigned $30,000 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $59,712. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $52,066 with a corresponding charge to derivative expense. During the year ended December 31, 2019, the related fair market value net changes of $12,348 were credited to fair market value changes, leaving a derivative liability of $39,718 The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $39,718 was recognized as gain on extinguishment of debt.
On April 1, 2020, Ralph Aiello, sold and assigned $7,500 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $52,212. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $16,667 with a corresponding charge to derivative expense. The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $16,667 was recognized as gain on extinguishment of debt.
On June 1, 2020, Ralph Aiello, sold and assigned $15,000 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $37,212. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $37,500 with a corresponding charge to derivative expense. The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $37,500 was recognized as gain on extinguishment of debt.
On July 1, 2020, Ralph Aiello, sold and assigned $15,000 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $22,212. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $15,819 with a corresponding charge to derivative expense. The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $15,819 was recognized as gain on extinguishment of debt.
Court Approved Settlement of Various Liabilities Under SEC section 3(a)(10)
On September 13, 2019 the Company entered into a settlement agreement and stipulation (“Settlement Agreement”) with Livingston Asset Management, LLC (“LAM”) in connection with the settlement of $3,998,152 of bona fide obligations the Company owed to certain of its creditors. The Settlement Agreement was subject to fairness hearing, and on November 15, 2019 a Federal court in the District of Maryland held a fairness hearing and granted approval of the Settlement Agreement. If the Settlement Agreement is satisfied in full, the Company shall reduce the Company’s debt obligations equal to $1,506,568 in exchange for the issuance of settlement shares of Company’s common stock pursuant to the terms of section 3(a)(10) of the Securities Act of 1933, in multiple tranches, at a price equal to the lowest closing bid price for the common stock for the twenty trading days immediately preceding the delivery of such tranche. At no time may LAM beneficially own more than 9.99% of the Company’s outstanding common stock.
The 3(a)(10) settlement includes the following liabilities:
TCA senior note and capitalized interest - $729,874;
Otis claims for amounts due for services provided (reclassified from settlement reserve) - $350,000; and
Attorney fees (note for $378,461 and $48,233 in fees and accrued interest) - $426,694.
Included in the convertible notes balance sheet amount is $1,457,307, classified as principal and $1,457,306, of put premium related to the 3(a)(10) settlement at March 31, 2020. The amounts covered in the settlement were reclassified from convertible notes payable, accrued interest and accounts payable, along with related put premiums related to the original notes payable. Additionally, included in the put premium above was $1,110,446, which was reclassified from settlement reserves to put premium related to the liabilities transferred to the 3(a)(10) settlement liability amount.
On December 23, 2019 the Company entered into a settlement agreement and stipulation (“Settlement Agreement”) with Livingston Asset Management, LLC (“LAM”) in connection with the settlement of $342,199 of bona fide obligations the Company owed to certain of its creditors. The Settlement Agreement was subject to fairness hearing, and on June 2, 2020 a Federal court in the District of Maryland held a fairness hearing and granted approval of the Settlement Agreement. If the Settlement Agreement is satisfied in full, the Company shall reduce the Company’s debt obligations equal to $342,199 in exchange for the issuance of settlement shares of Company’s common stock pursuant to the terms of section 3(a)(10) of the Securities Act of 1933, in multiple tranches, at a price equal to the lowest closing bid price for the common stock for the twenty trading days immediately preceding the delivery of such tranche. At no time may LAM beneficially own more than 9.99% of the Company’s outstanding common stock.
The 3(a)(10) settlement includes the following liabilities:
Trillium convertible note and capitalized interest - $82,590;
Oscaleta Partners LLC convertible note and capitalized interest - $19,059;
Victor Wexler’s claims as guarantor on liabilities arising from the Company’s purchases of inventory and he Company’s written agreement to indemnify Mr. Wexler against such claims by third parties - $154,515; and
Attorney fees (current securities counsel) - $79,500.
The settlement including the stock issue price discount qualifies as stock settled debt under ASC 480. Included in the convertible notes balance sheet amount is $335,665, classified as principal and $335,664, of put premium related to the 3(a)(10) settlement at December 31, 2020. The amounts covered in the settlement were reclassified from settlement reserves, convertible notes payable, accrued interest and accrued other expenses, along with related derivative liabilities related to the original notes payable. A gain realized upon the effective date of the 3(a)(10) settlement was not recognized as it was credited to settlement reserves.
As of March 31, 2021, $151,940, has been remitted to former creditors, reducing the aggregate 3(a)(10) obligation to $1,722,233 and the related put premium was $1,722,233.
Note 6 — Derivative Liabilities
During the year ended December 31, 2018, the Company reevaluated the note agreements and determined that all of the conversion features meet the standard for classification of those features as stock settled debt in accordance with ASC 480 – Distinguishing Liabilities from Equity, whereby a put premium is calculated using the stock price discount and recorded as a liability fully recognized as interest expense on the date the issued. The Company has recognized the put premiums as calculated by reclassifying the derivative liabilities and fully amortizing the corresponding debt discounts into interest expense.
During the year ended December 31, 2019, ten new notes were issued and one note was partially assigned to third parties and the conversion terms were restated. All of these notes contain conversion terms which are variable and therefore the notes include embedded derivatives that must be valued a fair market and revalued as of each subsequent reporting date. During the years ended December 31, 2020, three new notes was issued one of which has variable and the conversion terms was treated as an embedded derivative. The Company does not revalue embedded derivatives once the host instrument has matured, all of the convertible notes with embedded derivatives were matured as of December 31, 2020.
Level 3 Financial Liabilities – Derivative convertible note and warrant liabilities
The following are the major categories of assets and liabilities that were measured at fair value during the three months ended December 31, 2020 using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3):
| | At March 31, 2021 | | At December 31, 2020 |
Description | | Level 1 | | Level 2 | | Level 3 | | Level 1 | | Level 2 | | Level 3 |
Embedded conversion feature | | | — | | | | — | | | | 324,143 | | | | — | | | | — | | | | 324,143 | |
Derivative Liability | | | — | | | | — | | | $ | 324,143 | | | | — | | | | — | | | $ | 324,143 | |
The fair value of the embedded conversion feature of the convertible notes on the balance sheet date were calculated using a binomial option model valued with the following weighted average assumptions during the period ended:
| | March 31, 2021 | | December 31, 2020 |
Risk free interest rate | | | — | | | | 1.77 | % |
Dividend yield | | | — | | | | — | |
Expected volatility | | | — | | | | 215 | % |
Remaining term | | | — | | | | .25 - 1 year | |
Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.
Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.
Volatility: The Company calculates the expected volatility of the stock price based on the corresponding volatility of the Company’s peer group stock price for a period consistent with the underlying instrument’s expected term.
Remaining term: The Company’s remaining term is based on the remaining contractual maturity of the instruments.
Note 7 — Stockholders’ Deficit
Series A Preferred Stock
The Company is authorized to issue 25,000,000 shares of preferred stock, $.001 par value, with such rights, preferences, variations and such other designations for each class or series within a class as determined by the Board of Directors. The preferred stock is not convertible into common stock, does not contain any cumulative voting privileges, and does not have any preemptive rights. 51 shares of preferred stock have been designated as Series A Preferred Stock and issued to an entity controlled by the CEO and the Company’s Board of Directors. The following describes the Series A Preferred Stock designation:
Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) – (0.019607 x 5,000,000) = 102,036).
On May 25, 2017 fifty-one (51) shares of Series A Preferred Stock were issued to Grow Solutions Holdings, LLC, a Colorado limited liability company (the “LLC”) controlled equally by each member of the Board of Directors of the Company (the “Board”).
The Series A Preferred Stock has no dividend rights, no liquidation rights and no redemption rights, and was created primarily to be able to obtain a quorum and conduct business at shareholder meetings. All shares of the Series A Preferred Stock shall rank (i) senior to the Company’s common stock and any other class or series of capital stock of the Company hereafter created, (ii) pari passu with any class or series of capital stock of the Company hereafter created and specifically ranking, by its terms, on par with the Series A Preferred Stock and (iii) junior to any class or series of capital stock of the Company hereafter created specifically ranking, by its terms, senior to the Series A Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary.
On or about November 2, 2017, TCA instructed the escrow agent (under the pledge agreement) to deliver to TCA the pledged securities (i.e., 51 Series A Preferred shares). Grow Solutions Holdings, LLC the owner of the pledged securities executed an assignment of the securities in favor of TCA’s nominee, thereby granting TCA the majority voting rights. TCA installed Gerard Danos as Interim President and appointed Jacquelyn Gogin and Alyce Schreiber as members of the board of directors of the Company.
On April 13, 2018, TCA filed SEC Form 3, stating it had voting control of 51% of the outstanding common shares of the Company’s stock, through its beneficial ownership of 51 shares of the Series A Preferred stock.
On March 5, 2019, Chad Fischl, acquired control of 51 shares of the Series A Preferred Stock of the Company, representing 100% of the Company’s total issued and outstanding Series A Preferred Stock, from TCA Share Holdings, LLC a Limited Liability Company, in exchange for agreeing to become the President, and Chief Executive Officer. (See Note 10)
Series B Preferred Stock
On March 5, 2019, the Secretary of State of the State of Nevada delivered confirmation of the effective filing of the Company’s Certificate of Amendment to its Certificate of Incorporation (the “ Amendment to Certificate “), which established 100,000 shares of the Company’s Series B Preferred Stock, having such designations, rights and preferences as set forth therein, as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Certificate of Incorporation and bylaws.
The shares of Series B Preferred Stock, par value of $0.001 and have a liquidation value of $1,000 per share (the “Series B Liquidation Value”) and are convertible into 2,833 shares of common stock (the “Conversion Ratio”), subject to a limitation per beneficial owner of 9.9% of the outstanding common shares. The holders of shares of the Series B Preferred Stock shall be entitled to receive dividends out of any assets legally available, to the extent permitted by Nevada law, at an annual rate equal to 8% of the Series B Liquidation Value of such shares of Series B Preferred Stock, and shall accrue from the date of issuance of such shares of Series B Preferred Stock, payable quarterly in common stock valued at the closing trade price per share on the last trading day of the calendar quarter.
The holders of Series B Preferred Stock rank senior to the Company’s common stock and Series A preferred Stock and will vote together with the holders of the Company’s common stock on an as-converted basis on each matter submitted to a vote of holders of common stock (whether at a meeting of shareholders or by written consent). In any such vote, the number of votes that may be cast by a holder shall be equal to one (1) vote for each share of common stock into which such holder’s outstanding shares of Series B Preferred Stock may be converted. Each holder shall be entitled to notice of all shareholder meetings (or requests for written consent) in accordance with the Company’s bylaws.
On March 11, 2019, the shareholders of PRH, acquired control of 85,000 shares of the Series B Preferred Stock of the Company, representing 85% of the Company’s total issued and outstanding Series B Preferred Stock, in exchange for 100% of the issued and outstanding shares of PRH, per the terms of a Securities Exchange Agreement by and between the Company and PRH. The Series B Preferred shareholders have mutually agreed to defer dividends through December 31, 2020.
The Company issued Series B Preferred Shares to the following individuals in the amounts indicated:
Chad Fischl, CEO of the Company, - 4,746 Series B Preferred Shares;
Bailey Fischl - 4,746 Series B Preferred Shares;
Clara Fischl - 9,421 Series B Preferred Shares;
Carla Blampin - 9,421 Series B Preferred Shares;
Sharon Branconnier - 9,420 Series B Preferred Shares;
Jolene Branconnier - 9,421 Series B Preferred Shares;
Norman James Payton - 9,421 Series B Preferred Shares;
Ismail Abdul Fattah - 7,084 Series B Preferred Shares;
Ahmad Abdel Latif Yassine - 7,083 Series B Preferred Shares;
Adrian LaChance - 9,887 Series B Preferred Shares;
Emily LaChance - 2,175 Series B Preferred Shares; and
Carly LaChance - 2,175 Series B Preferred Shares.
On May 31, 2019, the Company issued 15,000 shares of Series B Preferred restricted shares at par value to Trillium Partners, LP for services.
Common Stock
The Company is authorized to issue 10,000,000,000 common shares with a par value of $0.001 per share. The Nevada Secretary of State approved the increase on July 15, 2020. As of March 31, 2021, and December 31, 2020, there were 2,394,678,523 and 1,875,799,430, shares of common stock issued and outstanding, respectively.
Regulation A Offering
On October 29, 2019, the Company filed Form 1-A to register an offering of its common stock. The final amendment was filed on January 9, 2020, increasing the total number of shares offered to 2,000,000,000 at a price per share of $0.0015 in order to raise up to $3,000,000 in capital for the Company. The offering became qualified by the Securities Exchange Commission, on February 20, 2020, with the filing of the Notification of Qualification.
On July 29, 2020 a final post-effective amendment to the offering statement made effective on February 20, 2020. The amendment increased the number of shares offered to 6,000,000,000 and changed the offering price to $.0005. The post-effective amendment was qualified on August 6, 2020.
Common Stock Issued Under Regulation A Offering
Between January 19, and February 9, 2021, the Company issued 228,124,884 shares of common stock to an investor at $.0005 per share for total proceeds of $114,063.
Common Stock Issued for Conversion of Notes Payable
Between January 1 and March 31, 2021, the Company issued 45,000,000 shares of common stock in settlement of $25,312 of principal and accrued interest related to the February 16, 2017 replacement convertible note first issued to OASIS and subsequently assigned to Oasis Capital, LLC.
Between January 28, and March 24, 2021, the Company issued 200,754,209 shares of common stock to Carebourn Capital, in settlement of $150,281 of accrued interest on convertible notes.
Note 8 — Related Party Transactions
The Company subleases office and development facilities at cost one of its subsidiaries. The terms are month to month until the Company fully occupies the planned space. The currently monthly payments are $2,700.
The Company has a shared service agreement in place, whereby the former CEO and executive officers of the Company and two related party companies are paid through Pure Roots Holding, Corp. a wholly-owned subsidiary of the Company. (See Note 10, Settlement Agreement with Chad Fischl).
Note 10 — Commitments and Contingencies
Settlement Agreement- Consulting Agreement Termination
On or about January 6, 2017, the Company terminated the Consulting Agreement with Cimarron Capital Ltd., a Nevada corporation controlled by Peter Aiello Sr. (“Cimarron”) pursuant to that certain Consulting Agreement by and between the Company and Cimarron, dated January 1, 2015 (the “Cimarron Termination”).
In connection with the Cimarron Termination, the Company and Cimarron entered into a Settlement and Release Agreement dated February 28, 2017 (the “Cimarron Settlement Agreement”). Under the Cimarron Settlement Agreement, the Company and Cimarron agreed to a mutual release of all claims in connection with the Cimarron Consulting Agreement and the Cimarron Termination for payment by the Company to Cimarron in the amount of $5,000 per month for a period of 14 months. Additionally, Cimarron agreed to certain lockup and leak-out provisions with respect to the sale of its shares of common stock of the Company. The Company has not made timely payments in accordance with the Settlement Agreement. The Company has recognized the liability of $70,000 in the settlement reserves.
Ralph Aiello Complaint and Settlement Agreement
The Company was involved in litigation against Ralph Aiello (the “Plaintiff” and together with the Company, the “Parties”). On January 19, 2017, the Plaintiff filed a complaint in the Supreme Court of the State of New York County of Nassau (the “Court”), alleging claims including breach of contract in connection with certain loans made by Plaintiff to the Company in the amount of $500,000 plus interest (the “Dispute”). On March 15, 2017, the Parties filed a Settlement Agreement (the “Settlement Agreement”) with the Court whereby the Company agreed to pay the Defendant $550,000 by September 15, 2018. The Company has not made timely payments in accordance with the Settlement Agreement. The Company is working to establish a payment plan for the Plaintiff and expedite the settlement of the Dispute. The Plaintiff has sold and assigned $277,788, of the notes in dispute as of March 31, 2021, and an additional $222,212, principal remains recognized on the balance sheet under convertible notes payable plus accrued interest.
Settlement - Summary Judgement in Favor of Vendor and Advisor/Investor
On October 5, 2018, Sunlight Supply, Inc. presented a motion seeking summary judgement for $219,104, representing unpaid product invoices, interest accrued between October 11, 2017 and October 26, 2018, and attorneys’ fees against One Love Garden Supply, LLC and an individual guarantor. On January 11, 2019, the court granted summary judgement in the favor of the plaintiff. The guarantor has settled the judgement in favor of the creditor in conjunction with the Company’s participation in the 3(a)(10) court approved settlement that includes payment to the guarantor for amounts owed to him by the Company. (See note 5)
On June 3, 2019, the Company entered into a settlement agreement with an individual and affiliated unincorporated entity for a maximum amount of $350,000. The individuals and the affiliated entities separately provided personal guarantees on certain liabilities of the Company and provided advisory services. The liability has been incorporated in the 3(a)(10) settlement as discussed in note 5.
Settlement Agreement- Chad Fischl
On November 16, 2020, the Company entered into a Settlement Agreement (“Agreement”) with its former CEO; wherein, it has agreed to pay a portion of the back wages to Mr. Fischl, as well as working out agreements with the former employees of the Company. The Agreement states that the Company will pay back wages of approximately $175,000 (CDN) to the employees, $211,776 (CDN) to Chad Fischl and Bailey Fischl (“Fischl Amount”), and that the Company assumes any liability for any unpaid taxes, in as much as is legally possible. The Agreement authorizes the Company to make 15 monthly payments of $14,118.40 (CDN) or until the Fischl Amount has been paid in full. In return Mr. Fischl agrees to return his Series A Preferred shares and Series B Preferred Shares (the “Shares”) that he and his family members’ control. The Company also agrees to $10,000 liquidated damages for any payment that is more than three days late, with each late payment also then accruing interest at a rate of 10% per annum on any payments that are not made, until they are paid in full with the then outstanding interest. The Agreement states that the Shares will not be returned until the entire Fischl Amount is paid. As of this filing $62,494 in payments have been made on the Agreement. The remaining balance is recorded in settlement reserves at March 31, 2021.
COVID-19 Pandemic
The COVID-19 pandemic had a significant adverse impact on the Company’s business, results of operations, financial condition and cash flows from operations during the year ended December 31, 2020 and is expected to continue to have an adverse impact on its performance in 2021.
Given the uncertainties surrounding the ongoing effects of the COVID-19 pandemic on the Company’s future financial condition and results of operations, the Company took certain actions to preserve its liquidity and strengthen its financial flexibility. The Company took certain actions starting in March 2020, some of which are ongoing, to (i) reduce payroll costs, through temporary furloughs, salary and incentive compensation reductions, decreased working hours and hiring freezes, as well as taking advantage of COVID-related government programs in international jurisdictions, (ii) eliminate or reduce expenses in all discretionary spending categories, (iii) reduce working capital, and (iv) reduce capital expenditures.
Operating Lease
The Company subleases facilities on a month-to-month basis. The agreement requires monthly payments of $2,700.
Litigation
In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance.
Except as disclosed below, the Company is unaware of any action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our Company’s subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.
Bronstein Complaint and Settlement Agreement
The Company was involved in litigation against Tal Bronstein, Kathleen Bronstein, and Milehigh Wholesale Inc. (the “Plaintiffs” and together with the Company, the “Parties”). On May 4, 2017, the Plaintiffs filed a complaint in the District Court, City and County of Denver (the “Court”), alleging claims including breach of contract in connection with the acquisition of Milehigh Wholesale Inc. and the employment of Mr. Bronstein in connection with such acquisition (the “Dispute”). On or about June 14, 2017, the Parties entered into a settlement agreement and release of all claims whereby upon payment by the Company of $16,000 to Plaintiffs by July 14, 2017, Plaintiffs would dismiss with prejudice their claims against the Company and release the Company from any and all claims, known or unknown, on conditions of such payment. On June 23, 2017, counsel for the Plaintiffs filed with the Court a Notice of Settlement with respect to the Dispute. On June 27, 2017, the Court ordered that the Parties file a Stipulated Dismissal within 35 days of the Order (August 1, 2017).
On or about July 10, 2017, the Company notified the Plaintiffs that it would not be able to pay the $16,000 by July 14, 2017 and renegotiated the Settlement Agreement and Release of All Claims (the “Agreement”) as follows: (i) on or before July 14, 2017, Company shall deliver to the office of Plaintiffs’ counsel a Certified check in the amount of $5,000 (ii) on or before August 14, 2017, Company shall deliver to the office of Plaintiffs’ counsel a certified check in the amount of $13,500 (iii) the parties intend that the total amount paid from Company to Plaintiffs will be $18,500 (iv) if Company fail to pay the $13,500 by August 14, 2017, they will pay $100 per day thereafter as an additional penalty payment for each and every day that the $13,500 is not paid until the full amount of $13,500 is paid, or until August 31, 2017 (v) no later than July 17, 2017, Counsel for the Parties will file an unopposed Motion to Extend the time by which they have to file the Stipulated Motion to Dismiss to and including August 31, 2017 (vi) if the Company fails to pay the $13,500 by August 31, 2017, they agree that Plaintiffs may then seek a default judgment to enter against the Company in the amount of $21,700, without decrease for the $5,000 expected to be paid on or before July 14, 2017. Further, all attorney fees and costs of collection thereafter shall be paid for by Company. The Company has fully recognized the liability of $21,700 in the settlement reserve as of December 31, 2020.
Alessi Complaint and Dismissal
The Company was involved in litigation against William Alessi (“Alessi”). On February 15, 2017, Alessi filed a complaint in the General Court of Justice, Superior Court Division, State of North Carolina, County of Mecklenburg (the “Court”), alleging claims including breach of contract or unjust enrichment (the “Dispute”). On July 12, 2017, the Honorable Jeff Hunt presiding over the matter issued an order in favor of the Company dismissing Alessi’s action with prejudice due to the Court’s lack of jurisdiction and further stating that the proper forum for all claims in connection with the Dispute is an American Arbitration Association proceeding. As of December 31, 2020, no further communication had been received from Mr. Alessi or his representatives.
Settlement Reserves
The Company has provided reserves covering the contingencies included in this footnote. Management reviews claims as asserted and may increase or decrease the amounts reserved periodically. Based on information known as of December 31, 2020, the Company believes the settlement reserves presented in the balance sheet are adequate in all material respects.
Contingent Consulting Fees
The Company entered into consultation agreements with Sanclair Holdings Corp and Omni Data Capital Corp. for financial advisory, marketing, sales, manufacturing service procurement and logistics on March 5, 2019. The agreements as amended provide for compensation at monthly rates of CDN 30,000 (Sanclair) and CDN 25,000 (Omni) payable upon achievement of specified sales and other results. During the year ended December 31, 2019, the specified results were not achieved, however the Company has potential liabilities of approximately $487,500, provided the benchmark results are achieved during future periods. The specified sales and other results have not been achieved as of March 31, 2021.
Note 11 — Subsequent Events
Common Stock Issued – Conversions of Convertible Notes Payable
In April, 2021 the Company issued 95,000,000 shares of common stock in settlement of $28,125 of principal and accrued interest related to the February 16, 2017 replacement convertible note held by Oasis.
The Company evaluated subsequent events after the balance sheet date through the date the financial statements were issued. The Company did not identify any additional material events or transactions occurring during this subsequent event reporting period that required further recognition or disclosure in these financial statements.
Grow Solutions Holdings, Inc.
CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2020
INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
GROW SOLUTIONS HOLDINGS, INC. AND SUBSIDARIES
CONSOLIDATED BALANCE SHEET
(Unaudited)
| | December 31, 2020 | | December 31, 2019 |
ASSETS | | | | | | | | |
Current Assets | | | | | | | | |
Cash | | $ | 32 | | | $ | 8,153 | |
| | | | | | | | |
Total Current Assets | | | 32 | | | | 8,153 | |
| | | | | | | | |
Total Assets | | $ | 32 | | | $ | 8,153 | |
| | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | | | | | | | | |
Current Liabilities: | | | | | | | | |
Accounts payable and accrued expenses | | $ | 1,694,116 | | | $ | 1,149,428 | |
Settlement reserves | | | 958,245 | | | | 1,053,115 | |
Convertible notes payable - net of discounts and premiums | | | 5,679,320 | | | | 5,266,377 | |
Derivative liabilities | | | 324,143 | | | | 576,030 | |
Unearned revenue | | | 56,765 | | | | 56,741 | |
| | | | | | | | |
Total Current Liabilities | | | 8,712,589 | | | | 8,101,691 | |
| | | | | | | | |
Total Liabilities | | | 8,712,589 | | | | 8,101,691 | |
| | | | | | | | |
Commitments and Contingencies (Note 10) | | | | | | | | |
| | | | | | | | |
Stockholders’ Deficit: | | | | | | | | |
Preferred stock - $0.001 par value: 51 shares authorized; 51 Series A preferred shares issued and outstanding, | | | 1 | | | | 1 | |
Preferred stock - par value $0.001: 100,000 shares authorized; 100,000 and 100,000 Series B Preferred shares, issued and outstanding, | | | 100 | | | | 100 | |
Common stock - $0.001 par value, 10,000,000,000 shares authorized, 1,875,799,430 and 330,666,887 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively | | | 1,875,797 | | | | 330,666 | |
Additional paid-in capital | | | 5,514,651 | | | | 6,284,074 | |
Accumulated deficit | | | (16,111,910 | ) | | | (14,702,157 | ) |
Accumulated other comprehensive income | | | 8,804 | | | | (6,222 | ) |
| | | | | | | | |
Total Stockholders’ Deficit | | | (8,712,557 | ) | | | (8,093,538 | ) |
| | | | | | | | |
Total Liabilities and Stockholders’ Deficit | | $ | 32 | | | $ | 8,153 | |
See accompanying notes to the consolidated financial statements
GROW SOLUTIONS HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019
(Unaudited)
| | For the Years Ended |
| | December 31, |
| | 2020 | | 2019 |
Operating Expenses: | | | | | | | | |
Selling, general, and administrative expenses | | $ | 779,177 | | | $ | 919,377 | |
Depreciation and amortization | | | 4,662 | | | | — | |
| | | | | | | | |
Total Operating Expenses | | | 783,839 | | | | 919,377 | |
| | | | | | | | |
Loss from Operations | | | (783,839 | ) | | | (919,377 | ) |
| | | | | | | | |
Other Income (Expenses): | | | | | | | | |
Gain on debt extinguishment | | | 193,140 | | | | 182,044 | |
Derivative liability income (expense) | | | (117,235 | ) | | | (940,610 | ) |
Change in fair market value of derivative liability | | | 125,566 | | | | 326,331 | |
Interest and financing costs | | | (827,385 | ) | | | (660,604 | ) |
| | | | | | | | |
Total Other Expenses | | | (625,914 | ) | | | (1,092,839 | ) |
| | | | | | | | |
Net Loss before Provision for Income Tax | | | (1,409,753 | ) | | | (2,012,216 | ) |
| | | | | | | | |
Provision for Income Tax | | | — | | | | — | |
| | | | | | | | |
Net Loss | | $ | (1,409,753 | ) | | $ | (2,012,216 | ) |
| | | | | | | | |
Basic and Diluted Loss Per Share | | $ | (0.001 | ) | | $ | (0.012 | ) |
| | | | | | | | |
Weighted Average Number of Common Shares Outstanding: | | | 1,252,284,848 | | | | 165,136,389 | |
| | | | | | | | |
Net Loss | | $ | (1,409,753 | ) | | $ | (2,012,216 | ) |
Foreign Currency Translation | | | 15,026 | | | | (6,222 | ) |
Total Comprehensive Income (Loss) | | $ | (1,394,727 | ) | | $ | (2,018,438 | ) |
See accompanying notes to the consolidated financial statements
CONSOLIDATED STATEMENT OF CHANGES IN
STOCKHOLDERS’ DEFICIT FOR THE YEARS ENDED
DECEMBER 31, 2020 AND 2019
(Unaudited)
| | Preferred Stock Series A | | Preferred Stock Series B | | Common Stock | | Additional Paid In | | Accumulated | | Accumulated Other | | Stockholders' (Deficit) |
| | Shares | | Amount | | Shares | | Amount | | Shares | | Amount | | Capital | | Deficit | | Comprehensive Income | | Equity |
Balance, December 31, 2018 | | | — | | | $ | — | | | | — | | | $ | — | | | | — | | | $ | — | | | $ | — | | | $ | — | | | | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Recapitalization due to merger | | | 51 | | | | 1 | | | | 85,000 | | | | 85 | | | | 92,497,617 | | | | 92,496 | | | | 5,160,156 | | | | (12,689,941 | ) | | | — | | | | (7,437,203 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of Series B preferred stock for services | | | — | | | | — | | | | 15,000 | | | | 15 | | | | — | | | | — | | | | (15 | ) | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for compensation | | | — | | | | — | | | | — | | | | — | | | | 12,972,089 | | | | 12,972 | | | | 40,487 | | | | — | | | | — | | | | 53,459 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for debt settlement | | | — | | | | — | | | | — | | | | — | | | | 36,096,770 | | | | 36,097 | | | | 501,745 | | | | — | | | | — | | | | 537,842 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Conversion of notes to equity, post-merger | | | — | | | | — | | | | — | | | | — | | | | 151,794,411 | | | | 151,795 | | | | 461,748 | | | | — | | | | — | | | | 613,543 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Put premiums reclassified in note conversions | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 157,259 | | | | — | | | | — | | | | 157,259 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance for 3(a)(10) settlement | | | — | | | | — | | | | — | | | | — | | | | 37,306,000 | | | | 37,306 | | | | (37,306 | ) | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss for the year ended December 31, 2019 | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | (2,012,216 | ) | | | | | | | (2,012,216 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Other comprehensive income – foreign currency items | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | (6,222 | ) | | | (6,222 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance, December 31, 2019 | | | 51 | | | | 1 | | | | 100,000 | | | | 100 | | | | 330,666,887 | | | | 330,666 | | | | 6,284,074 | | | | (14,702,157 | ) | | | (6,222 | ) | | | (8,093,538 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Conversion of notes to equity | | | — | | | | — | | | | — | | | | — | | | | 856,515,878 | | | | 856,516 | | | | (530,820 | ) | | | — | | | | — | | | | 325,696 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Put premiums reclassified in note conversions | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 130,572 | | | | — | | | | — | | | | 130,572 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance for 3(a)(10) settlement | | | — | | | | — | | | | — | | | | — | | | | 566,950,000 | | | | 566,950 | | | | (566,950 | ) | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Settlements under 3(a)(10) | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 136,940 | | | | — | | | | — | | | | 136,940 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares issued - subscription | | | | | | | — | | | | — | | | | — | | | | 121,666,665 | | | | 121,665 | | | | 60,835 | | | | — | | | | — | | | | 182,500 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss for the year ended December 31, 2020 | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | (1,409,753 | ) | | | | | | | (1,409,753 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Other comprehensive income – foreign currency items | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 15,026 | | | | 15,026 | |
Balance, December 31, 2020 | | | 51 | | | $ | 1 | | | | 100,000 | | | $ | 100 | | | | 1,875,799,430 | | | $ | 1,875,797 | | | $ | 5,514,651 | | | $ | (16,111,910 | ) | | $ | 8,804 | | | $ | (8,712,557 | ) |
See accompanying notes to the consolidated financial statements
Grow Solutions Holdings, Inc.
Consolidated Statement of Cash Flows
(Unaudited)
| | For the Years Ended |
| | December 31, |
| | 2020 | | 2019 |
Cash Flows from Operating Activities: | | | | | | | | |
Net loss | | $ | (1,409,753 | ) | | $ | (2,012,216 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | |
Depreciation | | | 4,662 | | | | — | |
Impairment | | | 16,699 | | | | — | |
Amortization of debt discounts | | | 202,119 | | | | 230,889 | |
Accretion of premium on convertible note | | | 368,292 | | | | — | |
Convertible notes issued for expenses | | | 14,396 | | | | 10,383 | |
Derivative expense | | | 117,235 | | | | 940,610 | |
Changes in fair market value of derivative liabilities | | | (125,566 | ) | | | (326,331 | ) |
Gain on debt extinguishment | | | (193,140 | ) | | | (182,044 | ) |
Common stock issued for expenses | | | 11,275 | | | | 7,416 | |
Common stock issued for compensation | | | — | | | | 240,556 | |
Changes in operating assets and liabilities: | | | | | | | | |
Unearned revenue | | | 24 | | | | 56,741 | |
Accounts payable and accrued expenses | | | 784,497 | | | | 484,701 | |
Settlements payable | | | — | | | | 270,358 | |
| | | | | | | | |
Cash Used in Operating Activities | | | (209,260 | ) | | | (278,937 | ) |
| | | | | | | | |
Cash Flows from Investing Activities: | | | | | | | | |
Purchase of furniture, computers and equipment | | | (21,361 | ) | | | — | |
| | | | | | | | |
Cash Used in Investing Activities | | | (21,361 | ) | | | — | |
| | | | | | | | |
Cash Flows from Financing Activities: | | | | | | | | |
Proceeds from common stock issued from subscriptions | | | 182,500 | | | | — | |
Repayments of convertible notes | | | (25,000 | ) | | | — | |
Net proceeds from convertible notes issued | | | 65,000 | | | | 287,090 | |
| | | | | | | | |
Cash Provided by Financing Activities | | | 222,500 | | | | 287,090 | |
| | | | | | | | |
Net Increase (Decrease) in Cash | | | (8,121 | ) | | | 8,153 | |
| | | | | | | | |
Cash - beginning of year | | | 8,153 | | | | — | |
| | | | | | | | |
Cash - end of year | | $ | 32 | | | $ | 8,153 | |
Supplemental Disclosures of Cash Flow Information: | | | | | | | | |
Cash paid for: | | | | | | | | |
Interest and Taxes | | $ | — | | | $ | — | |
Noncash financing and investing activities: | | | | | | | | |
Derivative cease to exist upon conversion of notes | | $ | — | | | $ | 319,016 | |
Debt discounts | | $ | 202,119 | | | $ | 202,117 | |
Initial derivative liabilities | | $ | 118,146 | | | $ | — | |
Issuance of common stock for 3(a)(10) settlement of note | | $ | 136,940 | | | $ | — | |
Issuance of common stock for note conversions | | $ | 79,350 | | | $ | 613,543 | |
Issuance of common stock for accrued interest of notes | | $ | 235,070 | | | $ | — | |
Issuance of common stock for fees charged in note conversions | | $ | 11,275 | | | | — | |
Reclassification of debt premium upon conversion | | $ | 130,572 | | | $ | 157,259 | |
See accompanying notes to the consolidated financial statements
GROW SOLUTIONS HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED
DECEMBER 31, 2020 and 2019
(UNAUDITED)
Note 1 — Organization and Operations
Grow Solutions Holdings, Inc. (formerly known as LightTouch Vein & Laser, Inc. and Strachan, Inc.) (the “Company”) was organized under the laws of the State of Nevada on May 1, 1981. The Company provided indoor and outdoor gardening supplies to the rapidly growing garden industry.
The Merger
Effective April 28, 2015, the Company entered into an Acquisition Agreement and Plan of Merger (the “the Merger”) with Grow Solutions, Inc., a Delaware corporation (“Grow Solutions”) and LightTouch Vein & Laser Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of the Company (“LightTouch Acquisition”). Under the terms of the Merger, Grow Solutions merged with LightTouch Acquisition and became a wholly owned subsidiary of the Company. The Grow Solutions’ shareholders and certain creditors of the Company received 44,005,000 shares of the Company’s common stock in exchange for all of the issued and outstanding shares of Grow Solutions. Following the closing of the Grow Solutions Agreement, Grow Solutions’ business became the primary focus of the Company and Grow Solutions management assumed control of the management of the Company with the former director of the Company resigning upon closing of the Agreement. Shareholders maintained 1,886,612 shares as part of the recapitalization.
As a result of the Merger, the Company discontinued its pre-Merger business. The Merger was accounted for as a “reverse merger,” and Grow Solutions, was deemed to be the accounting acquirer in the reverse merger. Consequently, the assets and liabilities and the historical operations that are reflected in the financial statements prior to the Merger are those of Grow Solutions and recorded at the historical cost basis and the consolidated financial statements after completion of the Merger include the assets and liabilities of Grow Solutions, historical operations of the Company, and operations of the Company and its subsidiaries from the closing date of the Merger. As a result of the issuance of the shares of the Company’s Common Stock pursuant to the Merger, a change in control of the Company occurred as of the date of consummation of the Merger. The Merger is intended to be treated as a tax-free exchange under Section 368(a) of the Internal Revenue Code of 1986, as amended. All historical share amounts of the accounting acquirer were retrospectively recast to reflect the share exchange.
Reverse Merger and Recapitalization
On March 5, 2019, the Company entered into a securities exchange agreement with the shareholders of Pure Roots Holding, Ltd., representing 100% of the outstanding shares thereof (collectively the “Seller “), and Pure Roots Holding, Ltd., a Wyoming corporation (“ PRH “), whereby the Company purchased from the Seller, 100% of the issued and outstanding restricted common stock of PRH in exchange for 85,000 restricted shares of the Company’s newly created Series B Preferred Stock (the “ Series B Preferred Stock “). The Seller subsequently distributed the Series B Preferred Stock of the Company to the shareholders of PRH.
The shares of Series B Preferred Stock have a par value of $0.001 and a liquidation value of $1,000 per share (the “Series B Liquidation Value”) and each share is convertible into 2,833 shares of common stock (the “Conversion Ratio”). The holders of shares of the Series B Preferred Stock shall be entitled to receive dividends out of any assets legally available, to the extent permitted by Nevada law, at an annual rate equal to 8% of the Series B Liquidation Value of such shares of Series B Preferred Stock, and shall accrue from the date of issuance of such shares of Series B Preferred Stock, payable quarterly in common stock valued at the closing trade price per share on the last trading day of the calendar quarter. The Series B shareholders have agreed to defer dividend rights until the Company earns sufficient revenues.
The holders of Series B Preferred Stock rank senior to the Company’s common stock and Series A preferred Stock and will vote together with the holders of the Company’s common stock on an as-converted basis on each matter submitted to a vote of holders of common stock (whether at a meeting of shareholders or by written consent). In any such vote, the number of votes that may be cast by a holder shall be equal to one (1) vote for each share of common stock into which such holder’s outstanding shares of Series B Preferred Stock may be converted. Each holder shall be entitled to notice of all shareholder meetings (or requests for written consent) in accordance with the Company’s bylaws. As a result of the issuance of the Series B Preferred Stock, there was a change in control of the Company as of the date of consummation of the Merger
On March 5, 2019, Chad Fischl, acquired control of 51 shares of the Series A Preferred Stock of the Company, representing 100% of the Company’s total issued and outstanding Series A Preferred Stock, from TCA Share Holdings, LLC a Limited Liability Company, in exchange for agreeing to become the President, Chief Executive Officer (CEO) and a Director.
The common stockholders of GRSO before the Merger (“Predecessor”) retained 92,497,617 shares of common stock, par value $0.001 per share. Upon the effectiveness of the Merger, the holders of the Predecessor’s Series A Preferred Stock tendered all 51 shares of the issued and outstanding Series A Preferred Stock to Chad Fischl. The Series A Preferred Stock has voting rights such that the 51 shares equated to 96,268,926 voting shares which represented 51% of the common voting rights, therefore the tender of the Series A Preferred Stock pursuant to the Merger, coupled with the issuance of the Series B Preferred Stock provides for the Chad Fischl to have had majority control over the Company as of the date of consummation of the Merger.
On March 5, 2019, in connection with the Chief Financial Officer Resignation, the Board appointed Mr. Wayne Hansen as Chief Financial Officer, effective March 5, 2019, and as a Director of the Company. Mr. Hansen resigned from both roles on November 15, 2019.
The Merger is being accounted for as a “Reverse Business Combination,” and PRH is deemed to be the accounting acquirer in the merger. Consequently, the assets and liabilities and the historical operations that will be reflected in the financial statements prior to the Merger will be those of PRH, and the consolidated financial statements after completion of the Merger will include the assets and liabilities of GRSO, historical operations of PRH and combined operations of PRH and GRSO from the Closing Date of the Merger.
The Merger will be treated as a recapitalization of the Company for financial accounting purposes. The historical financial statements of GRSO before the Merger will be replaced with the historical financial statements of PRH before the Merger in all future filings.
As PRH was a start-up venture, there were no operations, and no asset or liabilities; consequentially no comparative balance sheet, statement of operations, statement of changes in stockholder deficit or statement of cash flows is presented for the prior period. The financial condition and operating results of the combined entities since March 5, 2019, are included in the condensed consolidated financial statements for the Years ended September 30, 2019.
The Company’s new businesses are based on design, development, manufacture, sales and distribution of licensed technologically advanced systems for organic and other agricultural products farming “AeroPods”. The AeroPod offers a high efficiency grow solution having scalable, secure and low carbon footprint characteristics. The new business commenced operations during the year ended December 31, 2019.
On November 16, 2020, Chad Fischl resigned as CEO and Board member. Phil Sands was appointed CEO and Board member.
Note 2 — Going Concern and Management’s Plan
The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. For the year ended December 31, 2020, the Company has incurred a net loss of $1,409,753. The working capital deficit, stockholders’ deficit and accumulated deficit was $8,712,557, $8,712,557, and $16,111,910, respectively, at December 31, 2020. The Company has received a default notice on its payment obligations under the senior secured credit facility agreement (see Note 4), defaulted on its other pre-merger debt and has received demands for payment of past due amounts from creditors, consultants and service providers. It is management’s opinion that these matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. The ability of the Company to continue as a going concern is dependent upon management’s ability to implement a new business plan, raise additional capital as needed from the sales of stock or debt or find a partner to merge with. The Company has been implementing cost containment measures and restructuring or setting up payment plans with vendors and is working to restructure its secured obligations. The accompanying consolidated financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.
Note 3 — Summary of Significant Accounting Policies Basis of presentation
The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Pure Roots Holding Corp. All significant intercompany accounts and transactions have been eliminated in consolidation.
COVID-19 Pandemic
The COVID-19 pandemic had a significant adverse impact on the Company’s business, results of operations, financial condition and cash flows from operations during the year ended December 31, 2020 and is expected to continue to have an adverse impact on its performance in 2021.
Given the uncertainties surrounding the ongoing effects of the COVID-19 pandemic on the Company’s future financial condition and results of operations, the Company took certain actions to preserve its liquidity and strengthen its financial flexibility. The Company took certain actions starting in March 2020, some of which are ongoing, to (i) reduce payroll costs, through temporary furloughs, salary and incentive compensation reductions, decreased working hours and hiring freezes, as well as taking advantage of COVID-related government programs in international jurisdictions, (ii) eliminate or reduce expenses in all discretionary spending categories, (iii) reduce working capital, and (iv) reduce capital expenditures.
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Use of estimates and assumptions
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the allowance for bad debt on accounts receivable, reserves on inventory, valuation of goodwill and intangible assets for impairment analysis, valuation of the legal settlement reserve, valuation of stock-based compensation, the valuation of derivative liabilities and the valuation allowance on deferred tax assets.
Concentration of credit risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal and/or Canadian depository insurance coverage of $250,000 and CDN$100,000, respectively. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2020, the Company had cash of $80. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash deposits. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”) and/or Canadian Depository Insurance Corporation (“CDIC”).
Debt Discount and Debt Issuance Costs
Debt discounts and debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense based on the related debt agreements using the straight-line method. Unamortized discounts are netted against the related debt instruments.
Convertible Notes with Fixed Rate Conversion Options
The Company may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the note date with a charge to interest expense in accordance with ASC 480 - “Distinguishing Liabilities from Equity”.
Derivative Liabilities
The Company has certain financial instruments that are derivatives or contain embedded derivatives. The Company evaluates all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 810-10-05-4 and 815-40. This accounting treatment requires that the carrying amount of any derivatives be recorded at fair value at issuance and marked-to-market at each balance sheet date. In the event that the fair value is recorded as a liability, as is the case with the Company, the change in the fair value during the period is recorded as either other income or expense. Upon conversion, exercise or repayment, the respective derivative liability is marked to fair value at the conversion, repayment or exercise date and then the related fair value amount is reclassified to other income or expense as part of gain or loss on extinguishment.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.
The Company adopted Section 815-40-15 of the FASB ASC (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions.
The Company utilizes a binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The Company records the change in the fair value of the derivative as other income or expense in the consolidated statements of operations.
Revenue Recognition
Effective October 1, 2018, the predecessor company adopted Accounting Standards Codification (“ASC”) 606, Revenue From Contracts With Customers, which is effective for public business entities with annual reporting periods beginning after December 15, 2017. This new revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied. The Company’s initial application of ASC 606 did not have a material impact on its financial statements and disclosures and there was no cumulative effect of the adoption of ASC 606.
The Company sells consumer products through distributors to retail establishments. The purchase orders received specifies each item sold, the Company only needs to fulfill the performance obligation by shipment of specified items. Allowances for returns and discounts are recognized periodically. No other performance obligations exist under the terms of the contracts. The Company recognizes revenue for the agreed upon sales price when the products are shipped to the customer, which satisfies the performance obligation.
The Company sells aerogrow pods, and related products manufactured by contracted third parties to various parties. The Company also offers technical services related to use of the aerogrow pods. Contracts sales of aerogrow pods, related products and services will be evaluated using the five-step process outline above. There have been no sales of aerogrow pods, related products and services during the years ended December 31, 2020. Upon significant sales for such products and services, the Company will disaggregate sales by the lines of business to the extent that the product or service has different revenue recognition characteristics.
Stock-based compensation
Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation “, which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. The Company utilizes the Black-Sholes option pricing model and uses the simplified method to determine expected term because of lack of sufficient exercise history. Additionally, effective October 1, 2016, the Company adopted the Accounting Standards Update No. 2016-09 (“ASU 2016-09”), Improvements to Employee Share-Based Payment Accounting. Among other changes, ASU 2016-09 permits the election of an accounting policy for forfeitures of share-based payment awards, either to recognize forfeitures as they occur or estimate forfeitures over the vesting period of the award. The Company has elected to recognize forfeitures as they occur, and the cumulative impact of this change did not have any effect on the Company’s consolidated financial statements and related disclosures.
Loss Per Share
Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, which is the case for the years ended December 31, 2020 and 2019 presented in these consolidated financial statements, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. Excluding the principal amount of $1,737,233 from the 3(a)(10) settlement, convertible note principal and accrued interest outstanding at December 31, 2020, totaled $2,671,954. Based on the conversion terms of the aforementioned notes, the Company had 2,370,001,445, potentially dilutive shares as of December 31, 2020. Under the settlement obligation there are 2,241,590,968 shares issuable to Livingston Asset Management under the 3(a)(10) settlement which will be further reduced following receipt of creditor payment information as shares already held by Livingston or sold and awaiting funds disposition at brokers.
The Company had the following common stock equivalents at December 31, 2020 and December 31, 2019:
| | December 31, 2020 | | December 31, 2019 |
Convertible notes payable | | | 2,370,001,445 | | | | 3,243,266,774 | |
Settlement obligation under 3(a)(10) | | | 2,241,590,968 | | | | — | |
Options (expired May 25, 2020) | | | — | | | | 475,000 | |
Warrants | | | — | | | | 166,756 | |
Totals | | | 4,611,592,413 | | | | 3,243,908,530 | |
Income Taxes
The Company accounts for income taxes under ASC Topic 740 “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements.
The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.
Foreign Currency Translation
The Company follows Section 830-10-45 of the FASB Accounting Standards Codification (“Section 830-10-45”) for foreign currency translation to translate the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity’s functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash.
The functional currency of each foreign subsidiary is determined based on management’s judgment and involves consideration of all relevant economic facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions, including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency upon the parent and the nature of the subsidiary’s operations must also be considered. If a subsidiary’s functional currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary’s financial statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S. Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional currency would be included in the condensed consolidated statements of income and comprehensive income (loss). If the Company disposes of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the condensed consolidated statements of income and comprehensive income (loss). If the Company determines that there has been a change in the functional currency of a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the statement of income and comprehensive income (loss).
Based on an assessment of the factors discussed above, the management of the Company determined its subsidiary’s local currency (i.e. the Canadian dollar) to be the functional currency for its foreign subsidiary.
Subsequent events
The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company has evaluated events that occurred subsequent to December 31, 2020 and through the date the financial statements were issued.
Recent Accounting Pronouncements
In December 2019, the FASB issued authoritative guidance intended to simplify the accounting for income taxes (ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”). This guidance eliminates certain exceptions to the general approach to the income tax accounting model and adds new guidance to reduce the complexity in accounting for income taxes. This guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within those annual periods. The Company is currently evaluating the potential impact of this guidance on its consolidated financial statements.
In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivative and Hedging (Topic 815), which clarifies the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. The guidance clarifies how to account for the transition into and out of the equity method of accounting when considering observable transactions under the measurement alternative. The ASU is effective for annual reporting periods beginning after December 15, 2020, including interim reporting periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on our consolidated financial statements.
In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity’s own equity, and also improves and amends the related EPS guidance for both Subtopics. The ASU will be effective for annual reporting periods after December 15, 2021 and interim periods within those annual periods and early adoption is permitted. The Company is currently evaluating the impact of the new guidance on our consolidated financial statements.
Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements.
Note 4 – Settlement Reserves
The settlement reserve balance of $958,245, as of December 31, 2020, includes an estimate for default penalties under the terms of convertible notes payable issued by the predecessor company prior to December 31, 2018. Also included are other accrued expenses and the principal amount of $98,835, recorded by the predecessor company for the balance of amortizing notes. On June 2, 2020, $154,515 was reclassified to 3(a)(10) settlement as discussed in footnote 5 below. Additionally, $59,645 was credited to the settlement reserve.
Note 5 — Convertible notes
Since February 2019, the Company has been working with advisors and creditors to restructure outstanding debt issued prior to December 31, 2018, including amounts outstanding with L2 among other creditors. Management believes that amounts recorded as debt and settlement reserves related to notes are adequate to cover the expected settlements.
All convertible notes issued before March 2019, were reevaluated in light of ASC 480, which allows for treating certain convertible notes as stock settled debt. This treatment does not require the bifurcation of the embedded derivative, nor does it require a periodic revaluation of the fair market values. So long as the discount to the share price used for conversion remains constant a premium is calculated and charged to interest expense at the issuance date of the note and recognized as a liability which is added to note face amount net of any original issue discounts (OID). The derivative liability for each qualifying note was reclassified as put premium and allocated to each note based on the note conversion stock price discount.
Refer to the table at the end of the section of this note covering notes issued prior to December 2018 for current balance of principal, accrued interest and put premiums.
Senior Debt – TCA and L2
Effective December 7, 2015, the Company closed a Credit Agreement (the “Credit Agreement”) by and among the Company, as borrower, Grow Solutions, Inc. and One Love Garden Supply LLC as joint and several guarantors (such guarantors, collectively, the “Subsidiaries” and together with the Company, the “Borrowers”) and TCA Global Credit Master Fund, LP, a Cayman Islands limited partnership, as lender (“TCA”). Pursuant to the Credit Agreement, TCA agreed to loan the Company up to a maximum of $3,000,000 for the Company’s product division, construction and renovation of two stores, and inventory. An initial amount of $950,000 was funded by TCA at the closing of the Credit Agreement. Any increase in the amount extended to the Borrowers shall be at the discretion of TCA.
The amounts borrowed pursuant to the Credit Agreement are evidenced by a Revolving Note (the “Revolving Note”) and the repayment of the Revolving Note is secured by a first position security interest in substantially all of the Company’s assets in favor of TCA, as evidenced by a Security Agreement by and between the Company and TCA (the “Company Security Agreement”) and a first position security interest in substantially all of the Subsidiaries’ assets in favor of TCA, as evidenced by a Security Agreement by and among the Subsidiaries and TCA (the “Subsidiaries Security Agreement” and, together with the Company Security Agreement, the “Security Agreements”). The Revolving Note, in the original principal amount of $950,000, was due and payable, along with interest thereon, on June 7, 2017 (the “Maturity Date”), and bears interest at the rate of 18% per annum. Upon the occurrence of an Event of Default (as defined in the Credit Agreement) the interest rate shall increase to the Default Rate (as defined in the Credit Agreement).
Upon the occurrence of an Event of Default or mutual agreement between TCA and the Company, at the sole option of TCA, TCA may convert all or any portion of the outstanding principal, accrued and unpaid interest, and any other sums due and payable under the Revolving Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest daily volume weighted average price of the Company’s common stock during the five trading days immediately prior to such applicable conversion date, in each case subject to TCA not being able to beneficially own more than 4.99% of the Company’s outstanding common stock upon any conversion.
Amendment of TCA Credit Agreement
On February 14, 2017, the Company entered into a First Amendment to Credit Agreement (the “Amended Agreement”) by and between the Company and TCA. Pursuant to the Amended Agreement, the Original Note was severed, split, divided and apportioned into two separate and distinct replacement notes consisting of (i) First Replacement Note A, evidencing principal indebtedness of $325,000, and (ii) First Replacement Note B evidencing the reduced outstanding balance of principal indebtedness of $876,441.25 (collectively, First Replacement Note A and First Replacement Note B, the “Replacement Notes”). The Replacement Notes replaced and superseded the Original Note in its entirety by substituting one evidence of debt for another without extinguishing the indebtedness and obligations evidenced under the Original Note.
On March 23, 2017, a second note for $300,000 was assigned by TCA to L2. Leaving a principal balance due to TCA note of $576,441. TCA capitalized the interest and penalties leaving a new principal balance of $729,874.
On October 13, 2017, TCA notified the Company that there was a continuing and uncured default for non-payment.
On February 21, 2018, final results of an auction for the Company’s inventory and other assets were reported to the beneficial owner of those assets. The auctioned assets were pledged to TCA under various loan documents dated December 7, 2015. The proceeds of $141,364 less expenses were remitted to the State of Colorado for sales tax due ($100,734) and to TCA ($17,824).
On September 13, 2019, TCA entered into a settlement agreement and stipulation, whereby TCA executed a Claims Purchase Agreement with Livingston Asset Management LLC granting Livingston the right to settle the liability for $729,874, in payments following the court’s approval of the 3(a)(10) settlement contemplated.
Debt Purchase Agreement
On February 15, 2017 (the “Effective Date”), the Company entered into a Debt Purchase Agreement (the “Debt Purchase Agreement”) by and among the Company, TCA, and L2 Capital, LLC, a Kansas limited liability company (the “Assignee”). Pursuant to the Debt Purchase Agreement, on the Effective Date, TCA sold and assigned to Assignee, TCA’s right, title and interest in and to the monetary obligations evidenced under Replacement Note A thereby reducing the TCA outstanding principal indebtedness. Assignee shall subsequently purchase from TCA the remaining debt evidenced by First Replacement Note B in purchase tranches. The indebtedness underlying the Replacement Notes are evidenced by a newly issued 10% Senior Replacement Convertible Promissory Note.
Total assignments to L2 were $600,000 before the arrangement was terminated.
Issuance of 10% Senior Replacement Convertible Promissory Note
On February 15, 2017, the Company issued a 10% Senior Replacement Convertible Promissory Note (the “L2 Note”) to the Assignee in the principal amount of $1,201,441.25. The initial principal amount under the L2 Note is $325,000, representing the first tranche purchased by Assignee under First Replacement Note A and such amounts shall increase in tranches upon the purchase of such tranches by the Assignee from TCA pursuant to the Debt Purchase Agreement. The maturity date for each tranche shall be Nine months from that date of the purchase of that tranche and the Company shall pay interest to the Assignee on the aggregate unconverted and then outstanding principal amount of the L2 Note at the rate of 10% per annum.
The L2 Note is convertible at any time, in whole or in part, at the option of the holder into shares of common stock of the Company at a conversion price equal to 62.5% of the lowest closing bid price of the common stock in the prior twenty (20) trading days, which is subject to adjustment for stock dividends, stock splits, combinations or similar events.
Additionally, the terms under the L2 Note include make-whole rights whereby upon liquidation by the Assignee of the shares converted under the L2 Note, provided that the Assignee realizes a net amount from such liquidation equal to less than the conversion amount specified in the relevant conversion notice (such net realized amount, the “Realized Amount”), the Company shall issue to the Assignee additional shares, as defined.
The first tranche of $325,000 was fully converted in prior periods.
On March 23, 2017, the Company issued a second tranche note to L2 (L2-2) for $300,000.
Private Placement - Debt Offering 2016
During the year ended December 31, 2016, the Company entered into an agreement for the issuance of convertible notes to third party lenders for aggregate proceeds of $1,117,000. The notes accrue interest at 12% per annum maturing two years from issuance. The notes are convertible into shares of common stock at a conversion price of $0.80. These notes were analyzed, and no derivative liability has been recognized due to the fixed conversion price. One investor has assigned $277,788, of their note to third parties and the assigned notes were restated as described below under note changes. The total balance under the 2016 Debt Offering was $854,212, and $839,212, at December 31, 2020 and December 31, 2019, respectively.
Debt Issued During the Year Ended December 31, 2016
On December 15, 2016, the Company entered into an agreement for the issuance of a convertible note to a third-party lender for $285,775 with an original issue discount of $37,275. The note accrues interest at 8% per annum and matured on December 15, 2017. The notes are convertible into shares of common stock at a conversion price equal to approximately 58% of the average of the lowest 3 trading prices for the common stock during the 20-day trading period ending on the latest and complete trading day prior to the conversion. Notwithstanding the foregoing, the minimum conversion price under the Note is $0.20 (the “Floor Price”), provided that, at any time following 180 days from the Issuance Date, if the closing price of the common stock of the Company is equal to or less than the Floor Price for two consecutive trading days, the Floor Price will extinguish and be of no further force or effect. In connection with the issuance of this Note, the Company determined that the terms of the Note contain a conversion formula that caused variations in the conversion price resulting in the treatment of the conversion option as a bifurcated derivative to be accounted for at fair value. The initial derivative liability was determined to be $286,583, since the issuance of the note periodic changes in fair market value resulted in a derivative liability balance of $222,411, which was reclassified to put premium in conjunction with the note restructuring on July 14, 2017. Debt discounts of $202,783 were fully recognized as interest expense upon note restructure.
Carebourn Capital Debt Refinancing
On July 14, 2017 (the “Effective Date”), the Company and the Purchaser Agreed to cancel the Purchase Agreement, the Note and the related transaction documents and refinanced the original loan by the Company’s issuance of a Convertible Promissory Note dated the Effective Date (the “Note”). The principal amount of the Note is $262,877.42, the Purchase Price is $228,589.06, and the Company received $50,000 in proceeds from the Purchaser. The Maturity Date of the Note was July 14, 2018. The balance of the December 15, 2016 note was rolled into the new note for a total note payable balance of $262,877 and original debt discount of $34,288 was recorded and was fully recognized as interest expense as during prior periods due to the termination of former operations.
The Note terms remain the same as the original note above. The note conversion terms satisfy the conditions for treatment as stock settled debt in accordance with ASC 480, as such a put premium of $190,360 has been recorded and is included in convertible notes payable with a reclassification adjustment to derivative liabilities. The note balance at December 31, 2020 and December 31, 2019, was $262,877.
The JSJ Investments Inc. Debt Financing
On January 30, 2017 (the “Issuance Date”), the Company issued a 10% Convertible Promissory Note (the “JSJ Note”) in the principal amount of $100,000 in favor of JSJ Investments Inc. (“JSJ”). On or about January 30, 2017, the Company received $98,000 in net proceeds after deducting fees and expenses.
The JSJ Note bears interest at a rate of 10% per annum on the aggregate unconverted outstanding principal, subject to increase according to the terms and conditions of the JSJ Note. The JSJ Note is convertible in whole or in part, at the option of JSJ into shares of common stock of the Company at a conversion price equal to 60% of the lowest closing bid price of the common stock in the prior ten (10) trading days, which is subject to adjustment for stock dividends, stock splits, combinations or similar events.
Under the terms and conditions of the JSJ Note, the Company and JSJ agreed to enter into a mutually agreed upon Leak-Out Agreement whereby JSJ shall not sell more than the greater of (i) 20% of the trading volume per week or (ii) $20,000 in shares of common stock per week. The note was partially converted during the years ended December 31, 2020 and the balance at December 31, 2020 and December 31, 2019, was $79,000 and $100,000, respectively.
The Cicero Consulting Group, Inc. Debt Financing
On February 8, 2017 (the “Issuance Date”), the Company, entered into a Securities Purchase Agreement with Cicero Consulting Group, LLC (“Cicero”) pursuant to which the Company sold $50,000 in principal amount of a Convertible Promissory Note (the “Cicero Note”), of which the Company received.
The Cicero Note bears interest at a rate of 12% per annum on the outstanding principal, subject to increase according to the terms and conditions of the Cicero Note. The Cicero Note is convertible at any time from the Issuance Date, in whole or in part, at the option of Cicero into shares of common stock of the Company at a conversion price equal to 70% of the lowest closing bid price of the common stock in the prior five (5) trading days, which is subject to adjustment for stock dividends, stock splits, combinations or similar events. The note was partially converted during the years ended December 31, 2020 and the balance at December 31, 2020 and December 31, 2019, was $23,000 and $50,000, respectively.
Note issued for past due legal fees
On October 26, 2017, the Company issued a convertible note payable to Lucosky Brookman LLP for $378,461. The note was issued for unpaid legal services. The note has 8% annual interest and matured on October 26, 2018. The note has a default interest rate of 18%. The note and accrued interest can be converted into common stock at 60% of the average lowest 3 trading prices in the 10 trading days prior to conversion. In accordance with ASC 480, the Company is treating the note conversion feature as stock settled debt and a put premium of $252,307, has been recorded. The note principal was charged to accounts payable and settlement reserve. On September 13, 2019, the note holder executed a Claim Purchase Agreement for the amounts owed ($426,694) to Livingston Asset Management LLC which was approved for inclusion in the 3(a)(10) settlement approved by the court (as discussed below).
Promissory Note
On May 25, 2017 (the (“Issuance Date”), the Company, issued a Promissory Note to Brandi Blank (an individual investor) in the principal amount of $100,000 (the “note”). The Company received $100,000 in net proceeds from the sale of the note. The note is due on demand 180 days from the Issuance Date (the “Maturity Date”). Payment by the Company to Lender under the terms of the note may be made in either cash or common stock of the Company, at the option of the Lender. In the event the Company repays the note in common stock, such common stock will be issued at a price equal to the closing price of the Company’s common stock on the Maturity Date (the “Conversion Price”). The note bears interest at a rate of fifteen percent (15%) per annum, to be accrued through the Maturity Date. Interest may be paid in cash or common stock of the Company at the option of the Lender on the Maturity Date at the Conversion Price. Additionally, the Company will issue the Lender shares of common stock in an amount equal to thirty three percent (33%) of the outstanding balance of principal and interest under the note within 10 days of the issuance date. The obligation to issue stock was treated as a warrant for 494,012 shares of stock with an exercise price of $.0668, having a fair market value of $19,530 which was credited to additional paid in capital with a corresponding charge to debt discount and subsequently charged to interest expense due to the termination of operations during the year ended December 31, 2017. Subsequent changes to fair market value will be recognized on each reporting date. The value of the warrant was remeasured on December 31, 2020 and was not material for adjustment.
Below is summary of notes with conversion features issued prior to December 31, 2018, and are currently in default:
Name of Note holder | | Original Note Amount | | Principal | | Put Premium | | Accrued Interest |
| | | | December 31, 2020 | | December 31, 2020 | | December 31, 2020 |
L2 | | $ | 625,000 | | | | 170,670 | | | | 120,755 | | | | 65,789 | |
Carebourn | | $ | 262,877 | | | | 262,877 | | | | 190,360 | | | | 48,091 | |
JSJ | | $ | 100,000 | | | | 79,000 | | | | 52,667 | | | | 64,592 | |
Cicero | | $ | 50,000 | | | | 23,000 | | | | 9,857 | | | | 38,514 | |
Blank | | $ | 100,000 | | | | 100,000 | | | | — | | | | 50,303 | |
2016 Debt Offering | | $ | 1,117,000 | | | | 839,212 | | | | — | | | | 441,941 | |
Total Principal and Premium | | | | | | | | | | $ | 1,848,398 | | | | | |
Total Interest Accrued | | | | | | | | | | | | | | $ | 709,230 | |
The notes listed above have current principal following conversions and restructuring that totals $1,474,759, and related put premiums (as calculated by the Company) of $373,639. The Company believes that claims for default penalties may arise in future periods and has taken those contingent liabilities into consideration in establishing settlement reserves as discussed at Note 4.
Pre-merger notes (see table above): | | December 31, 2020 | | December 31, 2019 |
Principal | | | 1,474,759 | | | $ | 1,590,850 | |
Put premiums on stock settled debt | | | 373,639 | | | | 399,211 | |
Total pre-merger notes, net | | | 1,848,398 | | | | 1,990,061 | |
Post-merger (see descriptions below): | | | | | | | | |
Principal new issues | | | 331,644 | | | | 340,644 | |
Put premiums on stock settled debt | | | 55,372 | | | | 22,645 | |
Debt discount (OID and derivative liabilities) | | | (560 | ) | | | (152,359 | ) |
Assigned and restated notes | | | — | | | | 52,250 | |
Debt under 3(a)(10) settlement | | | 1,722,233 | | | | 1,506,568 | |
Put premium for 3(a)(10) liability | | | 1,722,233 | | | | 1,506,568 | |
Total post-merger notes, net | | | 3,860,921 | | | | 3,276,316 | |
Total convertible notes, net | | $ | 5,679,320 | | | $ | 5,266,377 | |
Issuance of New Convertible Notes
On March 7, 2019, the Company issued a convertible note payable to Trillium Partners LP for $55,000. The note has $5,000 original issue discount (OID), 10% annual interest and matured on March 31, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated at issuance to be $155,868, of which $105,868 was charged to derivative expense and $50,000 to debt discount. Debt discount along with OID is amortized to interest expense over the term of the note and was fully amortized during the years ended December 31, 2020. On June 2, 2020 the principal balance of $55,000, accrued interest of $8,634 and the related derivative liability of $67,019, were reclassified as 3(a)(10) settled liabilities as discussed below.
On March 12, 2019, the Company issued a convertible note payable to Ralph Aiello for $55,000. The note has $5,000 original issue discount (OID), 10% annual interest and matured on March 31, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated at issuance to be $175,012, of which $125,012 was charged to derivative expense and $50,000 to debt discount. Debt discount along with OID is amortized to interest expense over the term of the note. At December 31, 2020, the derivative liability decreased to $69,557. OID and debt discount were fully amortized and the principal balance was $55,000.
On March 29, 2019, the Company issued a convertible note payable to Oscaleta Partners LLC for $12,500. The note has $2,117 original issue discount (OID), 12% annual interest and matured on March 31, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated at issuance to be $49,903, of which $39,520 was charged to derivative expense and $10,383 to debt discount. Debt discount along with OID is amortized to interest expense over the term of the note. OID and debt discount were fully amortized at December 31, 2020. The principal balance was $12,500, accrued interest of $2,334 along with the related derivative liability of $15,808, were reclassified as 3(a)(10) settled liabilities as discussed below.
On June 6, 2019, the Company issued a convertible note payable to Ralph Aiello for $35,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on June 5, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $63,182, with $33,182 charged to derivative expense and $30,000 charged to debt discount. The fair market value decreased to $47,014 as of December 31, 2020. The principal balance was $35,000 at December 31, 2020.
On June 21, 2019, the Company issued a convertible note payable to Ralph Aiello for $35,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on June 5, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $62,648, with $32,648 charged to derivative expense and $30,000 charged to debt discount. The fair market value decreased to $49,193 at December 31, 2020 and the principal balance was $35,000.
On July 15, 2019, the Company issued a convertible note payable to Ralph Aiello for $35,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on July 14, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $98,917 with $68,917 charged to derivative expense and $30,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $35,024 as of December 31, 2020 and the principal balance was $35,000.
On August 27, 2019, the Company issued a convertible note payable to Ralph Aiello for $30,000. The note has: $5,000 original issue discount (OID, 10% annual interest and matured on August 26, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $59,834 with $34,834 charged to derivative expense and $25,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $41,018 as of December 31, 2020 and the principal balance was $30,000.
On October 9, 2019, the Company issued a convertible note payable to Ralph Aiello for $27,500. The note has: $2,500 original issue discount (OID, 10% annual interest and matured on October 8, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $63,795 with $38,795, charged to derivative expense and $25,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $30,034 as of December 31, 2020 and the principal balance was $27,500.
On November 27, 2019, the Company issued a convertible note payable to Ralph Aiello for $33,000. The note has: $3,000 original issue discount (OID, 10% annual interest and matures on November 30, 2020. The interest rate rises to 24% if unpaid after the maturity date. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50% of the lowest closing bid price in the 20 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $65,792 with $35,792, charged to derivative expense and $30,000 to debt discount to be amortized to interest expense over the life of the note. The derivative liability is revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The fair market value decreased to $30,035 as of December 31, 2020 and the principal balance was $33,000.
On November 13, 2019, the Company issued a convertible note payable to Livingston Asset Management LLC (LAM) for $5,000. The LAM paid expenses of $4,864 for the Company and an additional $136 was charged as OID. The note bears interest at 12%, and matured on May 12, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50%, of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $7,239, with $5,000 charged to debt discount to be amortized over the life of the note and $2,239 was charged to derivative expense. The derivative liability will be revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The derivative liability balance decreased to $6,335 and the principal was unconverted at December 31, 2020.
On January 30, 2020, the Company issued a convertible note payable to Trillium LP for $30,000. The Company received $25,000, in cash and an additional $1,500 was paid by Trillium directly to a third party on behalf of the Company. The note has $3,500, original issue discount (OID, 12% annual interest and matured on July 31, 2020. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50%, of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value of $71,510, with $26,500 charged to debt discount to be amortized over the life of the note and $41,010 was charged to derivative expense. The derivative liability will be revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The Company repaid $25,000 during the years ended December 31, 2020. As a result of the repayment the Company recognized a gain on debt extinguishment of $56,810. The fair market value decreased to $7,342 during the period.
On June 4, 2020, the Company issued a convertible note payable to Carebourn Capital in exchange for $40,000 in cash. The note has 8% interest and matures on June 1, 2021. The note can be converted into the Company’s common stock at a discount equal to 55% of the average of the three lowest trading prices during the twenty days prior to the conversion. Due to the fixed percentage discount the conversion feature is treated as stock settled debt under ASC 480. Accordingly, a put premium was calculated to be $32.727 and was charged to interest expense on the date the note was effective.
On August 4, 2020, the Company issued a convertible note payable to Trillium LP for $8,500. Trillium paid expenses of $8,032 for the Company and an additional $468 was charged as OID. The note bears interest at 12%, and matures on May 12, 2021. The OID will be amortized to interest expense over the life of the note. The note and accrued interest can be converted into common stock and at the lower of: $.01 or 50%, of the lowest closing bid price in the 30 trading days prior to conversion. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $911, which was charged to debt discount to be amortized over the life of the note. The derivative liability will be revalued to fair market value each reporting date and the change is recognized in fair market value changes on the statement of operations. The derivative liability balance decreased by an immaterial amount and remains at $911 and the principal was unconverted at December 31, 2020.
Note Assignments
On October 3, 2019, Ralph Aiello, sold and assigned $45,288, of principal and $3,104, of accrued interest for the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $89,712. Tri-Bridge Ventures LLC acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at 50% of the lowest trading price on the day prior to the conversion notice. In accordance with ASC 480, the Company is treating the note conversion feature as stock settled debt and a put premium of $48,392, has been recorded and charged to interest expense during the year ended December 31, 2019. The note was fully converted to shares of common stock and the put premium was reclassified to additional paid in capital as of December 31, 2019.
On October 7, 2019, Ralph Aiello, sold and assigned $30,000 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $59,712. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $52,066 with a corresponding charge to derivative expense. During the year ended December 31, 2019, the related fair market value net changes of $12,348 were credited to fair market value changes, leaving a derivative liability of $39,718 The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $39,718 was recognized as gain on extinguishment of debt.
On April 1, 2020, Ralph Aiello, sold and assigned $7,500 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $52,212. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $16,667 with a corresponding charge to derivative expense. The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $16,667 was recognized as gain on extinguishment of debt.
On June 1, 2020, Ralph Aiello, sold and assigned $15,000 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $37,212. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $37,500 with a corresponding charge to derivative expense. The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $37,500 was recognized as gain on extinguishment of debt.
On July 1, 2020, Ralph Aiello, sold and assigned $15,000 principal and accrued interest from the April 16, 2016 convertible note for $300,000 held, bringing a principal balance of $22,212. Trillium Partners LP acquired the principal and accrued interest and the note was restated. The note conversion terms state the principal and interest accrued can be converted into common stock at the lower of: $.01 or 50% of the lowest closing bid during the 20 trading days preceding the conversion notice. Due to the variable conversion pricing feature the note is considered to include a derivative for which a fair market value was calculated to be $15,819 with a corresponding charge to derivative expense. The note was fully converted during the years ended December 31, 2020 and derivative liability balance of $15,819 was recognized as gain on extinguishment of debt.
Court Approved Settlement of Various Liabilities Under SEC section 3(a)(10)
On September 13, 2019 the Company entered into a settlement agreement and stipulation (“Settlement Agreement”) with Livingston Asset Management, LLC (“LAM”) in connection with the settlement of $3,998,152 of bona fide obligations the Company owed to certain of its creditors. The Settlement Agreement was subject to fairness hearing, and on November 15, 2019 a Federal court in the District of Maryland held a fairness hearing and granted approval of the Settlement Agreement. If the Settlement Agreement is satisfied in full, the Company shall reduce the Company’s debt obligations equal to $1,506,568 in exchange for the issuance of settlement shares of Company’s common stock pursuant to the terms of section 3(a)(10) of the Securities Act of 1933, in multiple tranches, at a price equal to the lowest closing bid price for the common stock for the twenty trading days immediately preceding the delivery of such tranche. At no time may LAM beneficially own more than 9.99% of the Company’s outstanding common stock.
The 3(a)(10) settlement includes the following liabilities:
TCA senior note and capitalized interest - $729,874;
Otis claims for amounts due for services provided (reclassified from settlement reserve) - $350,000; and
Attorney fees (note for $378,461 and $48,233 in fees and accrued interest) - $426,694.
Included in the convertible notes balance sheet amount is $1,457,307, classified as principal and $1,457,306, of put premium related to the 3(a)(10) settlement at March 31, 2020. The amounts covered in the settlement were reclassified from convertible notes payable, accrued interest and accounts payable, along with related put premiums related to the original notes payable. Additionally, included in the put premium above was $1,110,446, which was reclassified from settlement reserves to put premium related to the liabilities transferred to the 3(a)(10) settlement liability amount.
On December 23, 2019 the Company entered into a settlement agreement and stipulation (“Settlement Agreement”) with Livingston Asset Management, LLC (“LAM”) in connection with the settlement of $342,199 of bona fide obligations the Company owed to certain of its creditors. The Settlement Agreement was subject to fairness hearing, and on June 2, 2020 a Federal court in the District of Maryland held a fairness hearing and granted approval of the Settlement Agreement. If the Settlement Agreement is satisfied in full, the Company shall reduce the Company’s debt obligations equal to $342,199 in exchange for the issuance of settlement shares of Company’s common stock pursuant to the terms of section 3(a)(10) of the Securities Act of 1933, in multiple tranches, at a price equal to the lowest closing bid price for the common stock for the twenty trading days immediately preceding the delivery of such tranche. At no time may LAM beneficially own more than 9.99% of the Company’s outstanding common stock.
The 3(a)(10) settlement includes the following liabilities:
Trillium convertible note and capitalized interest - $82,590;
Oscaleta Partners LLC convertible note and capitalized interest - $19,059;
Victor Wexler’s claims as guarantor on liabilities arising from the Company’s purchases of inventory and he Company’s written agreement to indemnify Mr. Wexler against such claims by third parties - $154,515; and
Attorney fees (current securities counsel) - $79,500.
The settlement including the stock issue price discount qualifies as stock settled debt under ASC 480. Included in the convertible notes balance sheet amount is $335,665, classified as principal and $335,664, of put premium related to the 3(a)(10) settlement at December 31, 2020. The amounts covered in the settlement were reclassified from settlement reserves, convertible notes payable, accrued interest and accrued other expenses, along with related derivative liabilities related to the original notes payable. A gain realized upon the effective date of the 3(a)(10) settlement was not recognized as it was credited to settlement reserves.
As of December 31, 2020, $151,940, has been remitted to former creditors, reducing the aggregate 3(a)(10) obligation to $1,722,233 and the related put premium was $1,722,233.
Note 6 — Derivative Liabilities
During the year ended December 31, 2018, the Company reevaluated the note agreements and determined that all of the conversion features meet the standard for classification of those features as stock settled debt in accordance with ASC 480 – Distinguishing Liabilities from Equity, whereby a put premium is calculated using the stock price discount and recorded as a liability fully recognized as interest expense on the date the issued. The Company has recognized the put premiums as calculated by reclassifying the derivative liabilities and fully amortizing the corresponding debt discounts into interest expense.
During the year ended December 31, 2019, ten new notes were issued and one note was partially assigned to third parties and the conversion terms were restated. All of these notes contain conversion terms which are variable and therefore the notes include embedded derivatives that must be valued a fair market and revalued as of each subsequent reporting date. During the years ended December 31, 2020, three new notes was issued one of which has variable and the conversion terms was treated as an embedded derivative.
Level 3 Financial Liabilities – Derivative convertible note and warrant liabilities
The following are the major categories of assets and liabilities that were measured at fair value during the three months ended December 31, 2020 using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3):
| | At December 31, 2020 | | At December 31, 2019 |
Description | | Level 1 | | Level 2 | | Level 3 | | Level 1 | | Level 2 | | Level 3 |
Warrant | | | — | | | | — | | | $ | — | | | | — | | | | — | | | $ | — | |
Embedded conversion feature | | | — | | | | — | | | | 324,143 | | | | — | | | | — | | | | 576,030 | |
Derivative Liability | | | — | | | | — | | | | 324,143 | | | | — | | | | — | | | | 576,030 | |
| | Derivative Liabilities |
Balance at December 31, 2019 | | $ | 576,030 | |
| | | | |
Charged to derivative expense on assignment and restatement of note | | | 69,986 | |
Charged to derivative expense on issuance of note | | | 47,249 | |
Classified as debt discount on issuance of note | | | 32,411 | |
Reclassified as 3(a)(10) liability under settlement (see note 5) | | | (82,827 | ) |
Reduction of derivative recorded as gain on extinguishment upon conversions or reclassified to additional paid in capital | | | (193,140 | ) |
Fair Value adjustments - convertible note | | | (125,566 | ) |
Balance at December 31, 2020 | | $ | 324,143 | |
The fair value of the embedded conversion feature of the convertible notes on the balance sheet date were calculated using a binomial option model valued with the following weighted average assumptions:
| | December 31, 2020 | | December 31, 2019 |
Risk free interest rate | | | 1.77 | % | | | 2.00 | % |
Dividend yield | | | — | | | | — | |
Expected volatility | | | 215 | % | | | 278 | % |
Remaining term | | | .25 - 1 year | | | | .74 year | |
Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.
Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.
Volatility: The Company calculates the expected volatility of the stock price based on the corresponding volatility of the Company’s peer group stock price for a period consistent with the underlying instrument’s expected term.
Remaining term: The Company’s remaining term is based on the remaining contractual maturity of the instruments.
During the years ended December 31, 2020, the Company marked the derivative feature of the warrants and the embedded conversion features to fair value and recorded gains of $125,566, relating to the change in fair value.
Note 7 — Stockholders’ Deficit
Series A Preferred Stock
The Company is authorized to issue 25,000,000 shares of preferred stock, $.001 par value, with such rights, preferences, variations and such other designations for each class or series within a class as determined by the Board of Directors. The preferred stock is not convertible into common stock, does not contain any cumulative voting privileges, and does not have any preemptive rights. 51 shares of preferred stock have been designated as Series A Preferred Stock and issued to an entity controlled by the CEO and the Company’s Board of Directors. The following describes the Series A Preferred Stock designation:
Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of common stock of the Company eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) – (0.019607 x 5,000,000) = 102,036).
On May 25, 2017 fifty-one (51) shares of Series A Preferred Stock were issued to Grow Solutions Holdings, LLC, a Colorado limited liability company (the “LLC”) controlled equally by each member of the Board of Directors of the Company (the “Board”).
The Series A Preferred Stock has no dividend rights, no liquidation rights and no redemption rights, and was created primarily to be able to obtain a quorum and conduct business at shareholder meetings. All shares of the Series A Preferred Stock shall rank (i) senior to the Company’s common stock and any other class or series of capital stock of the Company hereafter created, (ii) pari passu with any class or series of capital stock of the Company hereafter created and specifically ranking, by its terms, on par with the Series A Preferred Stock and (iii) junior to any class or series of capital stock of the Company hereafter created specifically ranking, by its terms, senior to the Series A Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary.
On or about November 2, 2017, TCA instructed the escrow agent (under the pledge agreement) to deliver to TCA the pledged securities (i.e., 51 Series A Preferred shares). Grow Solutions Holdings, LLC the owner of the pledged securities executed an assignment of the securities in favor of TCA’s nominee, thereby granting TCA the majority voting rights. TCA installed Gerard Danos as Interim President and appointed Jacquelyn Gogin and Alyce Schreiber as members of the board of directors of the Company.
On April 13, 2018, TCA filed SEC Form 3, stating it had voting control of 51% of the outstanding common shares of the Company’s stock, through its beneficial ownership of 51 shares of the Series A Preferred stock.
On March 5, 2019, Chad Fischl, acquired control of 51 shares of the Series A Preferred Stock of the Company, representing 100% of the Company’s total issued and outstanding Series A Preferred Stock, from TCA Share Holdings, LLC a Limited Liability Company, in exchange for agreeing to become the President, and Chief Executive Officer. (See Note 10)
Series B Preferred Stock
On March 5, 2019, the Secretary of State of the State of Nevada delivered confirmation of the effective filing of the Company’s Certificate of Amendment to its Certificate of Incorporation (the “ Amendment to Certificate “), which established 100,000 shares of the Company’s Series B Preferred Stock, having such designations, rights and preferences as set forth therein, as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Certificate of Incorporation and bylaws.
The shares of Series B Preferred Stock, par value of $0.001 and have a liquidation value of $1,000 per share (the “Series B Liquidation Value”) and are convertible into 2,833 shares of common stock (the “Conversion Ratio”), subject to a limitation per beneficial owner of 9.9% of the outstanding common shares. The holders of shares of the Series B Preferred Stock shall be entitled to receive dividends out of any assets legally available, to the extent permitted by Nevada law, at an annual rate equal to 8% of the Series B Liquidation Value of such shares of Series B Preferred Stock, and shall accrue from the date of issuance of such shares of Series B Preferred Stock, payable quarterly in common stock valued at the closing trade price per share on the last trading day of the calendar quarter.
The holders of Series B Preferred Stock rank senior to the Company’s common stock and Series A preferred Stock and will vote together with the holders of the Company’s common stock on an as-converted basis on each matter submitted to a vote of holders of common stock (whether at a meeting of shareholders or by written consent). In any such vote, the number of votes that may be cast by a holder shall be equal to one (1) vote for each share of common stock into which such holder’s outstanding shares of Series B Preferred Stock may be converted. Each holder shall be entitled to notice of all shareholder meetings (or requests for written consent) in accordance with the Company’s bylaws.
On March 11, 2019, the shareholders of PRH, acquired control of 85,000 shares of the Series B Preferred Stock of the Company, representing 85% of the Company’s total issued and outstanding Series B Preferred Stock, in exchange for 100% of the issued and outstanding shares of PRH, per the terms of a Securities Exchange Agreement by and between the Company and PRH. The Series B Preferred shareholders have mutually agreed to defer dividends through December 31, 2020.
The Company issued Series B Preferred Shares to the following individuals in the amounts indicated:
Chad Fischl, CEO of the Company, - 4,746 Series B Preferred Shares;
Bailey Fischl - 4,746 Series B Preferred Shares;
Clara Fischl - 9,421 Series B Preferred Shares;
Carla Blampin - 9,421 Series B Preferred Shares;
Sharon Branconnier - 9,420 Series B Preferred Shares;
Jolene Branconnier - 9,421 Series B Preferred Shares;
Norman James Payton - 9,421 Series B Preferred Shares;
Ismail Abdul Fattah - 7,084 Series B Preferred Shares;
Ahmad Abdel Latif Yassine - 7,083 Series B Preferred Shares;
Adrian LaChance - 9,887 Series B Preferred Shares;
Emily LaChance - 2,175 Series B Preferred Shares; and
Carly LaChance - 2,175 Series B Preferred Shares.
On May 31, 2019, the Company issued 15,000 shares of Series B Preferred restricted shares at par value to Trillium Partners, LP for services.
Common Stock
The Company is authorized to issue 10,000,000,000 common shares with a par value of $0.001 per share. The Nevada Secretary of State approved the increase on July 15, 2020. As of December 31, 2020, and December 31, 2019, there were 1,875,799,430 and 330,666,887, shares of common stock issued and outstanding, respectively.
Regulation A Offering
On October 29, 2019, the Company filed Form 1-A to register an offering of its common stock. The final amendment was filed on January 9, 2020, increasing the total number of shares offered to 2,000,000,000 at a price per share of $0.0015 in order to raise up to $3,000,000 in capital for the Company. The offering became qualified by the Securities Exchange Commission, on February 20, 2020, with the filing of the Notification of Qualification.
.On July 29, 2020 a final post-effective amendment to the offering statement made effective on February 20, 2020. The amendment increased the number of shares offered to 6,000,000,000 and changed the offering price to $.0005. The post-effective amendment was qualified on August 6, 2020.
Subscriptions of Common Shares
During the years ended December 31, 2020, Trillium Partners, LP, was issued a total of 121,666,665, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on February 20, 2020, the shares were issued under the terms of subscription agreements at the contracted price of $.0015, in exchange for a total of $182,500, in cash payments.
Other Common Stock Issuances
Common Stock Issued for Conversion of Notes Payable
Between January 1, 2020 and December 31, 2020, the Company issued 856,515,878, shares of its common stock in conversion of convertible notes payable as follows:
Carebourn Capital, LP was issued 148,000,000 common shares of the Company’s stock at the contracted price of $.00012 and $.0005, in exchange for $56,530, of accrued interest on its July 14, 2017, convertible note.
Cicero Consulting Group, LLC was issued 22,689,076, common shares of the Company’s stock at the contracted price of $.00119, in exchange for $27,000, principal of its February 8, 2017, convertible note.
JSJ Investments Inc. was issued 28,000,000, common shares of the Company’s stock at the contracted prices of $.00066 to $.0016, in exchange for $21,000, principal of its January 30, 2017, convertible note.
Oasis Capital, LLC was issued 247,478,000 common shares of the Company’s stock at the contracted prices of $.00015, $.0002 and $.0004, in exchange for $74,091, of accrued interest on its March 23, 2017, convertible note (assigned to Oasis by L2).
Trillium Partners, LP was issued 410,348,802, common shares of the Company’s stock at the contracted prices of $.0002 to $.00065, in exchange for $67,500, of principal, $47,760, of accrued interest and $11,275, of conversion fees on the notes received from Ralph Aiello from assignments. The liability under the assigned notes was fully liquidated through the conversion.
Shares Issued under 3(a)(10)
During the years ended December 31, 2020, 566,950,000, shares of common stock had been issued to Livingston Asset Management LLC under the 3(a)(10) arrangement. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On January 2, 2020, the Company issued 17,079,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On January 10, 2020, the Company issued 16,522,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On January 21, 2020, the Company issued 13,140,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On January 30, 2020, the Company issued 17,900,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On April 23, 2020, the Company issued 30,870,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On April 29, 2020, the Company issued 23,908,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On April 30, 2020, the Company issued 55,903,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On May 14, 2020, the Company issued 17,947,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On May 20, 2020, the Company issued 68,163,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On June 17, 2020, the Company issued 120,386,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares were issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On July 9, 2020, the Company issued 89,384,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares will be issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
On July 24, 2020, the Company issued 95,748,000 shares of common stock to Livingston Asset Management LLC under the terms of the 3(a)(10) court ordered settlement of related liabilities. The shares will be issued at par with an offset to additional paid in capital until sold and proceeds are remitted to the creditors.
Payment of 3(a)(10) Settlement
As of December 31, 2020, $105,000, had been remitted to former creditors and additional payments were pending under the 3(a)(10) settlement. The Company recognized $105,000 as reduction of the 3(a)(10) liability and $105,000 as liquidated put premiums with an offset to additional paid in capital.
Options
No options were granted during the years ended December 31, 2020.
The following is a summary of the Company’s option activity during the period from January 1, 2020 to December 31, 2020:
| | Number of Options | | Weighted- Average Exercise Price | | Weighted- Average Remaining Contractual Term (Years) | | Weighted- Average Grant-Date Fair Value | | Aggregate Intrinsic Value |
Outstanding and exercisable January 1, 2020 | | | 475,000 | | | $ | 0.40 | | | | 1.40 | | | $ | .40 | | | $ | — | |
Expired during the years ended December 31, 2020 | | | (475,000 | ) | | | | | | | | | | | | | | | | |
Outstanding and exercisable December 31, 2020 | | | — | | | | — | | | | — | | | | — | | | | — | |
The Company fully recognized the aggregate grant date fair market value of $486,865 during the year granted, in compensation expense for the stock options, therefore no accretion of residual life value of the options will be recognized in future years, unless more options are granted. The options expired May 25, 2020.
Note 8 — Related Party Transactions
The Company subleases office and development facilities at cost one of its subsidiaries. The terms are month to month until the Company fully occupies the planned space. The currently monthly payments are $2,700.
The Company has a shared service agreement in place, whereby the former CEO and executive officers of the Company and two related party companies are paid through Pure Roots Holding, Corp. a wholly-owned subsidiary of the Company.
During the year ended December 31, 2019 the Company entered into employment contracts with the CEO and the President of one of the operating divisions. The former CEO owns 100% of the outstanding Preferred Series A shares and 9.4% of the Preferred Series B shares and the President of the operating division owns 4.7% of the outstanding Preferred Series B shares.
Specifically, the officers are entitled to:
CEO – will receive a $7,500, monthly cash compensation payment.
For the year ended December 31, 2019, the total stock compensation for the officers amounted to approximately $322,000. Unpaid salary has been fully accrued as of December 31, 2019. The bonuses (total of $180,000) and stock compensation (total of $187,000) portions of the agreements were amended to be contingent on achievement of specific sales goals in 2020. As of December 31, 2020, the established sales goals have not been achieved. (See Note 10)
Note 9 – Income Taxes
The difference between the expected income tax expense (benefit) and the actual tax expense (benefit) computed by using the Federal statutory rate of 21% is as follows:
| | 2020 | | 2019 |
Expected income tax benefit at statutory rate of 21% | | $ | 296,000 | | | $ | 266,696 | |
Expected state tax benefit at statutory rate | | | — | | | | — | |
Change in valuation allowance | | | (296,000 | ) | | | (266,696 | ) |
Income tax expense (benefit) | | $ | — | | | $ | — | |
At December 31, 2020 the deferred tax valuation allowance increased by $296,000. The realization of the tax benefits is subject to the sufficiency of taxable income in future years. The deferred tax assets represent the amounts expected to be realized before expiration. The Company periodically assesses the likelihood that it will be able to recover its deferred tax assets. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing prudent and feasible profits.
Deferred tax assets and liabilities are provided for significant income and expense items recognized in different years for tax and financial reporting purposes. Temporary differences, which give rise to a net deferred tax asset, are as follows:
Deferred tax assets: | | 2020 | | 2019 |
Tax benefit of net operating loss carry-forward | | $ | 3,330,337 | | | $ | 3,034,337 | |
Less: valuation allowance | | | (3,330,337 | ) | | | (3,034,337 | ) |
Net deferred tax asset | | $ | — | | | $ | — | |
Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $12,868,000 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.
For the years ended December 31, 2020 and 2019, no amounts have been recognized for uncertain tax positions and no amounts have been recognized related to interest or penalties related to uncertain tax positions. The Company has determined that it is not reasonably likely for the amounts of unrecognized tax benefits to significantly increase or decrease within the next twelve months. The Company is currently subject to a three-year statute of limitations by major tax jurisdictions.
Note 10 — Commitments and Contingencies
Settlement Agreement- Consulting Agreement Termination
On or about January 6, 2017, the Company terminated the Consulting Agreement with Cimarron Capital Ltd., a Nevada corporation controlled by Peter Aiello Sr. (“Cimarron”) pursuant to that certain Consulting Agreement by and between the Company and Cimarron, dated January 1, 2015 (the “Cimarron Termination”).
In connection with the Cimarron Termination, the Company and Cimarron entered into a Settlement and Release Agreement dated February 28, 2017 (the “Cimarron Settlement Agreement”). Under the Cimarron Settlement Agreement, the Company and Cimarron agreed to a mutual release of all claims in connection with the Cimarron Consulting Agreement and the Cimarron Termination for payment by the Company to Cimarron in the amount of $5,000 per month for a period of 14 months. Additionally, Cimarron agreed to certain lockup and leak-out provisions with respect to the sale of its shares of common stock of the Company. The Company has not made timely payments in accordance with the Settlement Agreement. The Company has recognized the liability of $70,000 in the settlement reserves.
Ralph Aiello Complaint and Settlement Agreement
The Company was involved in litigation against Ralph Aiello (the “Plaintiff” and together with the Company, the “Parties”). On January 19, 2017, the Plaintiff filed a complaint in the Supreme Court of the State of New York County of Nassau (the “Court”), alleging claims including breach of contract in connection with certain loans made by Plaintiff to the Company in the amount of $500,000 plus interest (the “Dispute”). On March 15, 2017, the Parties filed a Settlement Agreement (the “Settlement Agreement”) with the Court whereby the Company agreed to pay the Defendant $550,000 by September 15, 2018. The Company has not made timely payments in accordance with the Settlement Agreement. The Company is working to establish a payment plan for the Plaintiff and expedite the settlement of the Dispute. The Plaintiff has sold and assigned $277,788, of the notes in dispute as of December 31, 2020, and an additional $222,212, principal remains recognized on the balance sheet under convertible notes payable plus accrued interest.
Settlement - Summary Judgement in Favor of Vendor and Advisor/Investor
On October 5, 2018, Sunlight Supply, Inc. presented a motion seeking summary judgement for $219,104, representing unpaid product invoices, interest accrued between October 11, 2017 and October 26, 2018, and attorneys’ fees against One Love Garden Supply, LLC and an individual guarantor. On January 11, 2019, the court granted summary judgement in the favor of the plaintiff. The guarantor has settled the judgement in favor of the creditor in conjunction with the Company’s participation in the 3(a)(10) court approved settlement that includes payment to the guarantor for amounts owed to him by the Company. (See note 5)
On June 3, 2019, the Company entered into a settlement agreement with an individual and affiliated unincorporated entity for a maximum amount of $350,000. The individuals and the affiliated entities separately provided personal guarantees on certain liabilities of the Company and provided advisory services. The liability has been incorporated in the 3(a)(10) settlement as discussed in note 5.
Settlement Agreement- Chad Fischl
On November 16, 2020, the Company entered into a Settlement Agreement (“Agreement”) with its former CEO; wherein, it has agreed to pay a portion of the back wages to Mr. Fischl, as well as working out agreements with the former employees of the Company. The Agreement states that the Company will pay back wages of approximately $175,000 (CDN) to the employees, $211,776 (CDN) to Chad Fischl and Bailey Fischl (“Fischl Amount”), and that the Company assumes any liability for any unpaid taxes, in as much as is legally possible. The Agreement authorizes the Company to make 15 monthly payments of $14,118.40 (CDN) or until the Fischl Amount has been paid in full. In return Mr. Fischl agrees to return his Series A Preferred shares and Series B Preferred Shares (the “Shares”) that he and his family members’ control. The Company also agrees to $10,000 liquidated damages for any payment that is more than three days late, with each late payment also then accruing interest at a rate of 10% per annum on any payments that are not made, until they are paid in full with the then outstanding interest. The Agreement states that the Shares will not be returned until the entire Fischl Amount is paid. As of this filing no payments have been made on the Agreement. The full amount owed has been recorded in accounts payable and accrued expenses at December 31, 2020.
Operating Lease
The Company subleases facilities on a month-to-month basis. The agreement requires monthly payments of $2,700.
Litigation
In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance.
Except as disclosed below, the Company is unaware of any action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our Company’s subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.
Bronstein Complaint and Settlement Agreement
The Company was involved in litigation against Tal Bronstein, Kathleen Bronstein, and Milehigh Wholesale Inc. (the “Plaintiffs” and together with the Company, the “Parties”). On May 4, 2017, the Plaintiffs filed a complaint in the District Court, City and County of Denver (the “Court”), alleging claims including breach of contract in connection with the acquisition of Milehigh Wholesale Inc. and the employment of Mr. Bronstein in connection with such acquisition (the “Dispute”). On or about June 14, 2017, the Parties entered into a settlement agreement and release of all claims whereby upon payment by the Company of $16,000 to Plaintiffs by July 14, 2017, Plaintiffs would dismiss with prejudice their claims against the Company and release the Company from any and all claims, known or unknown, on conditions of such payment. On June 23, 2017, counsel for the Plaintiffs filed with the Court a Notice of Settlement with respect to the Dispute. On June 27, 2017, the Court ordered that the Parties file a Stipulated Dismissal within 35 days of the Order (August 1, 2017).
On or about July 10, 2017, the Company notified the Plaintiffs that it would not be able to pay the $16,000 by July 14, 2017 and renegotiated the Settlement Agreement and Release of All Claims (the “Agreement”) as follows: (i) on or before July 14, 2017, Company shall deliver to the office of Plaintiffs’ counsel a Certified check in the amount of $5,000 (ii) on or before August 14, 2017, Company shall deliver to the office of Plaintiffs’ counsel a certified check in the amount of $13,500 (iii) the parties intend that the total amount paid from Company to Plaintiffs will be $18,500 (iv) if Company fail to pay the $13,500 by August 14, 2017, they will pay $100 per day thereafter as an additional penalty payment for each and every day that the $13,500 is not paid until the full amount of $13,500 is paid, or until August 31, 2017 (v) no later than July 17, 2017, Counsel for the Parties will file an unopposed Motion to Extend the time by which they have to file the Stipulated Motion to Dismiss to and including August 31, 2017 (vi) if the Company fails to pay the $13,500 by August 31, 2017, they agree that Plaintiffs may then seek a default judgment to enter against the Company in the amount of $21,700, without decrease for the $5,000 expected to be paid on or before July 14, 2017. Further, all attorney fees and costs of collection thereafter shall be paid for by Company. The Company has fully recognized the liability of $21,700 in the settlement reserve as of December 31, 2020.
Alessi Complaint and Dismissal
The Company was involved in litigation against William Alessi (“Alessi”). On February 15, 2017, Alessi filed a complaint in the General Court of Justice, Superior Court Division, State of North Carolina, County of Mecklenburg (the “Court”), alleging claims including breach of contract or unjust enrichment (the “Dispute”). On July 12, 2017, the Honorable Jeff Hunt presiding over the matter issued an order in favor of the Company dismissing Alessi’s action with prejudice due to the Court’s lack of jurisdiction and further stating that the proper forum for all claims in connection with the Dispute is an American Arbitration Association proceeding. As of December 31, 2020, no further communication had been received from Mr. Alessi or his representatives.
Settlement Reserves
The Company has provided reserves covering the contingencies included in this footnote. Management reviews claims as asserted and may increase or decrease the amounts reserved periodically. Based on information known as of December 31, 2020, the Company believes the settlement reserves presented in the balance sheet are adequate in all material respects.
Contingent Consulting Fees
The Company entered into consultation agreements with Sanclair Holdings Corp and Omni Data Capital Corp. for financial advisory, marketing, sales, manufacturing service procurement and logistics on March 5, 2019. The agreements as amended provide for compensation at monthly rates of CDN 30,000 (Sanclair) and CDN 25,000 (Omni) payable upon achievement of specified sales and other results. During the year ended December 31, 2019, the specified results were not achieved, however the Company has potential liabilities of approximately $487,500, provided the benchmark results are achieved during future periods. The specified sales and other results have not been achieved as of December 31, 2020.
Note 11 — Subsequent Events
Appointment to Board
As of February 5, 2021, Chad Fischl reaccepted and was reappointed as a Director of the Company.
Common Stock Issued Under Regulation A Offering
Between January 19, and February 9, 2021, the Company issued 228,124,884 shares of common stock to an investor at $.0005 per share for total proceeds of $114,063.
Common Stock Issued – Conversions of Convertible Notes Payable
On January 28, 2021, the Company issued 91,445,139 shares of common stock to Carebourn Capital, in settlement of $42,065 of accrued interest on convertible notes.
Between January 13 and April 30, 2021, the Company issued 140,000,000 shares of common stock in settlement of $78,750 of principal and accrued interest related to the February 16, 2017 replacement convertible note first issued to L2 and subsequently assigned to Oasis Capital, LLC.
Between February 28, and March 24, 2021, the Company issued 200,754,209 shares of common stock to Carebourn Capital, in settlement of $150,281 of accrued interest on convertible notes.
Issuance of Convertible Notes Payable
On March 17, 2021, the Company issued a 0% interest rate convertible promissory note in the principal amount of $53,000 in favor of Carebourn Capital, L.P. The note matures on March 17, 2022 and is convertible into shares of common stock of the Company at a conversion price equal to 55% of the lowest closing bid price in the prior twenty-five (25) trading days, The note will be treated as stock settled debt in accordance with ASC 480.
The Company evaluated subsequent events after the balance sheet date through the date the financial statements were issued. The Company did not identify any additional material events or transactions occurring during this subsequent event reporting period that required further recognition or disclosure in these financials
SIGNATURES
Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this Offering Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Saskatoon, Saskatchewan, Canada on June 21, 2021.
(Exact name of issuer as specified in its charter): | Grow Solutions Holdings, Inc. |
| |
This Offering Statement has been signed by the following persons in the capacities and on the dates indicated.
By: | /s/ Philip Sands | |
| Philip Sands, Chief Executive Officer (Principal Executive Officer). | |
(Date): June 21, 2021 | |
| /s/ Philip Sands | |
| Philip Sands, Chief Financial Officer (Principal Financial Officer, Principal Accounting Officer). | |
| | |
(Date): June 21, 2021 | |
SIGNATURES OF DIRECTORS: | | |
| | |
/s/ Philip Sands | | June 21, 2021 |
Philip Sands, Director | | Date |
PART III—EXHIBITS
Index to Exhibits
Number | Exhibit Description |
| |
1 | Opinion and Consent of Law Office of Matheau J. W. Stout |
2.1 | Articles of Incorporation |
2.2 | Bylaws |
3.1 | Specimen Stock Certificate |
3.2 | Subscription Agreement |
6.1 | Employment Agreement by and between the Company and Chad Fischl, dated March 5, 2019 |
6.2 | Convertible Promissory Note by and between the Company and Ralph Aiello, dated March 12, 2019 |
6.3 | Convertible Promissory Note by and between the Company and Oscaleta Partners, LLC, dated March 29, 2019 |
6.4 | Convertible Promissory Note by and between the Company and Ralph Aiello, dated June 6, 2019 |
6.5 | Convertible Promissory Note by and between the Company and Ralph Aiello, dated May 21, 2021 |
6.6 | Convertible Promissory Note by and between the Company and Ralph Aiello, dated August 26, 2019 |
6.7 | Convertible Promissory Note by and between the Company and Ralph Aiello, dated October 9, 2019 |
6.8 | Manufacturing and License Agreement by and between the Company and FarmBoys Design Corp, dated February 2019 |